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ABSTRACT
To study the nucleotide reduction system in Archaea, we have expressed the
Archaeoglobus fulgidus gene encoding the adenosylcobalamin (AdoCbl) dependent
ribonucleotide reductase (afuRNR) protein. Initial characterization of the recombinant
afuRNR indicates that it reduces CDP to dCDP in an AdoCbl dependent manner. One
astonishing finding is the capacity of afuRNR to reduce both diphosphate and
triphosphate nucleosides to their respective deoxynucleosides. This is the first instance of
a RNR displaying dual substrate selectivity.
Our investigation of redox regulation focused on thioredoxin reductase (TrR) and
thioredoxin (Tr). In addition to providing the reducing equivalents for many RNRs, TrRs
are involved in maintaining the intracellular redox environment. This process typically
involves the transfer of electrons from NADPH to Trs. Here the characterization of a
putative TrR (Ta0984) and Tr (Ta0866) from Thermoplasma acidophilum are presented.
To explore the apparent inability of taTrR to use NADPH or NADH as a reductant, we
carried out a complete electrochemical characterization, which ruled out redox potential
as the source of this non-reactivity. A 2.35 A resolution structure of taTrR, also
presented here, shows that despite the overall structural similarity to the well-
characterized TrR from E. coli, the "NADPH binding pocket" is not conserved. E. coli
TrR residues implicated in NADPH binding, H175, R176, R177, and R181 have been
substituted with E185, M186, Y187, and M191 in the ta protein. Thus, we have
identified a Tr and TrR protein system from T. acidophilum for which the TrR shares
overall structural and redox properties with other TrRs, but lacks the appropriate binding
motif to use the standard NADPH reductant. Our discovery of a TrR that does not use
NADPH provides a new twist in redox regulation.
Further, four A. fulgidus genes encoding four Trs (afuTr 1, afuTr 2, afuTr 3, and
afuTr 4) proteins have been identified and their proteins expressed. Electrochemical
characterization via protein-film voltammetry shows that the afuTrs reduction potentials
are -32 mV for afuTr 1, -301 mV for afuTr 2, -287 mV for afuTr 3, and -309 mV for
afuTr 4. This set of reduction potentials found in this Archaeon represents the greatest
range in a specific organism.
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INTRODUCTION
Nucleotide reduction and redox regulation are essential cellular processes. DNA
synthesis depends on a balanced supply of deoxynucleotides pools (1, 2). Loss of
deoxynucleotide equilibrium increases mutation rates in DNA replication and can lead to
cell death (3). Redox regulation in the cell is also intimately tied to cell survival. The
cytoplasm of the cell is generally a reducing environment due to the high concentration of
reductarits such as the NADPH dependent thioredoxin reductase (TrR) / thioredoxin (Tr)
system. -Cellular metabolism and integrity are maintained by carefully balancing the
redox state of all components for optimal overall function.
While nucleotide reduction and redox regulation are key processes in all
organisms, this thesis focuses on ribonucleotide reductases, thioredoxin reductases, and
thioredoxins from archaea. Archaea are the most obscure of life's three domains. The
members of this domain were first differentiated from bacteria based on rRNA sequence
patterns. The first archaea were isolated from high temperature, high salinity, and acidity
environments. Because of their ability to grow in such inhospitable environments, it has
been postulated that they contain vestiges of the first biochemical pathways. Recently,
with the advent of genomic sequencing, the secrets held in their genomes have been
revealed, yielding a trove of biological and evolutionary information. One surprising
observation has been how many of the features contained therein are specific to archaea.
Due to their extreme environmental growth conditions, there is interest in
elucidating the manner in which archaea have evolved to cope with, and maintain cellular
integrity. Two underlying questions are (1) how do archaea preserve genomic integrity;
(2) what mechanisms are used to regulate and maintain the redox environment inside the
cell?
This introduction chapter will (1) provide a brief introduction to the classes of
RNRs, (2) discuss the accepted regulation, (3) substrate preference, (4) and reaction
mechanism of RNR, (5) give an overview of RNR structures, (6) discuss the role of the
TrR / Tr system as a hydrogen donor to RNRs; (7) introduce the reader to features of
archaea; and (8) finish with the discussion of the current knowledge of RNR / TrR / Tr
systems in archaea.
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RIBONUCLEOTIDE REDUCTASES
Ribonucleotide reductases (RNRs) are enzymes that are present in all living
organisms. These enzymes catalyze the reduction of nucleotides to deoxynucleotides at
the 2' ribose site thus providing the building blocks for the synthesis and repair of DNA.
Activation and regulation of RNRs assures the maintenance of the proper ratios of
deoxynucleotides in the cell. Imbalances in deoxynucleotide levels increase mutagenesis
and are detrimental to the cell (Recently reviewed in (4-6).
The reaction carried out by RNRs is of interest to many fields of research.
Evolutionary biologists are drawn to the enzyme because of its proposed principal role in
the transformation from an RNA-based world to a DNA-based world (7-9). The
exquisite allosteric control of RNRs, which allow these enzymes to catalyze the reduction
of four unique substrates all in one active site amazes enzymologists, whereas the
similarity of the core structural elements between the seemingly unrelated amino acid
sequences of RNRs enthralls structural biochemists (10). Epidemiologists are interested
in these enzymes because of the possibility they hold for the development of unique
system-specific inhibitors of cancer, and organism-based diseases such as malaria and
tuberculosis (11-13).
RNRs need a hydrogen donor to re-reduce the disulfide bond of the active site
cystine to two thiols, the latter of which contribute reducing equivalents in the synthesis
of deoxynucleotides. Class I and class II RNRs contain a C-terminal CxxC motif, referred
to as the c-terminal tail, which 'swings' into the active site barrel and reduces the
oxidized active site cystine during every round of catalysis. In turn, the c-terminal tail
disulfide is reduced by thioredoxin for the next round of catalysis. Regeneration of Tr is
mediate using by TrR and NADPH. The thioredoxin reductase (TrR) and thioredoxin
(Tr) system from E. coli was the first system isolated as a hydrogen donor for RNRs, and
to date, this is the best characterized TrR / Tr system(14, 15).
CLASSES OF RIBONUCLEOTIDE REDUCTASES
Currently, RNRs are classified into three different classes (7) characterized by the
cofactor that initiates activation of the thiyl radical in the active site (Scheme 1.1 and
Table 1.1). The three RNR classes are reviewed below:
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Class I RNRs - The di-iron tyrosyl radical class I RNR prototype was first
isolated and characterized in the early 1960s from E. coli (16). Humans and higher order
organisms also contain a class I RNR. These enzymes are oligomers with the form
(a 2 12)n. In E. coli the a2 dimer is designated RI and is the catalytic portion of the
molecule, whereas the P2 dimer is designated R2 and is responsible for the radical
generation. The R2 monomer contains a ji-oxo-bridged diferric cluster and a tyrosine
(Y122) and generates a stable tyrosine radical. During catalysis, the radical species is
transferred over 35 A to the active site in the RI dimer (17, 18). Class I R1 structure
from E. coli was solved in 1994 (19), whereas a class I R2 structure from E. coli was
solved in 1990 (20) (Figure 1.1). To date, no structure of a R1R2 complex from class I
exists.
Class II RNRs - Studies with the organism L. leichmannii yielded the first
adenosylcobalamin-dependent RNR (RTPR) (21-24). Class II RNRs can be found in
bacteria, archaea, and one eukaryote. In this class, AdoCbl is the radical-generating
cofactor (24). The ability to use a small molecule to initiate the active site radical instead
of a separate. protein sets class II RNRs apart from the other classes. A class II
monomeric and a dimeric structure have been solved (10, 25) (Figure 1.2).
Class III RNRs - Class III RNRs were discovered in E. coli grown under
anaerobic conditions in 1989 (26) and have been found in all anaerobic organisms to
date: Class III RNRs are a 2 dimers, which are activated by a P activase protein that
contains an 4Fe-4S cluster and utilizes S-adenosylmethionine (AdoMet) to generate a
glycyl radical located on the catalytic subunit (27-30). A class III a2 structure from
bacteriophage T4 was recently solved (Figure 1.3) (31).
ALLOSTERIC REGULATION OF RIBONUCLEOTIDE REDUCTASES
A unique feature of RNRs is that one enzyme catalyzes the reduction of all four
nucleotides to their corresponding deoxynucleotides and that this substrate specificity is
regulated by the binding of deoxynucleoside triphosphates allosteric effectors to a distal
site.
Early work on E. coli RNR identified two allosteric sites in the R1 subunit that
regulate activity at the active site (see Scheme 1.2) (32). These sites have been identified
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as the activity site and the specificity site. The activity site is found at the N-terminus of
the class Ia RNRs and binds either ATP or dATP, with ATP stimulating overall activity
and dATP inhibiting catalytic activity (32). The specificity site, which is common to
class Ia and class Ib RNRs, binds dGTP, dTTP, dATP, and ATP (32). Binding of dGTP
stimulates the reduction of ADP to dADP, binding of dTTP induces the reduction of GDP
to dGDP, and finally binding of ATP or dATP to the specificity site promotes the
reduction of CDP or UDP to dCDP and dUDP (Scheme 1.3).
Subsequent work with Salmonella typhimurium lead to the isolation of a second
class I RNR, which differs from the classic RNR in that it is missing the N-terminus
amino acids comprising the nucleotide binding domain involved in regulating the overall
activity of class I RNRs (described above) (33). The S. typhimurium and E. coli class I
RNRs differ only in this respect. These observations lead to the separation of these
enzymes into class Ia for the originally isolated RNR and class Ib for the subsequently
isolated RNR. There is also a recently discovered class Ib RNR that uses a Fe-Mn
cofactor for radical generation (34).
The class II RNRs display a similar relationship between the binding of effectors
at the specifity site and the reduction of substrates at the activity site (35). No operational
activity site has been reported for a class II RNR.
Class III RNRs show similar effector-dependent substrate specificity as class Ia
RNRs. Early experiments suggested two separate allosteric binding sites, but these sites
exhibited slightly different specificity than the E. coli class Ia RNR. Class III RNR
effector binding experiments show that these RNRs can bind two dATP molecules and
only one ATP molecule (36). Also, unlike class Ia RNRs, when dATP binds to either
allosteric binding site, overall activity is inhibited. These sites have been called the
purine and pyrimidine binding sites. When ATP binds the pyrimidine site, the enzyme
reduces pyrimidines, and when dGTP or dTTP bind the purine site, the enzyme reduces
ATP and GTP (31, 36).
SUBSTRATE PREFERENCE FOR NDP VERSUS NTP
All class I and most class II RNRs use NDPs as substrates and class III RNRs use
NTPs as substrates. RTPR and two other class II RNRs, the RNR from the cyanobacteria
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Anabaena sp. Strain PCC7120 and the RNR from the eukaryote Euglena gracilis, are the
only characterized class II enzymes that use NTPs as substrates (21, 37, 38). The class
III RNRs use NTPs as substrates.
The structural source for this preference is not understood. Superposition of the
RTPR and T. maritima active site barrels do not reveal obvious structural differences that
would explain the substrate preference (please see discussion in Chapter 2 for more
detail).
MECHANISM OF THE RIBONUCLEOTIDE REACTION
Mechanistic studies performed by Professor JoAnne Stubbe's laboratory on E.
coli and L. leichmannii RNRs suggested that these seemingly distantly related enzymes
utilized the same catalytic mechanism (Scheme 1.4) (39). Recent structural work
confirmed that even though there is little conserved amino acid homology between the
classes of RNRs; there are highly conserved structural features that regulate specificity
and activity of RNRs (10, 19).
Although generated by different cofactors, once the radical is initiated, the
reduction of nucleotides proceeds in a similar manner for all RNRs (Scheme 1.4, Step 1).
The first step of the reaction is the abstraction of a hydrogen atom from the 3" position of
the substrate (2). The 2' hydroxyl group is protonated by one of the redox active
cysteines on the protein (3), followed by the loss of water, creating a radical-cation
intermediate (4). The radical-cation intermediate undergoes a two step one electron
reduction by the redox active cysteines, allowing the formation of the deoxy-2' carbon of
the pentose ring and the formation of a disulfide on the active site cysteines (5). This step
is followed by the return of the initial hydrogen to the 3' position and the regeneration of
the thiyl radical located on the finger loop (40).
STRUCTURES OF RIBONUCLEOTIDE REDUCTASES
There are structures of the E. coli apo RNR and the RNR complexed with an
effector and a substrate (Fig 1.1) (19, 41). The major difference in the crystallization
conditions between the two structures is that in the apo form, the active site cysteines
were oxidized, but in the complexed structure, they were fully reduced. The authors
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suggest that the in order for substrate to bind, the cysteines in the active site need to be
reduced (41). However, this statement contradicts the biochemical data. Although the
structure provided the first glimpse of the location of effector and substrate binding, it
does not explain the allosteric regulation of the specificity site and of active site.
The recent structure of RTPR gave a glimpse of how a monomeric RNR can be
allosterically regulated. In class I and class II dimeric RNRs, the allosteric binding site is
located at the ends of a 4-helix bundle, which composes the dimeric interface (two
helices from each monomer) (colored magenta in Figures 1.1 and 1.2). The effector
binding pocket is capped by a loop that locks in the effector (Figure 1.1A, inset). In the
monomeric RTPR structure, the effector binding helix bundle and loop have been
structurally conserved by what could be described as two 'cut and paste' events (10).
The recent structure of a class II RNR from Thermotoga maritima in complex with
substrate and effectors was the first structure of a dimeric class II RNR (Figure 1.2B).
Unfortunately, the engineered construct used to elucidate the tmRNR structure lacked 182
C-terminal residues (residues 645-827) which bind AdoCbl.
Although all three classes of RNR have low sequence homology, the structure of
the central core, where catalysis occurs is highly conserved (Figure 1.4) (10). The core of
all three classes of RNR is composed of a 10 strand a/3-barrel with two parallel five
stranded P-sheets oriented in anti-parallel fashion. The barrel harbors the active site
cysteine that forms the thiyl radical at the tip of the 'finger loop'. The barrel also
contains the cysteines which provide reducing equivalents during catalysis. The spacing
between the cysteine on the finger loop (C462 in E. coli)and the second cysteine (C439 in
E. coli) responsible for providing reducing equivalents appears to be an important marker
for identifying the class of RNR from sequence information alone. For class II RNRs the
conserved motif is NPC(G/A)EXsC(NN)L (Figure 1.5) (42). This motif is of variable
distance in class I RNRs and is not seen in class III RNRs. Structural comparison of
these motif loops shows that the motif loop in class I RNRs threads itself out the bottom
of the barrel and interacts with the same loop from the other monomer. In class II
structures, this loop extends to the end of the barrel Figure 1.6)
The significance of this conserved motif in class II RNRs is not clear. This
sequence is not involved in AdoCbl binding or in substrate or effector binding and
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recognition. Structural alignments of RNRs show that it is outside of the active site
barrel, where there is little conserved structure between the classes of RNRs. As seen in
the class I structure, there is no reason why this loop could not be of variable length
(Figure 1.6). The high level of conserved amino acids in this motif suggests that it may
play a role in a yet to be characterized cellular interaction.
Even though the current structural snapshots of different RNRs provide much
information about how and where substrate and effectors bind, we lack a complete
understanding of how RNRs are regulated. The large conformational changes proposed
to occur during catalysis have yet to be captured in crystallographic studies. The non-
physiological conditions of the crystallization of RNRs (pH 4.5-5.5) leads to questions
regarding the ionic interactions seen in the crystal structures between effectors and
protein. There is still much work to be done to unravel the structural rearrangements
needed to transmit information between the effectors bound at the specificity site and the
selection of substrate at the activity site.
THIOREDOXINS AND THIOREDOXIN REDUCTASES
The reduction of the RNR active site disulfide is accomplished using two different
mechanisms. Class I and class II RNRs contain two active site cysteines, which
contribute reducing equivalents in the synthesis of deoxynucleotide building blocks for
DNA synthesis. The active site disulfide in class I and class II RNRs is reduced during
every round of catalysis through cysteines in its c-terminal tail. These c-terminal
cysteines are in turn reduced by the NADPH dependent Tr / TrR / NADPH system or
glutathione system (43), whereas the cysteines in class III RNRs are reduced by formate
(44).
Trs are the major disulfide reductase family responsible for maintaining
intracellular proteins in their reduced state (45). Trs are small enzymes composed of
about 120 amino acids and are characterized by the active site sequence CxxC (46). Tr is
reduced by electrons from NADPH via TrR (Scheme 1.5). Tr and TrR proteins are
ubiquitous from archaea to eukaryote species (47).
TrR is an FAD-containing enzyme with a general structure that is composed of a
nucleotide binding domain and an FAD binding domain. The Tr / TrR system from E.
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coli was the first isolated hydrogen donor for ribonucleotide reductase (RNR) and is the
best characterized Tr / TrR system. The structures of E. coli Tr / TrR have been solved
by crystallography (Figure 1.7 and 1.8) (48, 49). Biochemical work on the TrR / Tr
system suggests that TrR is a highly flexible protein which undergoes large
conformational changes during catalysis. The crystal structure of E. coli TrR provides
evidence for this change in conformation (49). This structure of TrR shows that the
cysteines which participate in the reduction of Tr are buried deep in the interface of
between the FAD binding domain and the NADPH binding domain and that the NADPH
binding site is located 17 A from the isoalloxazine ring. The authors proposed a catalytic
model in which in the redox active cysteines are located near the FAD (FO conformation)
for re-reduction, then there is a 660 conformational change of the enzyme which brings
the NADPH is near the FAD (FR conformation) for hydride transfer from the NADPH to
the FAD moiety (Figure 1.7) (50). This large change was captured in the x-ray structure
of the E. coli TrR / Tr complex (Figure 1.8) (51).
Recent studies reveal that the TrR / Tr system is involved in regulation of many
cellular functions (52). Besides being a hydrogen donor for RNRs, Trs have been
implicated as having a role, for example, in reduction of H20 2, protein repair by
methionine sulfoxide reduction, regulation of chloroplast photosynthesis enzyme, redox
regulation of transcription factor, and regulation of apoptosis (43, 53, 54). Cellular redox
regulation is a complex interconnected system, and understanding the regulation of the
TrR / Tr system is essential to examining the flux of reducing equivalents through
cellular pathways.
ARCHAEA
Seminal work performed by Woese and Fox elucidated the third branch of life,
the archaea (55). Their study of small subunit ribosomal RNA sequences (SSU rRNA)
led to the isolation and characterization of SSU rRNA from Methanobacterium
thermoautotrophicum AH, a methanogen (56). Subsequent characterization of SSU
rRNA from several other methanogens gave rise to the identification of a new kingdom
of life. Originally, archaea were thought to reside only in extreme environments, but they
have now been found in all ecological niches (57). Most archaea organisms are difficult
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to cultivate and are recalcitrant to genetic manipulation due to cell wall structure and
natural resistance to common antibiotics (58)
Sequencing efforts have produced 52 annotated archaeal genomes with a further
35 genomes whose sequencing and annotation is currently being completed (NCBI
Entrez Genome Project http://www.ncbi.nlm.nih.gov/sites/entrez?db=genomeprj).
Analysis of the completed genomes reveals that there is much to be learned from these
organisms. Archaeal genomes have a large number of proteins that are unique to archaea
and for which no biological role can be assigned (> 50% in some organisms). Almost all
of the proteins that can be assigned to metabolic pathway homologues are awaiting
biochemical and biophysical characterization.
There has been growing interest in the study of archaea. They exhibit unique
molecular signatures that have expanded the known range of biochemical reactions and
are capable of using a wide assortment of molecules to provide the metabolic energy for
cellular reactions (59, 60). Their ability to inhabit and thrive under the most extreme
environmental conditions suggests novel pathways that allow for specialized survival
mechanisms. Biofilms and community structures of archaea are changing how scientists
view interactions between biological systems (61, 62). The exchange of signaling
molecules between species, gene expression profiles, and lateral gene transfer plays an
integral role in the endurance of archaeal systems. In addition, they hold evolutionary
records of key biologically relevant pathways (63, 64). The study of chemical processes
mediated by archaea potentially could yield a host of biological novelties.
ARCHAEAL RIBONUCLEOTIDE REDUCTASE SYSTEMS
Archaeal RNR systems present an exciting and unique opportunity for the study
of DNA damage and repair processes. Many archaeal organisms thrive under conditions
of extreme temperature, pH, and pressure. The biochemical processes involved in
maintaining the fidelity of DNA replication and repair is still being elucidated (Recently
reviewed in (65-67). Regretfully, there has been little progress in elucidating the role
RNRs play in this new environment because organisms are extremely difficult to grow
and manipulate. Recently, genomic data has allowed for the mining of extremophilic
genomes for putative RNR enzymes.
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Analysis of the 53 completed archaeal genomes reveal that there are a total of 79
annotated RNRs, with 20 organisms containing 2 or more RNRs (NCBI Entrez Genome
Project) (Table 1.2). There are 14 class I RNR subunits (only 4 subunits correspond to
the a protein), 32 class II RNRs, and 33 class III RNRs (this number does not include the
activating protein). One organism, Methanocorpusculum labreanum Z, does not contain
an annotated RNR. It would be interesting to reexamine this genome to look for a
possible analogue of an RNR.
How these organisms maintain and regulate the nucleotide pool responsible for
DNA damage and repair remains a mystery. As the characterization of these organisms
progresses, it will be exciting to see if their RNRs exhibit the same substrate preference
and allosteric regulation patterns seen in other RNRs, or if we will see the emergence of
novel substrate preferences and regulation. Biophysical and biochemical analysis of
archaeal RNRs is important to understanding the role these enzymes play in the
maintenance and regulation of nucleotide reduction.
The RNR from T. acidophilum (taRNR) is the only archaeal RNR to have been
characterized (9, 68). This RNR is a dimeric class II RNR which exhibits allosteric
effector patterns similar to those seen in E. coli class Ib RNRs (68). taRNR exhibits a
preference for nucleoside diphosphate substrates (9). The temperature optimum for the
reduction of substrates is 55 'C (9). To expand our knowledge of archaeal RNRs, we
propose to characterize a RNR from the archaeon Archaeoglobusfulgidus.
THIOREDOXIN REDUCTASE AND THIOREDOXINS IN ARCHAEA
Disulfide bond reduction has been studied in archaea in the context of protein
disulfide oxoreductases (69, 70). While there has been extensive effort undertaken to
understand prokaryote and eukaryote TrR / Tr systems, there is a paucity of work
completed on archaeal systems.
Genomic analysis of archaea reveals that of the 53 genomes, 13 do not contain
sequences which correspond to putative TrRs. The remaining 40 genomes contain a total
of 63 TrR sequences with 11 of them holding 2 or more putative TrRs (Table 1.3).
Compared to RNRs and TrRs, Tr genes are abundant. There are a total of 114
putative Trs in the annotated genomes. There are 10 organisms which do not contain
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putative Trs. Of the remaining genomes, 27 have two or more Trs with 12 of them
having four or more proteins each (Table 1.4). The organism with the most Trs,
Haloarcula marismortui ATCC 43049, has a total of 8 Trs. Deciphering why there are so
many Trs in one organism may help us understand how archaea have adapted to live
under environmentally stressful conditions.
Genome analysis has provided a wealth of information about redox regulation
players in archaea. To date biochemical analysis has been performed on TrR / Tr from
Aeropyrum pernix (71), a TrR from Pyrococcus horioshii (72, 73), and the TrR / Tr from
Sulfolobus solfataricus (74-77).
There is much to be done before a consensus is reached about whether pathways
involving RNRs, TrRs, and Trs are different in archaea than in other kingdoms. The
breadth of extreme environments in which archaea thrive suggests that there may be
alternate regulation patterns which provide preference of substrate in RNRs. The lack of
identifiable TrRs in some archaea suggests alternative pathways to providing reducing
equivalents in the cell. The study of important enzyme families in archaea provides an
opportunity to investigate how organisms have adapted to living at the extreme edges of
life.
This thesis investigates the RNR (afuRNR), four Trs (Tr-1-4) from
Archaeoglobus fulgidus, and the TrR (taTrR) from Thermoplasma acidophilum. The
second chapter covers the initial characterization of the recombinant afuRNR. Here we
show that afuRNR reduces CDP and CTP to their corresponding deoxynucleotides in an
AdoCbl dependent manner. In the third chapter we report the structural and biochemical
characterization of taTrR and our finding that taTrR does not use NADPH as a source of
reducing equivalents. We finish with the biochemical and electrochemical
characterization of the four afuTrs in chapter 4.
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Scheme 1.1 Metal-dependent activation of the thiyl radical of RNRs. The three classes
of RNRs are identified by the metal cofactor which initiates the abstraction of the
hydrogen atom, thus generating the radical at the active site cysteine. In the strictly
aerobic Class I RNRs, the radical is generated at the diferric cluster in the R2 subunit and
is translated through the R1 protein to the active site. In Class II RNRs, AdoCbl
undergoes homolytic cleavage creating a 5'-deoxy adenosyl radical which abstracts the
hydrogen atom from the active site cysteine. Class III RNRs function under anaerobic
conditions and use AdoMet to generate a stable glycyl radical. This radical in turn
abstracts the hydrogen atom from the active site cysteine to initiate the catalytic cycle.
Class I
diferric cluster
Class II
AdoCbl
idical
1k
Class III
AdoMet
4Fe4S
~I,4
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Scheme 1.2 Model of allosteric regulation for Class I and Class II RNRs. Only one
subunit monomer is shown in scheme. (A) Class Ia RNRs and some Class II RNRs have
an N-terminus activity site which regulates overall reduction of nucleotides by RNR.
When ATP is bound at the activity site, overall activity is up regulated, but when dATP is
bound, enzyme activity is down regulated. (B) Class Ib and most Class II RNRs do not
possess the N-terminus activity site. In all RNRs, the specificity site regulates which
nucleotide is reduced to its corresponding deoxynucleotide in the active site. See Scheme
1.3 for details of specificity regulation.
A
Act ity site
B
ity site
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Scheme 1.3 A schematic representation of the classic pattern of regulation as
exemplified in Class I and Class II RNRs. In Class Ia RNRs, overall activity is up
regulated when ATP is bound and down regulated when dATP is bound. The specificity
effectors are in brown boxes and substrates are in light grey boxes. When ATP or dATP
is bound at the specificity site, RNRs preferentially convert CDP or UDP to dCDP or
dUDP. The binding of dTTP at the specificity site preferentially reduces GDP to dGDP
and binding of dGTP to specificity site reduces ADP to dADP. In Class II RTPR the
substrates are nucleotide triphosphates instead of nucleotide diphosphates, but the
enzyme regulation follows the same pattern.
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Scheme 1.4 A minimal reaction mechanism for RNRs. In Class III enzymes, the distal
cysteine is lacking and the enzyme uses formate as the reductant. The first step of the
reaction is the abstraction of a hydrogen atom from the 3' position of the substrate (2).
The 2' hydroxyl group is protonated by one of the redox active cysteines on the protein
(3), followed by the loss of water, creating a radical-cation intermediate (4). The radical-
cation intermediate undergoes a two step one electron reduction by the redox active
cysteines, allowing the formation of the deoxy-2' carbon of the pentose ring and the
formation of a disulfide on the active site cysteines (5). This is followed by the return of
the initial hydrogen to the 3' position and the regeneration of the thiyl radical located on
the finger loop.
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Scheme 1.5 NADPH participation in cellular redox regulation. (A) The NADPH-
dependent redox regulatory pathways. (B) Mechanism of NADPH dependant cellular
reduction by the thioredoxin reductase system.
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Overview of the classes of RNRs. Table lists key features of classes of
Class
Ia Ib II III
Archaea / Archaea /
Bacteria / Archaea /
Distribution Bacteria / Bacteria /
Archaea Bacteria
Eukaryotes Eukaryotes
Anaerobic / Anaerobic /
Aerobic Aerobic Anaerobic
Aerobic Aerobic
Protein
cL2P 2  U2I 2 U/Q2 U213
Structure
Radical 4Fe-4S /
Fe-O-Fe Fe-O-Fe AdoCbl
Generator AdoMet
Catalytic Thiyl Thiyl Thiyl Thiyl
Radical
Redoxin- Redoxin- Redoxin-
Reductant Formate
(SH2) (SH 2) (SH 2)
Table 1.1
RNRs.
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Table 1.2 RNRs in completed archaea genomes. Table consists of all completed and
annotated Archaea genomes as of June 2008. Table includes name of organisms, what
archaea subdivision they are assigned, the organism reference sequence, the protein locus
tag, what class the particular RNR falls under, and the optimal growth temperature for the
organisms. Only one RNR, the Thermoplasma acidophilum RNR, has been previously
characterized. All others are putative RNRs annotated by sequence homology modeling
at the NCBI Entrez Genome Project. Some organisms have multiple RNRs.
Organism Group RefSeq Locus Tag Class Growth T
(0C)
Aeropyrum pernix Crenarchaeota NC_000854.2 APE_2062.1 II 90-95
K1
Archaeoglobus Euryarcaeota NC_009917.1 AF 1664 II 83
fulgidus DSM 4304
Caldivirga Crenarchaeota NC_009954.1 Cmaq_0639 II 85
maquilingensis
IC-167
Candidatus Other Archaea NC 010482.1 Kcr 0134 II N/A
Korarchaeum
cryptofilum OPF8
Candidatus Euryarchaeota NC 009712.1 Mboo_0022 II 37
methanoregula Mboo 1709 III
boonei 6A8
Haloarcula Euryarchaeota NC_006396.1 rrnAC 1622 II 40-50
marismortui ATCC
43049
Halobacterium Euryarchaeota NC_010364.1 OE3328R II 50
salinarum R1 OE4345R Ia - P
OE4346R Ia - a
Halobacterium sp. Euryarchaeota NC_002607.1 VNG2383G Ia - P 42
NRC-i VNG2384G Ia- a
Haloquadratum Euryarchaeota NC_008212.1 HQ2859A III 37-40
walsbyi DSM 16790
Hyperthermus Crenarchaeota NC 008818.1 COG1328F III 95-106
butylicus DSM 5456 Hbut 0854 II
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Organism Group RefSeq Locus Tag Class Growth T
(0C)
Ignicoccus hospitalis Crenarchaeota NC_009776.1 Igni_0036 III > 80
KIN4/1
Metallosphaera Crenarchaeota NC_009440.1 Msed_1716 II 70
sedula DSM 5348
Methanobrevibacter Euryarchaeota NC_009515.1 Msm_1383 III 37-40
smithii ATCC 35061
Methanocaldococcus Euryarchaeota NC_000909.1 MJ0832 II 85
jannaschii DSM 2661
Methanococcoides Euryarchaeota NC_007955.1 Mbur_2125 III 23.4
burtonii DSM 6242 Mbur 2140 III
Methanococcus Euryarchaeota NC_009635.1 Maeo_1041 III 42
aeolicus Nankai-3
Methanococcus Euryarchaeota NC_009135.1 MmarC5_1471 II1 24-25
maripaludis C5
Methanococcus Euryarchaeota NC_009975.1 MmarC6_0728 III 25-40
maripaludis C6
Methanococcus Euryarchaeota NC 009637.1 MmarC7_1227 III 25-40
maripaludis C7
Methanococcus Euryarchaeota NC_005791.1 MMP0227 III 25-40
maripaludis S2
Methanococcus Euryarchaeota NC_009634.1 Mevan_1241 III 30
vannielii SB
Methanocorpusculum Euryarchaeota NC_008942.1 N / A N / A 37
labreanum Z
Methanoculleus Euryarchaeota NC_009051.1 Memar_0306 III 21-25
marisnigri JR1 Memar_0320 III
Memar 1998 II
Methanopyrus Euryarchaeota NC_003551.1 MK0901 III 98
kandleri AV 19
Methanosaeta Euryarchaeota NC_008553.1 Mthe_1264 III >60
thermophila PT Mthe 1314 II
Methanosarcina Euryarchaeota NC_003552.1 MA0072 III 35-40
acetivorans C2A MA1665 II
Methanosarcina Euryarchaeota NC_007355.1 MbarA1037 III 35-40
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Organism Group RefSeq Locus Tag Class Growth T
(0C)
barkeri str. Fusaro Mbar A3615 II
Methanosarcina Euryarchaeota NC_003901.1 MM_1367 III 30-40
mazei Gol MM 2830 II 30-40
Methanosphaera Euryarchaeota NC_007681.1 Msp_0254 III 36-40
stadtmanae DSM
3091
Methanospirillum Euryarchaeota NC_007796.1 Mhun_2811 III 37
hungatei JF- 1
Methanothermobacter Euryarchaeota NC_000916.1 MTH652 II 65-70
thermautotrophicus MTH 1539 III
str. Delta H
Nanoarchaeum Nanoarchaeota NC_005213.1 NEQ345 III >80
equitans Kin4-M
Natronomonas Euryarchaeota NC_007426.1 NP3346A Ib - a 37-40
pharaonis DSM 2160 NP4434A Ib -
NP5066A Ib - P
NP6166A Ia -
NP6168A Ia - 1
Nitrosopumilus Crenarchaeota NC 010085.1 Nmar 1627 II 37
maritimus SCM1
Picrophilus torridus Euryarchaeota NC_005877.1 COG0209F II 60
DSM 9790
Pyrobaculum Crenarchaeota NC 003364.1 PAE3155 II 100
aerophilum str. IM2
Pyrobaculum Crenarchaeota NC 009376.1 Pars 1670 II >80
arsenaticum DSM
13514
Pyrobaculum Crenarchaeota NC 009073.1 Pcal 1797 II 90-95
calidifontis JCM
11548
Pyrobaculum Crenarchaeota NC 008701.1 Pisl 0226 III 100
islandicum DSM Pisl 0525 II
4184
Pyrococcus abyssi Euryarchaeota NC_000868.1 PAB2337 III 103
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Organism Group RefSeq Locus Tag Class Growth T
(oC)
GE5 PAB1057 II
Pyrococcus furiosus Euryarchaeota NC_003413.1 PF0440 II 100
DSM 3638 PF1971 III
Pyrococcus Euryarchaeota NC_000961.1 PH0021 III 98
horikoshii OT3 PH0363 II
Staphylothermus Crenarchaeota NC_009033.1 Smar_1080 III 92
marinus F 1
Sulfolobus Crenarchaeota NC_007181.1 Saci_ 112 Ia - P 70-75
acidocaldarius DSM Saci 1353 II
639 Saci_2188 Ia -
Saci_2212 Ia - P
Saci_2220 Ia -
Sulfolobus Crenarchaeota NC 002754.1 SS00929 II 85
solfataricus P2 SS02498 Ia - 1
Sulfolobus tokodaii Crenarchaeota NC 003106.2 ST1259 II 80
str. 7
Thermococcus Euryarchaeota NC_006624.1 TK1736 II 85
kodakarensis KOD1 TK2298 III
Thermofilum pendens Crenarchaeota NC_008698.1 Tpen 0335 III 88
Hrk 5
Thermoplasma Euryarchaeota NC_002578.1 Ta1475 II 59
acidophilum DSM
1728
Thermoplasma Euryarchaeota NC_002689.2 TVN0092 II 60
volcanium GSS1
Thermoproteus Crenarchaeota NC_010525.1 Tneu_0378 III 85
neutrophilus V24Sta Tneu_1608 II
ncultured Euryarchaeota NC_009464.1 RCIX705 III 35-40
methanogenic
archaeon RC-I
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Table 1.3 TrRs in completed archaea genomes. Table consists of all completed and
annotated archaea genomes as of June 2008. Table includes name of organisms, the
archaea subdivision to which they are assigned, the organism reference sequence, and the
protein locus tag. All protein, except for the TrRs from Aeropyrum pernix, Pyrococcus
horioshii, and Sulfolobus solfataricus, are putative TrRs annotated by sequence
homology at the NCBI Entrez Genome Project. Some organisms have multiple TrRs.
Organism
Aeropyrum pernix KI
Archaeoglobus fulgidus DSM 4304
Caldivirga maquilingensis
IC-167
Group
Crenarchaeota
Euryarcaeota
Crenarchaeota
RefSeq
NC 000854.2
NC 009917.1
NC 009954.1
Candidatus Korarchaeum Other Archaea NC 010482.1 Kcr 1054
cryptofilum OPF8
Candidatus methanoregula boonei Euryarchaeota NC_009712.1 N / A
6A8
Haloarcula marismortui ATCC Euryarchaeota NC_006396.1 rrnAC1129
43049 rrnAC1470
rmAC3545
pNG7078
Halobacterium salinarum R1 Euryarchaeota NC_010364.1 OE2805R
OE6204F
OE7085F
Halobacterium sp. NRC-1 Euryarchaeota NC_002607.1 VNG6074G
VNG6452G
VNG7055
Haloquadratum walsbyi DSM 16790 Euryarchaeota NC_008212.1 HQ1592A
HQ1652A
HQ2445A
Hyperthermus butylicus DSM 5456 Crenarchaeota NC 008818.1 Hbut 0180
Ignicoccus hospitalis KIN4/I Crenarchaeota NC 009776.1 N / A
Metallosphaera sedula DSM 5348 Crenarchaeota NC 009440.1 Msed 0632
Methanobrevibacter smithii ATCC Euryarchaeota NC 009515.1 Msm_034
35061
Methanocaldococcus jannaschii Euryarchaeota NC_000909.1 MJ1536
Locus Tag
APE 1061.1
AF1554
Cmaq_0211
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Organism Group RefSeq Locus Tag
DSM 2661
Methanococcoides burtonii DSM Euryarchaeota NC_007955.1 Mbur 0101
6242
Methanococcus aeolicus Nankai-3 Euryarchaeota NC_009635.1 Maeo 0766
Methanococcus maripaludis C5 Euryarchaeota NC_009135.1 N / A
Methanococcus maripaludis C6 Euryarchaeota NC_009975.1 N / A
Methanococcus maripaludis C7 Euryarchaeota NC_009637.1 N / A
Methanococcus maripaludis S2 Euryarchaeota NC_005791.1 MMP0959
Methanococcus vannielii SB Euryarchaeota NC_009634.1 N / A
Methanocorpusculum labreanum Z Euryarchaeota NC_008942.1 N / A
Methanoculleus marisnigri JRI Euryarchaeota NC 009051.1 N/A
Methanopyrus kandleri AV19
Methanosaeta thermophila PT
Methanosarcina acetivorans C2A
Methanosarcina barkeri str. Fusaro
Euryarchaeota
Euryarchaeota
Euryarchaeota
Euryarchaeota
NC 003551.1
NC 008553.1
NC 003552.1
NC 007355.1
MK1561
Mthe 1150
MA1368
Mbar A28987
Methanosarcina mazei Gol Euryarchaeota NC_003901.1 MM_2353
Methanosphaera stadtmanae DSM Euryarchaeota NC_007681.1 Msp_1413
3091
Methanospirillum hungatei JF- Euryarchaeota NC_007796.1 N / A
Methanothermobacter Euryarchaeota NC_000916.1 MTH708
thermautotrophicus str. Delta H
Nanoarchaeum equitans Kin4-M Nanoarchaeota NC_005213.1 N / A
Natronomonas pharaonis DSM 2160 Euryarchaeota NC_007426.1 NP1384A
NP1388A
NP2680A
NP3544A
Nitrosopumilus maritimus SCM1 Crenarchaeota NC_010085.1 Nmar_0672
Picrophilus torridus DSM 9790 Euryarchaeota NC 005877.1 PT00431
PT00734
Pyrobaculum aerophilum str. IM2 Crenarchaeota NC_003364.1 PAE1725
PAE2744
Pyrobaculum arsenaticum DSM Crenarchaeota NC_009376.1 Pars_0776
13514
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Organism
Pyrobaculum calidifontis JCM 11548
Pyrobaculum islandicum DSM 4184
Pyrococcus abyssi GE5
Pyrococcus furiosus DSM 3638
Pyrococcus horikoshii OT3
Staphylothermus marinus F 1
Sulfolobus acidocaldarius DSM 639
Group
Crenarchaeota
Crenarchaeota
Euryarchaeota
Euryarchaeota
Euryarchaeota
Crenarchaeota
Crenarchaeota
Sulfolobus solfataricus P2 Crenarchaeota NC 002754.1 SS0222
SS02416
SS02765
Sulfolobus tokodaii str. 7 Crenarchaeota NC 003106.2 ST0438
ST0546
ST2133
Thermococcus kodakarensis KODI Euryarchaeota NC_006624.1 TK2100
Thermofilum pendens Hrk 5 Crenarchaeota NC 008698.1 N / A
Thermoplasma acidophilum DSM Euryarchaeota NC_002578.1 Ta0984
1728
Thermoplasma volcanium GSS 1I Euryarchaeota NC_002689.2 TVN0470
TVN1129
Thermoproteus neutrophilus V24Sta Crenarchaeota NC_010525.1 N / A
ncultured methanogenic archaeon Euryarchaeota NC_009464.1 RRC321
RC-I RRC232
RefSeq
NC 009073.1
NC 008701.1
NC 000868.1
NC 003413.1
NC 000961.1
Locus Tag
Pcal 0626
Pisl 1704
PAB0500
PF1422
PH1426
NC 009033.1
NC 007181.1
N/A
Saci 0029
Saci 093
Saci 1169
Saci 2144
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Table 1.4 Trs in completed archaea genomes. Table consists of all completed and
annotated Archaea genomes as of June 2008. Table includes name of organisms, the
archaea to subdivision they are assigned, the organism reference sequence, and the
protein locus tag. All protein, except for the Trs from Aeropyrum pernix and SulJblobus
solfataricus, are putative Trs annotated by sequence homology at the NCBI Entrez
Genome Project. Some organisms have multiple Trs.
Organism Group RefSeq Locus Tag
Aeropyrum pernix K Crenarchaeota NC 000854.2 APE_0641
APE 1722
APE 2273.1
Archaeoglobus fulgidus DSM Euryarcaeota NC_009917.1 AF0711
4304 AF0769
AF1284
AF2144
Caldivirga maquilingensis Crenarchaeota NC_009954.1 Mboo 0072
IC-167 MbOO 0097
Mboo 1798
MBoo 2203
Candidatus Korarchaeum Other Archaea NC 010482.1 Kcr 0134
cryptofilum OPF8
Candidatus methanoregula Euryarchaeota NC_009712.1 Mboo_0022
boonei 6A8 Mboo 1709
Haloarcula marismortui ATCC Euryarchaeota NC_006396.1 rrnAC 1371
43049 rmAC2110
rmAC2141
rrnAC2458
rrnAC3126
rmB027
pNG6029
pNG7124
Halobacterium salinarum R1 Euryarchaeota NC_010364.1 OE1252R
OE1277F
OE2862F
OE4648F
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Organism Group RefSeq Locus Tag
OE6204F
OE7084F
Halobacterium sp. NRC- Euryarchaeota NC_002607.1 VNG6073G
VNG6453G
VNG7055
Haloquadratum walsbyi DSM Euryarchaeota NC_008212.1 HQ1323A
16790 HQ1614A
HQ1629A
HQ2511A
HQ2557A
Hyperthermus butylicus DSM Crenarchaeota NC_008818.1 Hbut_0700
5456 Hbut 1122
Ignicoccus hospitalis KIN4/I Crenarchaeota NC_009776.1 N / A
Metallosphaera sedula DSM Crenarchaeota NC 009440.1 Msed_0776
5348 Msed 1614
Methanobrevibacter smithii Euryarchaeota NC_009515.1 Msm_083
ATCC 35061
Methanocaldococcus jannaschii Euryarchaeota NC_000909.1 MJ0307
DSM 2661
Methanococcoides burtonii Euryarchaeota NC 007955.1 Mbur 0227
DSM 6242 Mbur 0334
Mbur 1670
Mbur 1851
Mbur 2325
Methanococcus aeolicus Euryarchaeota NC_009635.1 Maeo_0589
Nankai-3 Mbur 0334
Maeo 0589
Mbur 0334
Mbur1670
Mbur 1851
Mbur 1851
Methanococcus maripaludis C5 Euryarchaeota NC_009135.1 N / A
Methanococcus maripaludis C6 Euryarchaeota NC_009975.1 MmarC6_1697
Methanococcus maripaludis C7 Euryarchaeota NC_009637.1 N / A
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Organism
Methanococcus maripaludis S2
Methanococcus vannielii SB
Methanocorpusculum
labreanum Z
Group
Euryarchaeota
Euryarchaeota
Euryarchaeota
RefSeq
NC 005791.1
NC 009634.1
NC 008942.1
Locus Tag
MMP1635
N/A
N/A
Methanoculleus marisnigri JRI Euryarchaeota NC_009051.1 Memar_0227
Memar 1658
Methanopyrus kandleri AV19 Euryarchaeota NC_003551.1 N / A
Methanosaeta thermophila PT Euryarchaeota NC 008553.1 Mthe_0711
Mthe 1133
Methanosarcina acetivorans Euryarchaeota NC_003552.1 MA09651
C2A MA3212
MA3702
MA4254
Methanosarcina barkeri str. Euryarchaeota NC 007355.1 Mbar A1859
Fusaro Mbar A2283
Mbar A2310
Mbar A2577
Mbar A3617
Methanosarcina mazei Gol Euryarchaeota NC 003901.1 MM 0436
MM 0706
MM 2079
MM 2354
Methanosphaera stadtmanae Euryarchaeota NC_007681.1 Msp_O 103
DSM 3091 Msp_0820
Methanospirillum hungatei JF- Euryarchaeota NC 007796.1 Mhun_0815
.1 Mhun 2493
Mhun 3175
Methanothermobacter Euryarchaeota NC_000916.1 MTH807
thermautotrophicus str. Delta H
Nanoarchaeum equitans Kin4- Nanoarchaeota NC_005213.1 N / A
M
Natronomonas pharaonis DSM Euryarchaeota NC_007426.1 NP1310A
2160 NP1448A
NP1606A
NP3114A
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Organism Group RefSeq Locus Tag
NP3704A
NP3914A
NP4120A
Nitrosopumilus maritimus Crenarchaeota NC_010085.1 Nmar_0210
SCMI Nmar 0230
Picrophilus torridus DSM 9790 Euryarchaeota NC_005877.1 PTO0121
Pyrobaculum aerophilum str. Crenarchaeota NC_003364.1 N / A
IM2
Pyrobaculum arsenaticum Crenarchaeota NC 009376.1 Pars 1573
DSM 13514
Pyrobaculum calidifontis JCM Crenarchaeota NC 009073.1 Pcal_1702
11548
Pyrobaculum islandicum DSM Crenarchaeota NC 008701.1 Pisl 0610
4184
Pyrococcus abyssi GE5 Euryarchaeota NC_000868.1 N / A
Pyrococcus furiosus DSM 3638 Euryarchaeota NC_003413.1 PF1457
Pyrococcus horikoshii OT3 Euryarchaeota NC_000961.1 N / A
Staphylothermus marinus F1 Crenarchaeota NC_009033.1 Smar_0032
Smar 0093
Sulfolobus acidocaldarius DSM Crenarchaeota NC 007181.1 Saci_0041
639 Saci 1485
Saci 1823
Sulfolobus solfataricus P2 Crenarchaeota NC 002754.1 SS00368
SSO2232
Sulfolobus tokodaii str. 7 Crenarchaeota NC 003106.2 STSI71
ST2123
Thermococcus kodakarensis Euryarchaeota NC_006624.1 TK0838
KOD1
Thermofilum pendens Crenarchaeota NC_008698.1 Tpen_0425
Hrk 5 Tpen 1129
Thermoplasma acidophilum Euryarchaeota NC_002578.1 Ta0866
DSM 1728
Thermoplasma volcanium Euryarchaeota NC_002689.2 TVN0777
GSSI
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Organism Group RefSeq Locus Tag
Thermoproteus neutrophilus Crenarchaeota NC_010525.1 Tneu_1511
V24Sta
ncultured methanogenic Euryarchaeota NC_009464.1 RCIX 1080
archaeon RC-I RCIX1079
RCIX360
LRC226
LRC131
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Figure 1.1 Structures of Class Ia RNR from E. coli. (A) Ribbon representation of R1
dimer showing N-terminal activity site in blue (blue oval), specificity site in magenta
(magenta oval), and dimeric interface 4-helix bundle in cyan (PDB 4rlr). The structure
has GDP bound in the active site (black oval) and dTTP in the specificity site (magenta
oval). Inset highlights the placement of the effector atop the dimer interface. (B)
Ribbon representation of R2 dimer (PDB Irib). Orange circles indicate diferric sites in
R2 dimer. Red indicates a-helices, yellow indicates n-strands, and green indicates loop
regions. Models are not to scale.
A
B
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Figure 1.2 Structures of Class II RNRs. (A) Ribbon representation of RTPR monomer
showing the conserved specificity site in magenta, and 4-helix bundle in cyan (PDB 1111).
(B) Ribbon representation of the Class II RNR from Thermotoga maritima with the 4-
helix bundle dimeric interface in cyan and the specificity site in magenta (PDB lxjg).
Unfortunately, the T. maritima structure is missing the 182 C-terminal amino acids. Red
indicates a-helices, yellow indicates P-strands, and green indicates loop regions. Active
site is circled in black and specificity site is highlighted by magenta oval. Models are not
to scale.
A
B
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Figure 1.3 Structure of the bacteriophage T4 Class III RNR (PDB lh7a). Ribbon
representation of the Class III RNR showing the specificity site in magenta (magenta
circle), and dimeric interface 4-helix bundle in cyan. Red indicates a-helices, yellow
indicates P-strands, and green indicates loop regions.
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Figure 1.4 Ribbon diagram of the structurally conserved RNR n-barrel. Top and side
views of the 10-strand barrel active site. The top view of the barrel shows the finger loop
which contains the active site cysteine. (A) E. coli RNR, (B) RTPR (C) bacteriophage T4
RNR.
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Figure 1.5 Sequence alignment of Class II RNRs showing the conserved motif,
NPC(G/A)EX 8C(N/V)L, between the active thiyl radical cysteine (C436) and one of the
redox active cysteines, (C447). The two cysteines are highlighted by a star at the bottom
of the alignment. The spacing between these two cysteines varies between 12 and 15
amino acids for Class I RNRs.
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Figure 1.6 Structural locations of the conserved class-dependent motifs. (A) The class I
(Cx 22C in E. coli) motif (black oval mapped onto the E. coli structure) comprises residues
which extend from the barrel to the dimeric interface. (B) The class II CxIoC motif
(black circle) ends at the bottom of the T. maritima barrel. The dimer interface is colored
in cyan, the effector binding loop is colored in magenta, oa-helices are colored in red, 3-
sheets are colored in yellow, and the motif loops are colored in orange.
A
B
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Figure 1.7 Structures of the FO and FR form of TrR from E. coli (PDB ltdf (FO) and
lf6m (FR)). (A) Structure of the FR conformation of E. coli TrR. (B) Structure of the FO
conformation of E. coli TrR. The circle highlights the movement in the NADPH binding
domain relative to the FAD binding domain. The a-helices are colored in red and P-
sheets are colored in yellow. Figures are not to scale.
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Figure 1.8 Structure of the oxidized form of Tr from E. coli (PDB 2trx). The disulfide is
highlighted in the black circle. The a-helices are colored in red and P-sheets are colored
in yellow.
iL W I
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Figure 1.9 Structure of the complex of Tr and TrR from E. coli (PDB If6m) with the
TrR dimer is colored cyan and green and the Tr monomers are yellow and magenta. The
structure was solved with FAD and AADP +, an NADPH analogue.
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INTRODUCTION
Ribonucleotide reductases (RNRs) are present in all living organisms. Using radical-
based chemistry, they catalyze the reduction of nucleotides to deoxynucleotides, providing the
building blocks for DNA replication and repair. Due to their importance, they have been the
subjects of several recent reviews (1-3).
Despite their central function, RNRs are not evolutionarily conserved in terms of
substrate preference (ribonucleoside di- versus tri-phosphates), metallocofactors, or quaternary
structure and sequence. RNRs are named based on substrate preferences: ribonucleoside
diphosphate reductases (RDPRs) and ribonucleoside triphosphates reductases (RTPRs). They
are also divided into classes based on the cofactor requirements (Scheme 1.1). Class I RNRs,
found in eukaryotes, bacteria, bacteriophages, and viruses, utilize a diferric-tyrosyl radical.
Class II RNRs, found in bacteria, bacteriophages, algae, and Archaea, utilize coenzyme B 12
(adenosylcobalamin, AdoCbl). Class III RNRs, found in anaerobic bacteria and bacteriophages,
utilize a 4Fe-4S cluster and S-adenosylmethionine to generate a glycyl radical. While Class I
and III RNRs tend to be higher order oligomeric enzymes with the minimal composition of c2P2
and 213 respectively, Class II RNRs can be monomeric (ca) or dimeric (c 2). In terms of substrate
preference, all Class I and most Class II RNRs use nucleoside diphosphates (NDPs) as
substrates, but there are some Class II enzymes that use nucleoside triphosphates (NTPs) as
substrates, and no previously characterized RNR uses both NDPs and NTPs. Class III RNRs use
NTPs as substrates. The structural basis for this phosphate preference is unclear (4).
Despite these variations, the overall enzyme mechanisms appear to be conserved (5). For
each class of RNR, the metallocofactor is used to generate a thiyl radical in the active site of the
a-subunit. While the mechanism of that radical generation may be different, once the radical is
generated, the reduction of nucleotides proceeds in a similar manner (Figure 2.1) (6). The first
step of the reaction is the abstraction by the thiyl radical of the hydrogen from the 3' position of
the substrate. The subsequent multiple step radical rearrangement results in the loss of the 2'
hydroxyl group in the form of water. For class III RNR, reducing equivalents for the reaction are
provided by oxidation of formate (7). In class I and II RNRs, reducing equivalents are supplied
through active site disulfide formation. Re-reduction of the active site disulfide occurs via two
- Chapter 2 - Characterization of afuRNR
cysteine residues of the C-terminal tail. In turn, the C-terminal tail disulfide is re-reduced in a
thioredoxin (Tr)/thioredoxin reductase (TrR)/NADPH-dependent reaction (8, 9).
A unique feature of RNRs is that one enzyme catalyzes the reduction of all four
nucleotides to their corresponding deoxynucleotides, and that this substrate specificity is
regulated by the binding of deoxynucleoside triphosphates effectors to a distal site on the a-
subunits. Somehow, this distant effector binding changes the catalytic site conformation and
thus the preference for each ribonucleotide substrate. For the limited number of RNRs studied,
the rules of regulation (Scheme 2.1) are similar, but more experiments on a diverse group of
RNRs are needed.
In addition to the allosteric regulation of specificity, some RNRs are subject to allosteric
regulation of activity. An activity site, found at the N-terminus of Class Ia RNRs, binds either
ATP to stimulate overall activity and dATP to inhibit catalytic activity. Some Class I RNRs do
not have this site and are referred to as Class Ib enzymes. For a few Class II RNRs, the sequence
for an 'activity site' exists but no allosteric regulation of activity has been experimentally
demonstrated (10).
Despite the importance of RNR enzymes, there are a relatively small number of them that
have been well characterized, and some of the best-studied are from closely related organisms,
e.g. E. coli and Salmonella typhimurium. Most of the work has focused on Class I RNRs while
Class II and III remain relatively unexamined. To better understand this family of enzymes, we
have cloned and characterized a putative class II RNR from an extremophilic Archaeal organism.
Archaeoglobus fulgidus, first isolated from a geothermally heated sea floor at Vulcano Island,
Italy (11), is an anaerobic motile aquatic autotrophic and an organic sulfate / sulfite respirer
whose optimal growth temperature is 83 'C. We find that A. fulgidus RNR (afuRNR) is a
dimeric Class II RNR, which surprisingly shows evidence of activity for both nucleoside
diphosphate and nucleoside triphosphate substrates. Thus for this extreme environment, we find
the first example of an RNR which exhibits dual selectivity for the phosphorylation state of its
substrate.
MATERIALS AND METHODS
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Materials PfuTurboTM DNA Polymerase was obtained from Stratagene (Santa Clara, CA).
Genomic DNA was obtained from the American Tissue Culture collection (ATCC). Restriction
enzymes, calf intestine phosphatase (CIP), Klenow polymerase fragment, and TAQ polymerase,
were purchased from New England Biolabs (NEB, Brunswick, MA). Deoxynucleotides were
purchased from Amersham Biosciences (Piscataway, NJ). TOPl0, NovaBlue, Rosetta
competent cells, and pET28 vector, were purchased from Novagen (San Diego, CA). Zero
BluntTM TOPOTM PCR Cloning Kit was purchased from Invitrogen (Carlsbad, CA). Primers
were purchased from Integrated DNA Technologies (IDT) (Coralville, IA). Thrombin (bovine)
was purchased from CalBiochem (San Diego, CA). Qiaquick gel extraction minicolumn and
Qiagen Miniprep Kits were purchased from Qiagen. SDS-PAGE gels were obtained from Bio-
Rad Laboratories (Hercules, CA). All other chemicals used were purchased from Sigma-Aldrich
(St. Louis, MO). DNA sequencing was performed at MGH Sequencing Facility and at the MIT
Center for Cancer Research Biopolymers Lab (Cambridge, MA). RTPR purified by the Booker
method was a kind gift from Professor JoAnne Stubbe at MIT (12).
Analysis of Archaeoglobus fulgidus genome. The genome of Archaeoglobus fulgidus (RefSeq
NC_000917, GenBank AE000782) was analyzed using the web interface at the National Center
for Biotechnology Information (http://www.ncbi.nlm.nih.gov) for a putative adenosylcobalamin
(AdoCbl) ribonucleotide reductase (RNR) open reading frame (ORF). An ORF encoding a 752
amino acid protein, AF1664 was identified by sequence homology to known AdoCbl dependent
RNRs using PSI-BLAST (13). Protein sequences were aligned using the program ClustalW (14)
and the output was rendered using the web interface ESPript 2.2 (15) (Figure 2.2 and 2.3).
Cloning of afuRNR. The afuRNR gene was amplified by the polymerase chain reaction (PCR)
using genomic DNA from a cell suspension obtained from ATCC and the primers 5'-ATC GCA
TAT GAA GCT CAA TCG TAC TGC TGA AAC T-3' and 5'-TGC TCG AGT TCA ACC GCA
CCT CGT AAA CCC GCA G-3' for the putative afuRNR gene (restriction sites are underlined).
PCR products were cloned into the expression vector pET28a using NdeI and XhoI restriction
enzymes. The sequence of the pET28a-afuRNR construct was verified by dideoxy sequencing at
the MIT Biopolymers Sequencing Facility. The resulting construct, pET28a-afuRNR, was
transformed into RosettaM (DE3)pLysS cells for facile protein expression.
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Purification of recombinant afuRNR. RosettaTM (DE3)pLysS cells transformed with the pET28a-
afuRNR construct were used to inoculate TB media supplemented with 20 gtg ml' kanamycin
and 34 tg ml' chloroamphenicol. The culture was grown at 37 'C to an OD 600 of 0.8, prior to
induction with 0.8 mM isopropylthio-3-D-galactoside (IPTG) for 4 hrs. The cells were harvested
by centrifugation, resuspended in lysis buffer (10 mM TRIS-HCl pH 8.0, 150 mM NaCl, 10 mM
imidazole, 1 mM PMSF), and disrupted by sonication using a Digital Sonifier 250 (Branson, CT,
USA). Insoluble material was removed by ultracentrifugation at 40,000 x g using a Beckman
Avanti J-25 centrifuge (Beckman, CA, USA). The supernatant was then subjected to heating at
70 'C for 45 min, followed by centrifugation at 40,000 x g. The clarified supernatant was loaded
directly onto a Ni-NTA column, washed with 1 M NaCl buffer, and eluted with buffer containing
10 mM TRIS-HCl pH 8.0, 150 mM NaC1, 200 mM imidazole. Eluted fractions were analyzed
by an SDS-PAGE 4-20% gel and fractions containing protein that migrated at the size of the
predicted afuRNR sequence were pooled and concentrated using an Amicon stirred ultrafiltration
cell (Millipore, MA, USA).
The eluted protein was dialyzed (35 kDa MW cutoff) overnight in 20 mM HEPES, pH
7.5, 20 mM NaCl, 0.5 mM EDTA, 1 mM 1,4-dithio-DL-threitol (DTT) with thrombin (0.05 unit
ml-) to remove the N-terminal poly-His-tag. The resulting cleavage products were loaded onto
an SEC-200 high-prep gel-filtration size exclusion column from Amersham Biosciences
(Piscataway, NJ, USA), which was pre-equilibrated with storage buffer (10 mM HEPES, pH 7.0,
150 mM NaC1). Fractions were analyzed via SDS-PAGE (Figure 2.4) and those containing
protein with an approximate MW -84,000 kDa were pooled and concentrated using Centriprep
YM-10 filter from Amicon (Millipore, Bedford, MA, USA). Protein concentration was
determined using a Cary 300 spectrophotometer (Varian, CA, USA) and the theoretical
extinction coefficient (E280 = 94,450 M- cm-'), obtained from ProtParam (ExPaSy web server).
RNR radioactive enzyme assays. RTPR assays were conducted as described by Booker and
Stubbe (12) with minor modifications as described below. Briefly each assay mixture contained
25 mM HEPES (pH 7.5), 4 mM EDTA, 1 M NaOAc, 30 mM DTT, 1 mM [2-' 4C]-CTP (specific
activity 1.5 x 103 x 3.0 x10 3 cpm/nmol), 8 tiM AdoCbl, and 0.48 nmol of RTPR. The final
volume was 700 pL. The reaction mixture was incubated in light protective tubes for 5 min at 37
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'C, and an aliquot (100 L) containing everything except AdoCbl was removed at the 0 time
point. Each assay was initiated by the addition of AdoCbl, and at various time points, a 100-tL
aliquot was removed and quenched in 200 gIL of 2% perchloric acid. The contents were
neutralized with 180 gL of 0.2 N NaOH and 50 gL of 0.5 M Tris-HC1, pH 8.5, 1.0 mM EDTA.
Subsequent to the addition of 10 units of calf intestine phosphatase (CIP), the reaction was
incubated at 37 "C for 1.5 h. To each reaction vial 30 gL of carrier cytosine and dC (120 nmol)
were added, and the reaction was diluted to 1.5 mL with H20. Each reaction was loaded onto
0.75 X 7 cm AGl-X2 columns (borate form, 50-100 mesh) prepared by the method of Steeper
and Steuart (1970) (16). Each column was washed with 12 mL of H20, and a 1-mL portion of
the eluate was subjected to scintillation counting. Changes to the described assay include an
increase in the final volume of 700 ptL (compared to 510 pL), and that the assays were
performed in light protective 1.5 ml eppendorf tubes instead of a dark room. The light protective
tube assay was developed to minimize the experimental hazards of working at such high
temperatures.
For assays of afuRNR, the light protective tubes were also used. In addition, experiments
were performed at 83 oC (instead of 37 oC) and the reactions were neutralized by rapid quenching
in liquid nitrogen instead of 2 % perchloric acid. Briefly, an assay mixture contains the
following: 0.06 - 4.9 mM ['4C]-CDP (S.A. = 1.5 x 103 - 3.0 x 103 cpm/nmol), 25 mM HEPES
pH 7.5 (instead of 50 mM HEPES), 10 mM MgC12, 40-80 jtM afuRNR, 1.4 - 34 mM DTT and
0.74 to 43 tM AdoCbl in a final volume of 700 tL. The assay was performed as follows. The
mixture containing each reagent except AdoCbl was incubated at 83 oC for 5 min. For the initial
time point, a 100 jtL aliquot was removed and quenched in liquid nitrogen. The reaction was
started by the addition of AdoCbl to the mixture. At different time points, a 100 jtL aliquot was
removed and quenched in liquid nitrogen. After all reactions were stopped, alkaline phosphate
buffer (NEB Buffer 3 - 50 mM TRIS-HCl pH 7.9, 100 mM NaCl, 10 mM MgC12, 1 mM DTT)
was added followed by addition of 10 U calf intestine alkaline phosphatase (final volume = 250
jL). The samples were then incubated at 37 oC for 1 hour. Finally, products were separated
using the boronate column method and each 1 mL sample of flow through was analyzed using a
scintillation counter (16). In this chapter, 1 unit (U) of enzyme activity is defined as 1 nmol
substrate converted per min (1 U = 1 nmol / min) (See Scheme 2.2).
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Stability of AdoCbl in light protective tubes. To verify that AdoCbl was stable in the light
protective 1.5 mL eppendorf tubes used in the modified RTPR and afuRNR assays, we subjected
AdoCbl to visible light exposure in both clear 1.5 mL tubes and 1.5 mL light protective tubes.
Experimental mixtures containing 25 mM HEPES, 10 mM MgCl 2, and 39 AiM AdoCbl were
placed into clear 1.5 ml eppendorf and light protective 1.5 ml eppendorf tubes at 25 'C. A 100
gL aliquot was removed from each tube and a UV/visible spectrum was recorded from 800 to
240 nm using a Cary 300 spectrophotometer (Figure 2.5). Aliquots were removed every 2 min
for the duration of 10 min with a final timepoint taken at 20 min and subsequent spectra recorded
from 600 to 240 nm.
AdoCbl has been reported to undergo a photolysis reaction in the presence of visible light
(17, 18). The instability of AdoCbl is marked by a change in the UV/visible spectra of the
coenzyme. The formation of product from the light induced photolysis of AdoCbl can be
followed by monitoring the visible spectra changes between 300 and 600 nm. In Figure 2.5A,
AdoCbl present in the clear 1.5 mL tube and in the standard RNR assay mixture displays light-
induced Co-C bond homolysis followed by conversion into the product hydroxocobalamin (19).
There is an appearance of a peak at 352 nm, and the well defined isosbestic points at 335, 367
nm, and 482 nm indicate a single reaction was accountable for the spectral changes. The final
spectrum is very similar to the spectra of hydroxocobalamin (20, 21).
In contrast, the AdoCbl RNR reaction mixture contained within the light protective tube
exhibited no measurable change in the absorbance spectra over the duration of the experiment
(Figure 2.5B). In this experiment, there is no development of the peak at 352 nm indicating that
there is no light induced photolysis of AdoCbl (see Figures 2.5A).
Controls to verify stability of substrates at 83 C. Before assays were conducted with a
thermophilic RNR enzyme, controls were carried out to determine the stability of substrates at
the organism's temperature optima of 83 'C.
Spectra of DTT in 1.0 mL of buffer (25 mM HEPES, pH 7.5, 10 mM MgCl 2) was
collected at 83 'C to check the stability of DTT at this temperature. The total concentration of
DTT was 30.0 mM. UV/vis spectra were collected from 600 to 240 nm using a Cary 300
spectrophotometer (Figure 2.6). An initial aliquot of 100 pL was collected at 25 oC and the
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sample incubated at for 5 min at 83 'C. Additional aliquots were taken at 15 min and 30 min
after the first 83 'C time point and subsequent spectra recorded from 600 to 240 nm.
The change in absorption spectra between a reduced and oxidized DTT can be monitored
at 283 nm (E283 = 273 M 1 cm-) as was reported by Cleland in 1964 (22). The spectrum of 30
mM DTT in RNR reaction buffer at 25 'C indicates that there is some oxidation (A283 = 0.38)
present in the DTT solution (Figure 2.6). As the temperature is increased to 83 'C, DTT exhibits
an increase in oxidation as seen by the increase in absorbance at 283 nm over the 30 min
duration of the experiment (A283 = 0.68). In RNR assay buffer, there is an 8.33% oxidation of
DTT over the duration of the experiment. Although there is oxidation of DTT at 83 'C in 30
min, the assay is only 7.5 min long.
The stability of AdoCbl in 1.0 mL of buffer (25 mM HEPES, pH 7.5, 10 mM MgCl2) at
83 'C in the presence and absence of DTT was monitored by UV/visible spectra. The total
concentrations of DTT and AdoCbl were 30 mM and 47 gM respectively. UV/vis spectra were
recorded from 600 to 240 nm (Figure 2.7). The spectra of AdoCbl in RNR reaction buffer
(Figure 2.7) or AdoCbl plus DTT in RNR assay buffer (Figure 2.7B) do not show changes within
the absorbance range of AdoCbl. Absorbance differences around 290 nm (Figure 2.7B) can be
attributed to the changes in DTT oxidation state as described above (Figure 2.6).
The stability of substrates CDP and CTP at 83 'C was analyzed using HPLC. A 1.0 mL
reaction solution was prepared consisting of 1.0 mM CDP or 1.0 mM CTP in either 25 mM
HEPES, pH 8.0, 20 mM MgCl 2 or 50 mM Tris-HCl pH 8.0, 20 mM MgC12. These solutions
were incubated at 83 oC for 5 min. An initial 100 ptL aliquot was collected and flash frozen in
liquid nitrogen and lyophilized. Subsequent aliquots were collected at 5 min intervals, treated in
the same manner as described above, for a total of 20 min. Lyophilized samples were
resuspended in 100 jpL HPLC running buffer A (described below).
Chromatographic separation of nucleotides was achieved using an Alltima C18 column
(Alltech Inc., Nicholasville, KY). All analytical columns were 250 x 4 mm, with a 5-pm particle
size. Products were separated from substrate using an isocratic buffer system consisting of 50%
buffer A (10% acetonitrile and 90% H20) and 50% buffer B (10% acetonitrile and 90% 1.5 M
ammonium acetate (pH 7)). The flow rate was 1.0 mL/min, and UV spectra were recorded at 260
nm.
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This method shows that CDP is stable in HEPES (RNR assay buffer) over the course of
20 min (Figure 2.8A). However in Tris-HCI buffer CDP degradation occurs fairly rapidly,
resulting in a >40% loss of CDP over the course of the experiment (Figure 2.8B).
For CTP, over the course of a 20 min experiment in HEPES (RNR assay buffer) at 83 oC,
there is only a slight change in the relative ratios of CTP, CDP, and CMP in the sample between
the initial timepoint at 5 min 83 'C (Figure 2.9A) and the 25 min time point at 83 oC (Figure
2.9B). While some of the CMP and CDP in the 5 min time point is likely due to temperature
dependent degradation, some samples of CTP from our supplier (Sigma-Aldrich) do have CMP
and CDP contaminants. In contrast, when Tris-HCl is used in place of HEPES, the degradation
of CTP is substantially increased. After incubation at 83 oC for five min (T = 5), it is apparent
that a significant amount of CTP has degraded to CDP and CMP (Figure 2.10A) compared to
that of CTP in HEPES buffer (Figure 2.9A). At the 25 min, all of the CTP has degraded to CDP
and CMP (Figure 2. 10B). Due to the temperature sensitivity of the Tris-HCI buffer, all assays of
RNR were conducted with HEPES b0uffer.
HPLC analysis of CDP afuRNR reaction products. An afuRNR reaction consisting of 1.0 mM
CDP was carried out as described above. An initial 100 jtL aliquot was collected and flash
frozen in liquid nitrogen and lyophilized to denature protein. The reaction was allowed to
proceed for a total of 25 min, and a 100 gL aliquot was collected and treated as described above.
Lyophilized samples were resuspended in 100 jtL HPLC running buffer A.
Chromatographic separation of nucleotides was achieved using an Alltima C18 column
(Alltech Inc., Nicholasville, KY). All analytical columns were 250 x 4 mm, with a 5-jim particle
size. The mobile phase consisted of Buffer A (10 mM tetrabutylammonium hydroxide, 10 mM
KH2PO4, 0.25% methanol, pH 7.0) and buffer B (2.8 M tetrabutylammonium hydroxide, 100
mM KH2PO4, 30% methanol, pH 5.5). All mobile phase buffers were filtered and degassed.
Separation of nucleotides was achieved with the Alltima C18 column using a 95 min gradient
0% B, at 20 min 10% B, at 25 min 30% B, at 75 min 55% B, and at 95 min 100% B with a
continuous gradient between concentrations. All separations were performed at the rate of 1.0
ml/min.
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Single base overhang primer extension assay. Three 17-mer oligonucleotides (5'-GTT CTG
AAA ATG GTC GC-3', 5'- CTT CTG AAA ATG GTC GC-3', and 5'-TTT CTG AAA ATG
GTC GC-3') and a complementary 16-mer oligonucleotide (5'-GCG ACC ATT TTC AGA A-3')
were obtained from IDT Inc., and purified on a 20% PAGE gel. Next, each 17-mer
oligonucleotide was phosphorylated at the 5'-end with 1.5 mM 32P-ATP (Perkin Elmer, MA,
USA), in a 1 x T4 polynucleotide kinase buffer, using 20 units of T4 polynucleotide kinase
(NEB, MA, USA) in a volume of 20 tL. The mixture was incubated at 37 'C for 60 min. The
reaction was quenched by heating at 90 'C for 5 min and then desalted using Micro Bio-Spin
chromatography columns containing Bio-Gel P-6 (Bio-Rad Laboratories) to remove
unincorporated ATP. The phosphorylated 17-mers were then incubated with equal amounts of
the 16-mer complementary strand in a 20 tL solution containing 50 mM Tris-HCl, pH 7.6, 10
mM MgCl 2, and 1.0 mM DTT. To allow for strand annealing, the mixture was brought to 90 oC
for 5 min and was then slowly cooled to room temperature before finally cooling to 4 oC.
afuRNR assays were performed as described above but with 1.0 mM CTP, GTP, or ATP
as substrates, 25 mM HEPES pH 7.5, 10 mM MgCl 2, 0.65 jiM afuRNR, 20 mM DTT, and 8.0
gM AdoCbl except as noted in figure legend. Each reaction was run for 10 - 25 min and then
quenched by rapid cooling on ice. A polymerase extension assay was conducted using 10 units
of the Klenow polymerase (New England BioLabs) for 60 min at 37 oC. The sample was
supplemented with denaturing buffer and was heated at 90 oC for 5 min to stop the polymerase
reaction and to denature the oligomers. This step was followed by rapid chilling on ice, and
separation on a 20% polyacrylamide gel with 7.0 M urea, and then visualization of gel using
phosphoimagery (See Scheme 2.3).
The reactions using RTPR were conducted in an assay mixture composed of 1.0 mM
CTP, GTP, or ATP, 25 mM HEPES pH 7.5, 10 mM MgCl2, 1 M NaOAc, 0.85 jiM RTPR, 20
mM DTT and 8.0 tM AdoCbl for 20 min. The polymerase extension assay and subsequent
separation and visualization of reaction were conducted as described above.
RESULTS
Cloning, purification, and characterization of afuRNR. Using the A. fulgidus genome database, a
putative ribonucleotide reductase homologue was identified from a ORFs (Accession no.
AF1664). Comparison of this sequence with all known protein sequences using PSI-BLAST
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revealed sequence similarities with other characterized AdoCbl dependent Class II RNRs (Figure
2.2). The AF1644 gene encodes a protein of 752 amino acids with a predicted molecular mass of
84,456 Da (Figure 2.3). The deduced amino acid sequence suggests that afuRNR does not
contain an N-terminal ATP activation domain found in the T. acidophilum RNR (10); however, it
does contain a conserved CxloC sequence identified as the classic Class II AdoCbl dependent
RNR motif (23). This ORF was subsequently amplified by PCR, cloned, sequenced, and
compared to the sequence in the A. fulgidus genome database.
Purified afuRNR protein yields absorption spectra with absorbance maxima at 279 nm.
Expression and subsequent purification yields -28 mg from a 1 liter culture. The molecular
mass of the protein is estimated to be approximately 84 kDa by SDS-PAGE (Figure 2.4). This
molecular mass is in agreement with values predicted by the gene analysis. The native molecular
mass is determined to be about 160 kDa by gel-filtration using a Sephacryl SEC-200 HR 16/60
column. These results suggest that the native state of afuRNR is a homodimer, similar to other
reported Class II RNRs (10).
Biochemical characterization of afuRNR. To examined whether afuRNR is a Class II enzyme in
that it requires AdoCbl to generate the thiyl radical we carried out activity assays in the presence
and absence of AdoCbl. In the presence of AdoCbl, afuRNR displays enzyme-dependent
reduction of CDP to dCDP. The rate of reduction increases with an increase in afuRNR
concentration (Figure 2.11, red line and blue line). In the absence of AdoCbl, there is no
measurable conversion of CDP to dCDP (Figure 2.11, black line). The MgCl2 dependence of
afuRNR was also investigated. In the absence of MgCl 2, there is CDP reduction, but activity
increases to maximum activity between 1.00 and 10.0 mM MgCl2 (Figure 2.12). The
temperature profile of afuRNR enzyme activity fits the reported optimal growth conditions of 83
'C for A. fulgidus (Figure 2.13). The activity of the enzyme drops significantly at 90 oC and is
abolished at 100 oC. These results show that afuRNR is a Class II RNR whose optimal activity
is at 83 'C and with a concentration of MgCl2 greater than 1.0 mM.
The Km for CDP, AdoCbl, and DTT were determined (see Figures 2.14-2.16). Table 2.1
compares the results for afuRNR with the published results for RTPR and the only other
Archaeal thermophilic RNR; T. acidophilum RNR. The biochemical characteristics of afuRNR
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are comparable to those previously published, with Kms for substrate in mM range and the Km
for AdoCbl in the gtM range.
Substrate phosphorylation state preference. The preference of afuRNR for CMP, CDP, and CTP
was investigated using a radioactive assay. As is true for all RNR enzymes, there is no
discernable activity with CMP (data not shown). However, with CDP and CTP as the substrate,
afuRNR displays reductive activity (Figure 2.17, blue and magenta lines). This result is
surprising since all characterized RNRs have preference for either a diphosphate or a
triphosphate, but do not accept both. As a control, the radiolabeled CDP and CTP substrates
were used with RTPR, an RNR which uses only triphosphates as substrates. As seen in figure
2.17, RTPR exhibits activity when CTP is used as substrate (black line) but there is no
measurable activity when CDP is used (red line).
Because this result is surprising, we wanted to confirm that CDP is in fact being
converted to dCDP and that the observed enzyme activity is not due to a CTP contaminant. Thus
the identity of the product of the afuRNR reaction with CDP as substrate was determined via
HPLC. The HPLC method separates CDP (Figure 2.18A) and dCDP (Figure 2.18B) as shown
by the standard spectra. In addition, CTP can be easily distinguished form CDP or dCDP as it
elutes with a peak separation which is greater than 20 min (Figure 2.18C). Using this method,
we were able to verify that dCDP is being produced by afuRNR, confirming that CDP is a
substrate and that activity with CDP is not due to a CTP contamination (Figure 2.18F,
UV/visible spectra; 2.18G, radioactive trace). Unfortunately, we were not able to use HPLC to
confirm that CTP is a substrate, since it was not possible to resolve the CTP substrate from the
product (data not shown). The lack of definitive identification of CTP reaction products lead to
the development of a primer extension assay to allow for the identification of the products of the
CTP reduction reaction.
The general scheme of the primer extension assay is given in Scheme 2.3. The assay
exploits the ability of a polymerase to incorporate deoxynucleoside triphosphates into a
radiolabeled primer across from the complementary template with a corresponding base pair
overhang. The radiolabeled extended primer is then separated from non-extended substrate
primer on a PAGE gel. Since the Klenow polymerase fails to incorporate ND(T)Ps and only
incorporates their deoxynucleotide counterpart (24-26), this assay tests for RNR activity when
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deoxynucleotides are not provided. Further, to discriminate between the di- versus triphosphate
nucleoside products of the RNR reaction, this assay takes advantage of the discretion of a
polymerase for dNTP over a dNDP.
The results of a primer extension assay with the products from the afuRNR nucleotide
reduction assay are shown in Figure 2.19A. When NTPs are used as substrates for the RNR
reaction, the dNTP products are incorporated by the polymerase into the primer and we observe
the extension of the primer by one base. If NDPs are substituted in the RNR reaction, the
polymerase can not incorporate the dNDPs and as such, there is no primer extension and no
separation on the PAGE gel (Figure 2.19A).
If the activity of the polymerase demonstrated in Figure 2.19 is due to a small
contaminant of dNTP in the NTP samples or if it is due to low level reactivity of the polymerase
with NTPs themselves, there should be no positive correlation between the extent of the RNR
assay and the amount of 17-mer formed by the subsequent primer extension. All time points
should show the same amount of 17-mer or less if the containment is being degraded at the high
temperatures. To investigate this issue of time dependence, the afuRNR assay was run for 180 s
with products removed at various time points. We find a clear dependence on the extent of
afuRNR assay and the amount of 17-mer formed (Figure 2.20A). When the afuRNR assay is
allowed to proceed for longer time periods more 17-mer is produced, providing evidence that the
polymerase activity is due to the time-dependent formation of dNTP by afuRNR and not to a
contamination. When no afuRNR is added in the presence of NTPs, no extension is observed
(Figure 2.19B, C). For comparison with afuRNR, we carried out a similar time-dependent
reaction using RTPR (Figure 2.20B). We find the complete conversion of radiolabeled primer to
the corresponding 17mer occurring after the RTPR assay is run for 120 s. Although the primer
extension reaction using afuRNR-produced products does not proceed to completion like the one
using RTPR produced products, comparison of both results along with the results observed in
Figure 2.19A provide strong evidence that afuRNR can reduce NTPs to their corresponding
dNTPs. We believe that the lack of completion in the case of afuRNR may be due to
temperature dependent degradation or dCTP since that assay was carried out at 83 'C compared
to 37 oC for RTPR.
DISCUSSION
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Due to their central function in DNA replication, RNRs have been targeted in anti-
parasitic, anti-viral and anti-tumor therapies. While RNRs have proven to be successful
chemotherapeutic targets (27), progress with anti-parasitic therapies has been slower. Although
one could imagine that class and species specific differences could be exploited to develop
targeted RNR inhibitors, the lack of biochemical and structural data on the Class II and III
enzymes has impeded their development. In addition, the small number of characterized RNRs
from any class has left questions unanswered about basic properties of these enzymes such as
substrate preference for NDPs versus NTPs, and whether the rules of allosteric regulation are in
fact common to all RNRs. Here we have gone to the extremes of life in studying an RNR from
A. fulgidus, a sulfur-reducing thermophilic Archaeon that grows between 60 'C and 90 'C. By
characterizing this enzyme from this extremophile we are probing the question of which features
of RNRs are truly conserved.
We identified ORF (AF1664) in the A. fulgidus genome as a putative Class II RNR based
on the presence of a highly conserved 10-amino acid sequence block connecting active site
cysteine residues (C322 - C333 in T. maritima; 408 - 419 in L. leichmannii and 436 - 4475 A.
fulgidus). While the identity of all residues in this motif is not completely conserved, the spacing
between cysteines is absolute (23). In Class I RNRs, the distance between the active site
cysteines is more variable. Since these connecting residues in both classes comprise a loop that
runs on the bottom of 1-barrel structure, the rationale for this conservation is not clear (see
Chapter 1 for more discussion). However, this motif does appear to be a good predictor as we
show here that AF1664 is in fact a Class II RNR (Figure 2.22), dependent on AdoCbl for activity
(Figure 2.11s). As with many of the characterized Class II RNRs, size exclusion
chromatography suggests that this Class II enzyme is a dimer.
Due to the high growth temperature of the A. fulgidus organism (60-90 'C), assaying this
RNR is non-trivial. First it was necessary to establish buffer conditions under which substrates
and cofactors are stable at high temperatures. While Tris-HCl buffer did not protect substrates
from degradation at high temperatures, HEPES buffer did (Figure 2.9). To improve
reproducibility, we modified the assay to use liquid nitrogen to quench this high-temperature
reaction rather than ice, which did not cool the reaction quickly enough. We also used light-
protective tubes to prevent light-induced cleavage of AdoCbl, rather than performing the
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reactions in the dark as was done previously (12). Controls with clear and light-protective tubes
show that photolysis is not an issue when the light-protective tubes are used (Figure 2.5). In our
hands, reproducibility was dramatically increased when assays are carried out using light-
protective tubes outside of a darkroom. This assay improvement could be utilized when studying
non-thermophilic Class II enzymes.
With this modified assay in hand, the biochemical properties of afuRNR were
investigated. The activity of afuRNR is enhanced 3 fold in the presence of MgCl 2 concentration
(Figure 2.12), and in terms of temperature-dependence of activity, afuRNR displays very little
measurable activity at 30 oC, which increases slowly until the temperature reaches 60 'C. The
enzyme exhibits the greater than 60% activity between 70 oC and 90 'C with highest activity
measured at 83 'C. At 100 °C the activity is abrogated (Figure 2.13). The 20 oC range of activity
of afuRNR is similar to other RNRs, allowing for deoxynucleotide production under a range of
environmental stresses. Interestingly, the enzyme displays higher CDP reduction in absence of
allosteric effectors than in their presence (data not shown). While this seems to contradict the
rules of allosteric regulation of substrate specificity in which effectors enhance activity with
particular substrates, more work must be done before conclusions are drawn. Because afuRNR's
activity without effectors is comparable to the activity of other RNRs (Table 2.1), all assays were
performed without effectors present. It should be noted that other RNRs are assayed without
effectors. In one case, sodium acetate is used to enhance activity instead of adding effectors to
the reaction mix (28).
afuRNR's unusual behavior with effectors was only the first observation of nonstandard
activity. The investigations of the substrate preference of afuRNR towards nucleotides lead to
surprising results. As expected, there was no activity with CMP as substrate. But when CTP
was substituted for CDP in the reduction assay, the enzyme exhibited reduction activity. When
the kinetic parameters were analyzed, the results were even more perplexing as the K,s for both
CDP and CTP are similar. The K, of afuRNR for CDP is 0.92 mM and the K, for CTP is 1.29
mM (Figure 2.21). The cellular concentrations of nucleotides in A. fulgidus have not been
measured, but assuming that they were within the concentration range of other organisms (For E.
coli: ATP = 3.1 mM, ADP = 0.84 mM, CTP = 0.28 mM, CDP = 0.07 mM, GTP = 0.47 mM, and
GDP = 0.20 mM), both CDP and CTP should be substrates for afuRNR (29).
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One other thermophilic RNR was initially reported to be active with both NDP as well as
NTPs, but upon closer examination, the activity with NTPs was found to be due to temperature
dependent hydrolysis leading to formation of NDPs (30). Our control experiments however
show that in HEPES buffer, CTP does not hydrolyze significantly although it does hydrolyze
more than CDP. To rule out that small amounts of CDP in the CTP sample are responsible for
the measured activities, we set about to verify that dCTP is in fact produced by afuRNR. For
completeness, we also confirmed that CTP contamination of CDP samples is not the source of
the activity with that nucleotide. For the latter, we used an HPLC analysis that clearly
distinguishes dCDP from CDP and CTP (Figure 2.18), allowing us to verify dCDP production.
Unfortunately, this method failed to resolve dCTP as a product of the afuRNR reaction.
However, due to the greater instability of triphosphate nucleotides at 83 'C, it is impossible to
tell if the failure to identify dCTP was due to degradation or to a lack of reactivity with CTP.
Regrettably, the RNR assay requires the removal of all the deoxynucleoside phosphates, making
it impossible to distinguish if the substrate acted upon by the enzyme is a diphosphate or a
triphosphate nucleoside.
The inability to confirm by HPLC the product of afuRNR activity with CTP led to the
development of a primer extension assay (See Scheme 2.3). Since a primer can only be extended
by a polymerase if dNTP is available, primer extension serves as proof of dNTP production.
Negative control experiments with dNDP confirm the lack of primer extension with
deoxynucleoside diphosphates (Figure 2.19A), while a positive control with dNTP-producing
RTPR shows primer extension when an RNR is used as a source of deoxynucleoside
triphosphates. When afuRNR is reacted with CTP, the primer is extended, while no primer
extension is observed with CDP. To rule out that a contaminant of dCTP in the CTP sample
could lead to a false positive, we ran a no-enzyme control in the presence of CTP and the
absence of afuRNR, the primer is not extended confirming that primer extension is afuRNR
dependent. This experiment serves as the best evidence to date that an RNR is active with both
NDPs and NTPs.
In light of the primer extension result for afuRNR, it is interesting to think about the
molecular mechanism among RNR enzymes for determining substrate preference for NDPs and
NTPs. When the structure of Class II RTPR was determined (4), the active site of this NTP-
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specific RNR was compared with that of NDP-specific Class I RNR from E. coli in the hope of
identifying the structural differences responsible for this variation in substrate specificity.
However, there were no obvious structural differences to explain specificity, no extra positively
charged residues to bind the extra phosphate, no extra pocket that could be detected. With the
phosphate binding regions so similar, it is unclear why either enzyme does not bind either
substrate. When the second structure of a Class II RNR became available, this topic was
revisited (31). Unlike the Class II enzyme from L. leichmannii (RTPR), the Class II enzyme
from T. maritima uses NDPs as substrates (10). Again, structural comparisons showed similar
active sites with no clear structural rationale to explain this specificity (Figure 2.23). It should be
noted that all structures currently available are in an open, non-catalytic state. Presumably, the
structure of a closed, catalytic RNR will show variations in the substrate phosphate binding area
that will explain the specificity. However, given the similarities in the size and in amino acid
content in these active sites, the idea of a dual specificity RNR is plausible from a structural
perspective.
While there is nothing inconsistent with the idea of a dual specificity RNR from a
structural perspective, the cellular perspective is harder to rationalize. Maintenance of the levels
of dNTPs is essential to the cell's survival (32). Too much or too little of any given dNTP is
harmful (33, 34). For the majority of organisms that use Class I or Class II RNRs, dNDP are
produced, and the regulation of dNTP levels occurs via nucleotide kinases (35). How the correct
balance of dNTPs can be maintained in the cellular context where the one RNR enzyme
produces both dNDPs and dNTPs is an open question. A genomic investigation of A. fulgidus
shows that it contains all the standard nucleotide kinases to convert nucleotide diphosphates to
nucleotide triphosphates. However, these proteins have not been characterized from this
organism and may enforce a regulatory mechanism that is unique. Another possibility is that the
cellular regulation of this RNR will control dNTP balance. Given that the allosteric regulation of
afuRNR appears to vary from the norm, it is possible that this Class II enzyme has evolved such
that its use of NDP substrates versus NTP substrates is highly regulated, and that either NDPs or
NTPs is rarely, if ever, used under in vivo conditions. Perhaps instability of dNTPs due to high
temperature is a problem for the organism as well as for the scientist studying the organism's
enzymes, and that as a result, A. fulgidus will have nonstandard concentrations of nucleotides.
Further work will be necessary to resolve these questions.
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These studies of an RNR from an extremophile challenge some of the paradigms in the
RNR field. While it is clear that we still have much to learn about this fascinating and medically-
important enzyme family, this work suggests the importance of expanding our studies of these
enzymes to cover additional evolutionary ground. If we wish to exploit species and class
dependent differences between RNRs for drug design purposes, we need more data about RNRs
from outlying organisms. At the extremes, there promise to be some surprises.
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Scheme 2.1 A schematic representation of the classic pattern of regulation as exemplified in
Class I and Class II RNRs. In Class Ia RNRs, overall activity is up regulated when ATP is
bound and down regulated when dATP is bound. The specificity effectors are in brown boxes
and substrates are in light grey boxes. When ATP or dATP is bound at the specificity site, RNRs
preferentially convert CDP or UDP to dCDP or dUDP. The binding of dTTP at the specificity
site preferentially reduces DGP to dGDP and binding of dGTP to specificity site reduces ADP to
dADP. In Class II RTPR the substrates are nucleotide triphosphates instead of nucleotide
diphosphates, but overall, enzyme regulation follows the same pattern.
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Scheme 2.2 Modified RNR 14C radioactive nucleotide reduction assay. (A) Instead of carrying
out the assay in a dark room to avoid light induced C-Co homolysis of AdoCbl cofactor, the
reaction mixture is contained in a 1.5 ml light protective eppendorf tube. (B) At each timepoint a
100 gL sample is removed from the 700 gL reaction mixture and quenched in liquid nitrogen.
(C) Each sample was then subjected to CIP digest to remove all 5'-phosphates. (D) Nucleoside
substrates were separated from deoxynucleoside substrates using the borate affinity column
method. A 1 mL aliquot of elution is mixed with 9 mL of scintillation fluid and subject to
scintillation counting.
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Scheme 2.3 Scheme of primer extension assay. (A) Polymerase lacking a 3' to 5' exonuclease
activity extends the 32P radiolabeled primer by inserting the corresponding base pair. (B)
Reaction mixture is denatured and separated by 20% denaturing PAGE. Bands are then
visualized on a phosphoimagery.
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Table 2.1 Kinetic parameters of A. fulgidus ribonucleotide reductase, L. leichmannii
ribonucleoside triphosphate reductase (36) and T. acidophilum ribonucleotide diphosphate
reductase (37). The assays were carried out as described under experimental procedures, and the
kinetic data were derived from Michaelis-Menten equation. Mean values of at least three
independent measurements, together with standard deviations, are given.
Substrate Km Effector REF
A. fulgidus AdoCbl 11 + 7.6 gM N/A This work
A. fulgidus CDP 0.92 ± 0.55 mM N/A This work
A. fidlgidus CTP 1.29 ± 0.14 mM N/A This work
A. fulgidus DTT 4.18 ± 0.78 mM N/A This work
1.0 mM CTP / 1 mML. leichmannii AdoCbl 0.30 M 1.0 dATP (36)dATP
L. leichmannii CTP 0.13 mM 1 mM dATP (36)
L. leichmannii ATP 0.22 mM 1 mM dGTP (36)
T. acidophilum ADP 0.64 mM 100 gM AdoCbl / 1 mM (37)dGTP
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Figure 2.1 Reaction of RNRs. The thiyl radical generated by the diferric tyrosine radical (Class
I), AdoCbl (Class II), or glycyl radical (Class III) abstracts a hydrogen atom from the substrate
initiating a multi-step rearrangement which results in the net loss of the 2' hydroxyl of the
nucleoside moiety. The reducing equivalents are provided in Class I and II RNRs by the
oxidation of two active site cysteines to a disulfide bond, while in Class III RNRs, the reducing
equivalents are provided by the oxidation of formate. Finally, the thiyl radical is regenerated and
the product, either a dNDP or dNTP is formed (Figure modified from (4)).
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Figure 2.2 Structural alignment of afuRNR and two characterized thermophilic dimeric Class II
RNR sequences from PSI-BLAST (13). Sequences were aligned using the program ClustalW
(14) and the output was rendered using the web interface ESPript 2.2 (15). Sequences are A.
fulgidus (gi:6626247), T. acidophilum (gi:30407158), and T. maritima (gi:12057205). White
letters in red blocks are strictly conserved residues. Numbers correspond to each organism's
amino acid sequence. Red letters in blue boxes are more than 50% conserved residues. Top line
is structural elements of the T. maritima structure (PDB 1XJE). Numbering of core barrel
elements is according to RTPR structure (4)
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Figure 2.2 (cont.) Alignment of selected dimeric Class 11 AdoCbl dependent RNR sequences
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Figure 2.3 DNA and corresponding amino acid sequence of ORF AF1664 from A. fulgidus
encoding for a putative RNR. DNA sequence was verified at the MIT Biopolymers Laboratory.
(black = nucleotide sequence, green = corresponding 1-letter amino acid sequence; numbers on
left correspond to nucleotide numbers)
1 atgaagctca atcgtactgc tgaaactgtg ctcagaaaga ggtatcttct caaggatgat
in k 1 n r t a e t v 1 r k r y 1 1 k d d
61 gaaggtaacg taattgagac tccagaagag atgtgctgga gggttgccag ggcaattgca
e g n v i e t p e e m c w r v a r a i a
121 aaggctgagg agaattacgg aaacaatgct gaagagtggg ctgaaaagtt cttcaagctc
k a e e n y g n n a e e w a e k f f k 1
181 ctctgggagc agaagttcat gcccaactcc ccaacgctga tgaatgcggg gacggagctg
1 w e q k f m p n s p t 1 m n a g t e 1
241 aatcagcttt ctgcatgctt cgtcatcccc gttgaggact ccattgacgg cattttcaag
n q 1 s a c f v i p v e d s i d g i f k
301 gccctctggg atatggcgaa ggttcaaaag agcgggggag ggacgggatt cagcttttca
a 1 w d rn a k v q k s g q g t g f s f s
361 aggctgagac cgaagggaga tatagtaaaa tccacaatgg gcgttgcaag cggaccggta
r 1 r p k g d i v k s t m g v a s g p v
421 agcttcatga aaatatttga tgctgcgacg gagcagataa agcagggagg gaggagaaga
s f m k i f d a a t e q ± k q g g r r r
481 ggggcaaaca tgggcgttct gaacgtccac cacccggaca ttgaggaatt cataaaggcg
g a n m g v I n v h h p d i e e f i k a
541 aaatgggagg agggggtgct gagaaacttc aacatcagcg ttgccgcaac cgacgccttc
k w e e g v 1 r n f n i s v a a t d a f
601 atggaagctt tgaagaaaga tgatgattac gacctcatca accccagaac gggggaggtt
mn e a I k k d d d y d i n p r t g e v
661 gtaaggagag ttcccgccag aaagatattc aatttgattg tggagggagc atggcgcaac
v r v p a r k i f n 1 i v e g a w r n
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Figure 2.3 (cont.) DNA and corresponding amino acid sequence of ORF AF1664 from A.
fulgidus
721 ggagagccgg gaatgatttt catcgacacc ataaaccgct tcaaccccac tccgcacgtg
g e p g m i f i d t i n r f n p t p h v
781 ggacagattg aagcaacaaa cccctgcgga gagcaaccgc tcctgcccta cgaatcctgc
g q e a t n p c g e q p 1 1 p y e s c
841 aaccttggca gcataaacct cgcaaagttc gttaaagatg gggaaatcga ctgggatggg
n 1 g s i n 1 a k f v k d g e i d w d g
901 ctcagggagg ttgtctggat tgccgtgagg tttttggatg acgttatcga tgtcaacagc
I r e v v w i a v r f 1 d d v i d v n s
961 taccccattc ccgaaatcga gcagatgacc aaagccaacc gcaaaatagg tctcggagtt
y p i p e i e q m t k a n r k i g 1 g v
1021 atgggctggg ctgacatgct ctttctgctc aacatcccct acgacagcga tgaagccatc
m g w a d m 1 f 1 1 n i p y d s d e a i
1081 cagcttgctg agaaggtgat gaagttcatt caggaggaaa gtcacagggc ttcgcagcag
q 1 a e k v m k f i q e e s h r a s q q
1141 ctggcggagg agaggggtgt tttccccaac tggaagggca gcgtgtggga gaagaaggga
1 a e e r g v f p n w k g s v w e k k g
1201 ataaagatga ggaacgcaac gacaacaaca atcgcaccaa cgggaacgat aagcattatc
i k m r n a t t t t i a p t g t i s i i
1261 gctggctgtt caagcggaat agagccgatt ttcgctttag catacaagag aacgaacatt
a g c s s g i ep i f a 1 a y k r t n i
1321 cttgacggag aagagttctt cgagataaat gagatattcg aggaagtttt aaggagaaga
1 d g e e f f e i n e i f e e v 1 r r r
1381 gggctgtaca cagatgagct gattgagaaa gttgccgaaa aaggcagcat tcaggaaata
g 1 y t d e 1 i e k v a e k g s i q e i
1441 gaggagattc ccgaggacat aaggagggtc ttcaagtgcg ctctcgacat ctctccagag
e e i p e d i r r v f k c a 1 d i s p e
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Figure 2.3 (cont.) DNA and corresponding amino acid sequence of ORF AF1664 from A.
fulgidus.
1501 tggcatgtga gaatgcaggc ggccttccag aagtacacgg acaatgcggt cagcaaaacc
w h v r m q a a f q k y t d n a v s k t
1561 ataaatatgc cgaactctgc tacgcggaaa gacgttgaga aggctttcct gctggcatac
i n m p n s a t r k d v e k a f 1 I a y
1621 gagcttggat gtaagggcat aaccgtttac agagatggca gcagagagga gcaggttctc
e 1 g c k g i t v y r d g s r e e q v I
1681 agaataaaga aggctgagga ggagaagaag gaggcgaagc cgagaccccc tgccaagtac
r i k k a e e e k k e a k p r p p a k y
1741 atcgagccga ggccgaggcc gaggataacc accggcagaa cgattgagac cagaacaggc
i e p r p :c p r i t t g r t i e t r t g
1801 tgcggttccc tgtatgtgac catcaacgag gacgagtacg ggattgccga agtcttcgtg
c g s 1 y v t i n e d e y g i a e v f v
1861 cagcttggaa aaagcggagg ctgcgctgcg tcgcagacag aggcaatggg gaggctgctt
q 1 g k s g g c a a s q t e a m g r 1 1
1921 tcagtcgcgc ttaggagttg gattgaccct gaggtgctga taaggcagct caagaacata
s v a 1 r s w i d p e v I i r q 1. k n i
1981 cgctgtccct cgccaggatt cgacaacgga gaggtcataa catcctgcgc ggatggagtg
r c p s p g f d n g e v i t s c a d g v
2041 gcaaaggttc tcgaaaagca cctaaaggga gagtacaaga aaataaagtt cgaagttgag
a k v 1 e k 1- 1 k g e y k k I k f e v e
2101 ggaatcaagc ccctcacggc cttcaccggc gaggctgagg agagagagga gccgaggacg
g i k p 1 t a f t g e a e e r e e p r t
2161 aagcagattg gcggagtgtg tcctgaatgc gggaatgttc ttgagtacgg ggagggttgc
k q i g g v c p e c g n v 1 e y g e :T c
2221 gcaacctgca ggttctgcgg gtttacgagg tgcggttga
a t c r f c g f t r c g -
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Figure 2.4 SDS-PAGE (4-20% gradient (w/v)) gel of the isolated afuRNR from the
overexpression of E. coli RosettaTM (DE3) pLysS strain. Lanes 1 and 10 are molecular weight
markers; lane 2 is Ni-NTA flow through; lane 3 is elution buffer A (10 mM TRIS-HCI pH 8.0,
150 mM NaCl, 10 mM imidazole) wash; lane 4 is elution buffer B (10 mM TRIS-HCl pH 8.0,
1.0 M NaC1, 200 mM imidazole) wash; lane 5 is elution buffer C wash (10 mM TRIS-HCl pH
8.0, 150 mM NaCl, 30 mM imidazole); lanes 6-9 are elution buffer D wash (10 mM TRIS-HCl
pH 8.0, 150 mM NaCl, 200 mM imidazole).
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Figure 2.5 Examination of the ability of 'light protective' eppendorf tubes to prevent Co-C
bond homolysis in (A) clear 1.5 mL eppendorf tube and in (B) light protective 1.5 mL eppendorf
reaction tubes (USA Scientific, Ocala, FL). Aliquots were collected at 0 (black line), 2 min (red
line), 4 min (blue line), 6 min (aqua line), 8 min (magenta line), 10 min (green line), and 20 min
(brown line). Arrows indicate the direction of change in absorbance as AdoCbl is converted to
hydroxocobalamin. The formation of hydroxocobalamin is a result of light induced Co-C
homolysis followed by H20 binding. There was no appreciable change in absorbance from the
sample of AdoCbl in the light protective reaction tubes over the time of RNR activity assay.
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Figure 2.6 Stability of DTT at 83 'C in RNR Buffer. An initial UV/visible spectra of DTT (30
mM) was collected at 25 C in RNR buffer (50 mM HEPES, 20 mM MgC12) prior to raising the
temperature to 83 C. After a 5 min equilibration period, spectra were obtained every 5 min for a
total of 30 min. Each spectrum was as follows: 25 C (red line), 83 C after 5 min incubation at
83 C (blue), 83 oC at 20 min (aqua), and 83 C at 30 min (magenta). Black line is buffer blank.
Oxidation of DTT can be monitored by measuring the increase in absorbance at 283 nm.
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Figure 2.7 Stability of AdoCbl at 83 C. (A) Spectral recordings of AdoCbl in light protective
reaction tubes in RNR reaction buffer (25 mM HEPES, pH 8.0, 20 mM MgCl 2) at 83 C (A)
without DTT and (B) with 30.0 mM DTT. Samples were incubated at 83 oC for 5 min and
spectra were collected for a total of 10 min. Graph displays timepoint at 0 (red line), 5 (blue
line), and 10 (aqua line) min. In B, the absorbance in the 290-310 nm wavelength range can be
attributed to the DTT spectra (See Figure 2.6). Black line is buffer blank.
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Figure 2.8 Stability test of CDP in HEPES and Tris-HCl buffer at 83 C. CDP added to both the
RNR reaction buffer (25 mM HEPES, pH 8.0, 20 mM MgC12), and Tris-HCI reaction buffer (50
mM Tris-HC1, pH 8.0, 20 mM MgC12) for 20 min at 83 oC. (A) HPLC elution profile of CDP in
HEPES RNR reaction buffer. (B) HPLC elution profile of CDP in Tris-HCl buffer (50 mM
Tris-HC1, pH 8.0, 20mM MgCl2). Over course of the reaction, CDP was observed to decompose
into CDP and CMP.
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Figure 2.9 Stability test of CTP in HEPES RNR reaction buffer at 83 'C. (A) Initial
HPLC elution profile of CTP in HEPES RNR reaction buffer after 5 min incubation at 83
oC to mimic RNR assay conditions. (B) HPLC elution profile of CTP in HEPES
reaction buffer (25 mM HEPES, pH 8.0, 20 mM MgCl 2) at 25 min. Over course of the
20min, CTP exhibits slight change in ratios of peaks.
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Figure 2.10 Stability test of CTP in Tris-HCI buffer at 83 'C. (A) Initial HPLC elution profile
of CTP in Tris-HCl reaction buffer (50 mM Tris-HC1, pH 8.0, 20 mM MgC12) after 5 min
incubation at 83 'C to mimic RNR assay conditions. (B) HPLC elution profile of CTP in Tris-
HCl reaction buffer at 25 min. There is substantial degradation of CTP after the 5 min reading,
and by 25 min all of the CTP has been decomposed into CDP and CMP.
n6
0.5
0.4
0.3
0.2
0.1
eo.o
o
a 1.0
0.8
0.6
0.4
0.2
0.0
0 20 40
Time (min)
- Chapter 2 - Characterization of afuRNR
Figure 2.11 The RNR from A. fulgidus is AdoCbl dependent. No observable reduction of CDP
by afuRNR in the absence (black line and squares) of AdoCbl, but afuRNR, in the presence of
AdoCbl, reduces CDP to dCDP in an enzyme dependent manner (1 mM [2-14C]-CDP (S.A. = 1.5
x 103 - 3.0 x 103 cpm/nmol), 25 mM HEPES pH 7.5, 10 mM MgC12, 0.40 tM (red line) or 0.80
gM afuRNR (blue line), 9.23 mM DTT and 0.85 jM AdoCbl).
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Figure 2.12 Dependence of afuRNR on MgC12 concentration. The 700 tL reaction mixture
contained 1.0 mM [2- 14C]-CDP (S.A. = 1.5 x 103 - 3.0 x 103 cpm/nmol), 20 mM HEPES, pH
7.5, 0.40 LM afuRNR (30 ptL of 3.5 tg/ tL), 30 mM DTT 29 pM AdoCbl and 0.5 - 15.0 mM
MgC12 and was carried out at 83 oC.
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Figure 2.13 Temperature dependence of afuRNR activity. The afuRNR displays maximum
activity at 83 oC. This is in agreement with the optimal growth temperature of A. fulgidus which
is reported at 83 oC (38). The 700 tL assay mixture contained 1.0 mM [2-14C]-CDP (S.A. = 1.5
x 103 - 3.0 x 103 cpm/nmol), 25 mM HEPES pH 7.5, 10 mM MgCl 2, 0.40 tM afuRNR (30 gL of
3.5 gg/gLL), 29 mM DTT, and 43.4 jtM AdoCbl.
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Figure 2.14 Km Determination of afuRNR for CDP. The aparent Km for CDP is 0.92 +0.16
mM. The 700 pL assay mixture contained 0.06 - 4.9 mM [2-14C]-CDP (S.A. = 1.5 x 103 - 3.0 x
103 cpm/nmol), 25 mM HEPES pH 7.5, 10 mM MgC12, 0.40 gM afuRNR (30 CgL of 3.5 pg/pL),
30 mM DTT and 35.0 pM AdoCbl at 83 'C.
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Figure 2.15 Km Determination of afuRNR for AdoCbl. The aparent Km for AdoCbl is 11 ±7.6
[iM. The assay mixture contained 1.0 mM [2-14C] CDP (S.A. = 1.5 x 103 - 3.0 x 103 cpm/nmol),
25 mM HEPES pH 7.5, 10 mM MgC12, 0.40 CiM afuRNR (30 ltL of 3.5 ig/L), 29 mM DTT
and 0.74 - 43 M AdoCbl at 83 oC.
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Figure 2.16 Km Determination of afuRNR for DTT. The aparent Km for DTT is 4.18 ±0.78
mM. The assay mixture contained 1.0 mM [2-14C]-CDP (S.A. = 1.5 x 103 - 3.0 x 103
cpm/nmol), 25 mM HEPES pH 7.5, 10 mM MgC12, 0.40 tM afuRNR (30 pL of 3.5 tg/[pL), 26
gM AdoCbl, and 0 - 36 mM DTT at 83 oC.
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Figure 2.17 Reduction of CDP and CTP by afuRNR and RTPR. afuRNR reduces both CDP
(blue line) and CTP (magenta line) to their corresponding deoxynucleotides under RNR reaction
buffer conditions. In contrast, RTPR reduces CTP (black line) to dCTP but does not reduce CDP
(red line) to dCDP. A 700 jpL afuRNR assay mixture contained 1.0 mM [2- 14C]-CDP or [2-14C]-
CTP (S.A. = 1.5 x 103 - 3.0 x 103 cpm/nmol), 25 mM HEPES pH 7.5, 10 mM MgCl 2, 0.40 tM
afuRNR, 26 pM AdoCbl, and 35 mM DTT at 83 'C. A 700 tL RTPR assay mixture contained
1.0 mM [2-14C]-CDP or [2-14C]-CTP (S.A. = 1.5 x 103 - 3.0 x 103 cpm/nmol), 25 mM HEPES
pH 7.5, 1.0 M NaOAc, 10 mM MgCl 2, 0.48 CtM RTPR, 8.0 pM AdoCbl, and 30 mM DTT at 37
oC.
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Figure 2.18 HPLC analysis of afuRNR CDP reaction. (A) UV/visible spectra of CDP standard
elution profile. (B) UV/visible spectra of dCDP standard elution profile. (C) UV/visible spectra
of CTP standard elution profile. (D) UV/visible spectra of afuRNR reaction mixture before
addition of AdoCbl. (E) Radiogram of afuRNR reaction mixture before addition of AdoCbl. (F)
UV/visible spectra of afuRNR reaction after 20 min. (G) Radiogram of endpoint of afuRNR
reaction after 20 min.
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Figure 2.19 Primer extension assay measuring incorporation of dNTPs produced by afuRNR
reaction. (A) Reactions were run in the presence and absence of each NTP or NDP as control for
nucleotide insertion to its complementary base. The 1+ (18-mer) primer extension seen in the
ATP product extension is a known artifact of the Klenow fragment polymerase attributed to high
concentration of dATP. (B) Primer extension is afuRNR dependent. Due to the longer
incubation time (25 min) and the higher afuRNR concentration (300 gM) all of the 16mer is
converted to 17mer. The lane marked 'P' is the primer control. (C) The incubation of NDPs,
dNDPs, or NTPs in RNR assay buffer mixture in the absence of afuRNR does not lead to primer
extension by the Klenow fragment polymerase.
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Figure 2.20 Primer extension assay showing incorporation of dNTPs. (A) Time course of
afuRNR dNTP products incorporated into complementary strand using Klenow fragment
polymerase. (B) Time course of RTPR dNTP products incorporated into complementary strand
by Klenow fragment polymerase.
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Figure 2.21 Km Determination of afuRNR for CTP. The apparent Km for CTP is 1.3 ±0.14
mM. The 700 tL reaction mixture contained 0.07 - 5.25 mM [14 C]-CTP (S.A. = 2.0 x 103 - 3.0
x 103 cpm/nmol), 25 mM HEPES pH 7.5, 10 mM MgC12, 0.46 pM afuRNR, 30 mM DTT and
35 pM AdoCbl at 83 'C.
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Figure 2.22 Sequence alignment of Class II RNRs showing the conserved motif,
NPC(G/A)EX 8C(N/V)L, between the active thiyl radical cysteine (C436) and one of the redox
active cysteines, (C447). The two cysteines are highlighted by a star at the bottom of the
alignment. The spacing between these two cysteines varies between 12 and 15 amino acids for
Class I RNRs.
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Figure 2.23 Stick and surface representation of T. maritima and RTPR active site. (A) Stick
representation of the active site of T. maritima with GDP co-crystallized in the active site plus
residues within 4 A of substrate. (B) Surface representation of T. maritima active site with
substrate. (C) Stick representation of the active site of RTPR with GDP modeled in the active
site and residues within 4 A of substrate. (D) Surface representation of RTPR active site with
modeled substrate. Colors correspond to: red for oxygen, dark blue for nitrogen, and grey for
carbon. The active site cysteine is colored in Yellow in the space fill model.
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INTRODUCTION
Tight regulation of the cellular redox environment is crucial for cell survival.
Cellular viability relies on the reduction of metabolites for energy production, on the
oxidation of small molecules to assemble structural scaffolds, and on the maintenance of
the proper disulfide state in the extracellular or intracellular environments. An imbalance
in redox regulation can trigger a cascade of genetic responses, the most extreme of which
can lead to cell death (Reviewed in (1-3)).
The principal protein systems that act as reductants are NADPH-dependent
thioredoxin reductase (TrxR) / thioredoxin (Trx), and glutathione reductase (GrR) /
glutathione (GS) / glutaredoxin (Grx) (Figure 3.1A) (1, 2, 4, 5). NADPH reduces the
FAD of TrxRs, which in turn reduces Trxs through disulfide exchange (Figure 3.1B).
The TrxR / Trx system is responsible for providing reducing equivalents for many
cellular processes including the reduction of ribonucleotide reductase (RNR) during the
conversion of nucleotides to deoxynucleotides (6). This reaction is essential for
maintaining the appropriate levels of deoxynucleotides in the cell for DNA repair, and for
cellular replication (7, 8). The significance of the redox regulation of these and other
biochemical pathways has lead to renewed interest in anti-bacterial or anti-tumorgenic
therapies that are targeted to disrupt redox regulation (1, 9, 10).
Here we study putative TrxR and Trx from Thermoplasma acidophilum, an
organism first isolated from a self-heating coal refuse pile at the Friar Tuck mine in
southwest Indiana. This organism lacks a cell wall and optimal growth occurs at 59 'C
and at pH 1-2 (11). Despite the organism's ability to grow at low pH, the cytoplasmic pH
of T. acidophilum was reported to be between 5.5 and 6.9 (12, 13). The 1.56 Mb
genomic sequence of T. acidophilum encoding 1,509 open reading frames (ORFs) has
been reported (14), allowing us to identify a putative TrxR (Ta0984) and Trx (Ta0866).
We report the cloning, expression, and purification of gene products Ta0984 and
Ta0866, and show that Ta0866 exhibits thioredoxin-like activity, and that Ta0984 is able
to reduce T. acidophilum Trx (taTrx), establishing its identity as a thioredoxin reductase.
An accompanying paper describes the full electrochemical characterization of T.
acidophilum TrxR (taTrxR). While the redox potential is within the expected range for
TrxRs, we find that the standard TrxR reducing agents NADPH or NADH do not reduce
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the taTrxR flavin. The X-ray structure of taTrxR to 2.35 A resolution presented here
reveals a major modification of the classic TrxR NADPH binding site, suggesting that T.
acidophilum may utilize a novel reductant.
EXPERIMENTAL PROCEDURES
Materials. The organism Thermoplasma acidophilum (ATCC number 27656) was
obtained from the American Tissue Culture Center. TOPO and TOPO Zero Blunt PCR
cloning kits were obtained from Invitrogen (Carlsbad, CA). NovaBlue competent cells,
RosettaTM (DE3) pLysS competent cells, and pET28a plasmid were purchased from
Novagen (Madison, WI, USA). pfuTurbo DNA Polymerase and a PCR Optimization Kit
were obtained from Stratagene (Cedar Creek, TX, USA). Primers were obtained from
Integrated DNA Technologies (Coralville, IA, USA). Nickel nitrilotriacetic acid (Ni-
NTA) was purchased from Qiagen (Valencia, CA, USA). Restriction enzymes were
purchased from New England BioLabs (Beverly, MA, USA). Kanamycin,
chloroamphenicol, TRIS-HCl, ethylenediaminetetraacetic acid (EDTA), and
phenylmethylsulfonylfluoride (PMSF) were obtained from Sigma-Aldrich (St. Louis,
MO, USA).
Genomic analysis of Thermoplasma acidophilum genome. The genome of
Thermoplasma acidophilum DSM1728 (RefSeq NC_002578, GenBank AL139299) was
analyzed using the web interface at the National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov) for putative thioredoxin reductase (TrxR) and thioredoxin
(Trx) open reading frames (ORFs). An ORF encoding a 319 amino acid protein, Ta0984,
and an ORF encoding for a 113 amino acid protein, Ta0866, were identified by sequence
homology to known TrxRs and Trxs using PSI-BLAST (15). Protein sequences were
aligned using the program ClustalW (16) and the output was rendered using the web
interface ESPript 2.2 (17) (Figure 3.2 and 3.3).
Cloning of taTrxR and taTrx. The taTrxR and taTrx genes were amplified by the
polymerase chain reaction (PCR) using genomic DNA from a cell suspension and the
primers 5'- A TGC CAT ATG GCA TAT GGA ATT TAA CCT GCA TGC AGT A-3'
and 5'-TCA GCC AAG CTT CAT TTT TTG GAT ATA GAA TCA-3' for taTrxR and 5'
A TGC CAT ATG GCA TAT GAA GAA TTA TAT GGG CTG CG-3' and 5'-TAG CGG
CCG CTC AGA CGG AAT CGC AGG GA-3' for taTrx (restriction sites are underlined).
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PCR products were cloned into the expression vector pET28a using NdeI and HindIII
restriction enzymes for taTrxR and NdeI and NotI for taTrx. The sequence of the
pET28a-taTrxR and pET28a-taTrx cDNA was confirmed at the MIT Biopolymers
Sequencing Facility (Figures 3.4 and 3.5). After confirmation of the correct sequences,
the resulting constructs were transformed into RosettaTM (DE3)pLysS cells for facile
protein expression.
Purification of recombinant taTrxR and taTrx. RosettaTM (DE3)pLysS transformed with
either pET28a-taTrxR or pET28a-taTrx constructs were used to inoculate TB media
supplemented with 20 jlg mL- kanamycin and 34 jg mL chloroamphenicol. The
culture was grown at 37oC to an OD600 of 0.8 and induced with 0.8 mM isopropylthio-3-
D-galactoside (IPTG) (not in materials)for 4 hrs. The cells were harvested by
centrifugation, resuspended in lysis buffer (10 mM TRIS-HCl pH 8.0, 150 mM NaC1, 10
mM imidazole, 1 mM PMSF), and disrupted by sonication using a Digital Sonifier 250
(Branson, CN, USA). Insoluble material was removed by centrifugation at 40,000 x g
using a Beckman Avanti J-25 centrifuge (Beckman, PA, CA, USA). The supernatant was
subjected to heating at 700 C for 45 min, and then centrifuged at 40,000 x g. The clarified
supernatant was loaded onto a Ni-NTA column, washed with high salt buffer, and eluted
with buffer containing 10 mM TRIS-HCl pH 8.0, 150 mM NaC1, 200 mM imidazole.
Eluted fractions were analyzed by an SDS-PAGE 4-20% gel and those fractions
containing proteins with comparable size to taTrxR or taTrx were concentrated using an
Amicon (Millipore, MA, USA) ultrafiltration stir cell.
The eluted protein was dialyzed overnight in 20 mM HEPES, pH 7.5, 20 mM
NaCl, 0.5 mM EDTA, 1 mM 1,4-dithio-DL-threitol (DTT) with thrombin (0.05 unit mL
1) to remove the N-terminal poly-His-tag. The digested protein fraction was loaded onto
an SEC-30 high-prep size exclusion column from Amersham Biosciences (Piscataway,
NJ, USA), which was pre-equilibrated with storage buffer (10 mM HEPES, pH 7.0, 20
mM NaCI). Fractions containing protein of either MW -34 kDa (taTrxR) or MW -13
kDa (taTrx) were concentrated using Centriprep YM-3 filter from Amicon (Millipore,
Bedford, MA, USA). Protein purity was analyzed by SDS-PAGE 4-20% gel (Figure 3.6)
and protein concentration was determined from the theoretical extinction coefficient at
280 nm (23,040 M-1 cm' for taTrxR and 16,500 M-'cm- for taTrx) (ProtParam, ExPaSy
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web server). A Cary 300 spectrophotometer (Varian, CA, USA) was used to analyze the
purified taTrxR for flavin incorporation.
Temperature stability ofNADPH and NADH. NADPH (0.22 pM) and NADH (0.26 tM)
were analyzed for temperature dependent degradation in 50 mM TRIS-HC1, pH 7.5, 150
mM NaCl (Figure 3.7). Initial UV-visible spectra were collected at 20 oC from 800 to
240 nm. The temperature was increased to 800 C and the reaction was allowed to
equilibrate for 5 min before full spectra were collected. The reaction was cooled to 200 C
and then another full spectrum was collected. To measure time dependent degradation,
NADPH or NADH was heated to the desired temperature (20 oC, 60 oC, and 80 'C) and a
reading was collected at 340 nm in 5 min increments for 45 min. Degradation of
NADPH or NADH was inferred from the decrease in absorbance at 340 nm normalized
to 100 % of the absorbance for the sample at time zero. Experiments were performed in
triplicate.
Activity of taTrx measured by insulin and DTT assays. Purified taTrx was assayed for
disulfide reductase activity by the insulin reduction method (18). The standard assay
mixture contained 1.25 mM bovine insulin, 100 mM potassium phosphate, pH 7.0, 2 mM
EDTA and taTrx (43 gM, 66 ItM, or 70 jtM). The reaction was initiated by the addition
of 1 mM DTT. An increase in absorbance at 650 nm was monitored at 25 'C.
Purified oxidized taTrx was also assayed for its ability to be reduced by ecTrxR
using the 5,5'-dithiobis(2-nitrobenzoate (DTNB) method (19). Briefly, this colorimetric
assay measures the Trx dependant reduction of DTNB to 5-thio-2-nitrobenzoic acid
(TNB), which absorbs strongly at 405-414 nm, using TrxR and NADPH as electron
donors. The reaction was performed using 3.8 tM ecTrxR, in 50 mM TRIS-HC1, pH 8.0,
2 mM EDTA, 0.5 mM NADPH, and 0.6 mM DTNB. Each assay was initiated by the
addition of taTrx (5 - 60 jM) to reaction mixture and the conversion of DTNB to TNB
was monitored by the increase in absorbance at 412 nm.
Titration of taTrxR and ecTrxR with NADPH and NADH. taTrxR (43.3 jtM) was titrated
with NADPH or with NADH (0.5 to 5.0 mole NAD(P)H / mole FAD) under anaerobic
conditions at 590 C in 50 mM TRIS, pH 7.5, 150 mM NaCl. Spectra were collected from
800 nm to 240 nm to monitor the reduction of the enzyme bound flavin by NADPH or
NADH. ecTrxR (40.5 jtM) was titrated with NADPH or with NADH (0.5 to 5.0 mol
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NADPH or NADH / mol FAD) under anaerobic conditions at 25 'C in 50 mM TRIS, pH
7.5, 150 mM NaC1. Spectra for NADPH reduction of ecTrxR were recorded as described
above. The reduction of bound FAD was monitored by observing the change in
absorbance at 457 nm over 45 min. For taTrxR, spectra were collected every minute and
for ecTrxR spectra were collected every 0.1 min for initial 5 min and then every 5 min
thereafter.
Ability of taTrxR to reduce taTrx. To verify that the reduced taTrxR was capable of
passing electrons to taTrx, the xanthine/xanthine oxidase reduction system, described by
Massey and co-workers, was used (20). After complete reduction of a sample of taTrxR,
the re-oxidation of taTrxR (4 1 M) was monitored spectroscopically in the visible region
following the addition of taTrx or ecTrx (8 jtM). The taTrxR reduction system was as
follows: in a 1 cm path length cuvette stirred continuously and held at 250 C in an
MBraun Labmaster glove box, a solution of 100mM phosphate buffer (pH 7.5) with 1
jtM benzyl viologen, 250 tM xanthine and 4 RtM taTrxR, an aliquot of xanthine oxidase
was added to a final concentration of- 0.25 nM, to initiate the reaction. This solution
was monitored in the visible region of the spectrum, using an SI Photonics
spectrophotometer contained within the glove box, over the course of 1.5 hours, upon
which complete reduction of the taTrxR was achieved. Oxidized Trx was then added to a
final concentration of 8 gM, and the spectral features were monitored.
Analysis of T. acidophilum genome for alternative redox regulation pathways. To
investigate if T. acidophilum uses alternative characterized reduction pathways, the T.
acidophilum genome was mined for known pathways by using NCBI BLAST (15) to
compare known proteins involved in the formation of glutathione or of coenzyme F420 to
the ORFs of T. acidophilum. Pathway members were identified using ExPASy
PATHWAY service (http://ca.expasy.org/cgi-bin/lists?pathway.txt).
Crystallization and data collection. taTrxR was crystallized by incubating 2.0 AL of
protein solution (65 mg mL-1 taTrxR in 10 mM HEPES, pH 7.5 and 20 mM NaCl) and
2.0 jL of precipitant solution (0.28 M MgCI 2, 0.1 M Bis-Tris, pH 5.5, 25% (w/v) PEG
3350) in a sitting drop at room temperature. Crystals had rhombohedral geometry, and
their bright yellow color confirmed the incorporation of flavin adenine dinucleotide
(FAD) by the enzyme. Crystals appeared cubic and grew to approximately 100 gm per
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side in 3 to 4 days. These crystals were soaked for 30 seconds in a cryo-protectant
solution of 0.28 M MgCl2, 0.1 M Bis-Tris, pH 5.5, 25% (w/v) PEG 3350, 25% PEG 400,
before cryo-cooling in liquid nitrogen.
All diffraction data were collected at 100 K at the Advanced Light Source
(Berkeley, CA), beam line 5.0.2. Data were processed and scaled using DENZO and
SCALEPACK from the HKL (21) program suite (See Table 1). The crystals belong to
the 123 (I-centered cubic) space group (a = b = c = 165.95 A), with one homodimer per
asymmetric unit.
Molecular replacement solution and refinement. The crystal structure of the thioredoxin
reductase was solved by the method of molecular replacement. Initial phases were
obtained from a full length poly-alanine model of thioredoxin reductase from Escherichia
coli (PDB code 1TDE) (22). The solution was found using PHASER (23) with two
search models consisting of the flavin binding domain and the NADPH-binding domain
of the E. coli structure, utilizing data from a resolution range of 4.0 - 12.0 A. PHASER
was first used to find a solution for the FAD-binding domain of taTrxR (residues 1 - 126
and 250 - 319). This solution was fixed and a second round of molecular replacement
was performed to find the NADPH-binding domain (residues 127 - 249).
Refinement was carried out in CNS (24) with rigid body refinement followed by
simulated annealing. Manual fitting of amino acid residues was done using XFIT (25).
Subsequent rounds of refinement included simulated annealing, energy minimization, and
B-factor refinement without sigma cutoff. Topology and parameter files for the FAD
moiety were obtained from HIC-UP (26) (PDB code 1NIP). Water molecules were
added with CNS and were manually checked against 2Fo-Fc and Fo-Fc electron density
maps. A composite omit map was prepared in CNS and used to confirm the assignment
of model atoms. The final model contains a biologically relevant dimer in the
asymmetric unit, which consists of residues 14-319 for molecule 'A' of 319 and residues
13-319 of 319 for molecule 'B', one flavin molecule per monomer and 114 water
molecules.
RESULTS
Cloning, purification, and characterization of taTrxR and taTrx. Using the T.
acidophilum genome database, we identified two ORFs (Accession no. Ta0984 and
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Ta0866): one encoding a putative thioredoxin reductase and the other one encoding a
thioredoxin homologue. The Ta0984 gene encodes a protein of 319 amino acids with a
predicted molecular mass of 34116 Da (Figure 3.4). The deduced amino acid sequence
contains 28% identity (48% similar) to the ecTrxR (Figure 3.2). The Ta0866 gene
encodes a 133 amino acid protein (Figure 3.5) with a CxxC disulfide-reducing motif and
displays 34% identity (58% similarity) to ecTrx (Figure 3.3). These ORFs have been
amplified by PCR, cloned, sequenced, and compared to the sequence in the T.
acidophilum genome database.
The purified taTrxR yields visible absorption spectra typical for flavoproteins
with absorbance maxima at 380 and 460 nm. Freshly purified protein has an A280 / A460
ratio of between 7.5 and 8.0, in agreement with the full incorporation of FAD as
previously observed for ecTrxR (27). Expression and subsequent purification yields
-18.5 mg from a 1 liter culture. The molecular mass of the protein is estimated to be
approximately 34 kDa by SDS-PAGE (Figure 3.6A). This molecular mass is in
agreement with values predicted by the gene analysis. The native molecular mass is
determined to be about 70 kDa by gel-filtration using a Sephacryl SEC-75 HR 16/60
column. These results suggest that the native state of taTrxR is a homodimer, similar to
ecTrxR (28). Expression of taTrx yields a protein of 13.2 kDa as analyzed by SDS
PAGE (Figure 3.6B). Subsequent gel-filtration using a Sephacryl SEC-30 HR 16/60
column reveals a native molecular mass of -13 kDa, suggesting that the taTrx is a
monomer in its native state.
Lack of activity of taTrxR with NADPH or NADH. All previously characterized TrxRs
are reduced by NADPH (Reviewed in (2, 29, 30)). For ecTrxR, reaction of NADPH with
the FAD cofactor occurs rapidly (2,000 turnovers FAD-' min-') with a Km for NADPH of
1.2 tM (31). While there is no measurement of Km for NADH with ecTrxR, it has been
estimated to be 400 fold higher than that of NADPH (28). Therefore, it is surprising that
titration of taTrxR with concentrations of up to 5 fold molar excess NADPH does not
reduce its FAD cofactor, showing no spectral change in the visible part of the spectra
(Figure 3.8A). For comparison, titration of ecTrxR with NADPH results in a rapid
reduction of the bound FAD, decreasing the absorbance at 460 nm (Figure 3.8C).
Titration of taTrxR with NADH shows minimal reduction of FAD as indicated by the
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small change in the shoulder at 460 nm (Figure 3.8B). Although NADPH is the preferred
substrate for ecTrxR, NADH does reduce the flavin to some extent in this protein (Figure
3.8D). The reduction is, in fact, greater than that observed for taTrxR. Compared to the
rapid reduction of ecTrxR by NADPH (turnover rate is 2,000 FAD -1 min -1) (31), the
changes observed for taTrxR appear too slow and too small to be physiologically relevant
(Figure 3.8E). The inability of NADPH or NADH to rapidly reduce taTrxR is not due to
instability of these components at 59 oC, the physiological temperature of T. acidophilum.
Analysis of the time-dependent degradation of NADPH and NADH at 59 oC shows that
there is negligible degradation at 5 min under assay conditions, not enough to explain this
lack of activity (Figure 3.7). At the higher temperature of 80 OC, degradation is
increased, but even then less than 10% of NADPH or NADH is degraded during the first
five minutes of the assay, and only 30% is degraded by 45 minutes (Figure 3.7).
Disulfide reductase activity oftaTrx. The lack of measurable activity between taTrxR and
NADPH prevented the use of a coupled assay for taTrx activity, requiring us to turn to
other methods to characterize the taTrx. The reduction of insulin disulfides can be
monitored by following the increase in turbidity at 650 nm due to the precipitation of the
free B-chain (18). The recombinant taTrx reduced insulin in a protein concentration-
dependent manner (Figure 3.9). To investigate whether taTrx is able be reduced by
ecTrxR we performed the DTNB assay using NADPH, ecTrxR, and taTrx. taTrx is
reduced by ecTrxR, with an estimate of the apparent Km of 14.4 (±7.0) 1iM for the
ecTrxR (Figure 3.10). This Km value is higher than for the ecTrxR / ecTrx system (Km of
2.8 jiM) (31), which is not surprising in that the two proteins (ecTrxR and taTrx) did not
evolve to interact. These experiments confirm that the taTrx is a thioredoxin-like protein
capable of performing disulfide exchange.
Thioredoxin reductase activity of taTrxR. To verify that taTrxR can catalyze a disulfide
exchange with taTrx, we pre-reduced taTrxR using a modified xanthine / xanthine
oxidase system (see methods) at 25 oC; after complete reduction of the taTrxR flavin, the
reduced enzyme was treated with oxidized taTrx. Upon the introduction of two
equivalents of taTrx, the taTrxR was rapidly oxidized, achieving complete re-oxidation
of the FAD within one min (Figure 3.11). This experiment indicates that taTrxR is a
biologically relevant TrxR, which does not use NADPH as a reductant.
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Overall Structure. The structure of taTrxR was solved to 2.35 A resolution with the
physiological dimer in the asymmetric unit and an R and Rfree of 22.6% and 26.8%,
respectively (See Table 1 for statistics). Each taTrxR monomer consists of an FAD-
binding domain (residues 14-125 and 251-319) and an "NADPH binding domain"
(residues 126-250) (Figure 3.12A). Each domain of taTrxR is quite similar to the
equivalent domain of ecTrxR, with an r.m.s.d. of 1.23 A for the 166 Ca of the FAD-
binding domain, and an r.m.s.d of 1.17 A for 121 Ca of the "NADPH-binding domains"
(Figure 3.12B and 3.12C). The taTrxR structure has one FAD molecule bound in a
similar conformation as the ecTrxR structure (Figure 3.13), and with similar protein-FAD
interactions (Figure 3.14).
ecTrxR is known to undergo a large conformational change during catalysis,
rotating between a "flavin oxidizing" form (FO) and a "flavin reducing" form (FR) (22,
32, 33). In the FR form, the FAD domain is positioned such that NADPH can reduce the
FAD by hydride transfer (Figure 3.12A). In the FO form, the FAD domain is positioned
above the disulfide such that the FADH2 can be oxidized by the disulfide. Structures of
both conformations are available for the E. coli enzyme: the structure of wild type
ecTrxR represents the FO state, and a structure of a complex between ecTrxR and ecTr
represents the FR state. Interestingly, while all other structures of uncomplexed TrxRs
are in the FO state, the taTrxR structure is of the FR form. The taTrxR FR conformation
is very similar to that of ecTrxR in the FR state with an r.m.s.d. of 1.30 A for chain A and
1.73 A for chain B when all the C] atoms are superimposed. As with the ecTrxR FR
structure, the taTrxR FAD domain is positioned near the putative NADPH binding site,
and away from the catalytic cysteines (Cysl45 and Cys148), which are oxidized with an
S-S distance of 2.04 A. A discussion of the conformational dynamics of TrxRs is
available in the accompanying paper.
Major Differences in the Domain that Typically Binds NADPH. Structural
superposition of the "NADPH binding domains" from ecTrxR and taTrxR reveal that the
backbone of residues 184 - 191 of the taTrxR structure is constrained into a slightly
different conformation than is found in ecTrxR. This different loop conformation
appears to result from the presence of a proline (P188) in the taTrxR sequence (Figure
3.15C), and not the presence or absence of nucleotide in the structure (Figure 3.17). This
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variation in loop conformation is subtle and is unlikely to explain the lack of affinity of
NADPH for the ta enzyme. In contrast, while the "NADPH-binding domains" for
taTrxR and ecTrxR display an overall similar fold, close examination reveals several
highly conserved residues in all bacterial TrxRs that are not conserved in the taTrxR
sequence. The ecTrxR structure, which was co-crystallized with NADP+, shows that the
NADPH 2'-phosphate is surrounded by a histidine (H175) and three arginines (R176,
R177, and R181) creating a positively charged pocket that complements the negatively
charged phosphate (Figures 3.15A, 3.18A, and 3.16A). The lower activity (400-fold) for
NADH compared to NADPH (28) is presumably due to the loss of interactions between
the cofactor and residues that form this positively charged pocket (Figure 3.18C). In
taTrxR, none of the residues that form this pocket are conserved. The classic NADPH
binding motif 'VxxxHRRDxxRA' is replaced with 'VxxxEYMPxxMC' in taTrxR
(Figure 3.15D). ecTrxR's histidine 175, which points directly toward the 2'-phosphate of
the NADPH, is substituted with a glutamic acid (El 185) in taTrxR, and the three arginine
residues (R176, R177, and R181) are replaced by a tyrosine (Y186) and two methionines
(M187 and M191) (Figures 3.15B and 3.15C). These substitutions dramatically change
the electrostatics of this protein surface (Figures 3.18 and 3.16). In a model of NADH
bound to taTrxR, an unfavorable interaction between E185 and the 2'-phosphate of
NADPH is relieved (Figure 3.18D), but neither NADPH nor NADH would be expected
to bind with any kind of reasonable affinity, consistent with the lack of rapid reduction of
FAD by these molecules. Analysis of all known bacterial and archaeal genomes shows
that only one other organism, the close cousin to T. acidophilum, Thermoplasma
volcanicum, contains an identical 'VxxxEYMPxxMC' sequence. All others use a variant
of the Arg-rich 'VxxxHRRDxxRA' motif.
DISCUSSION
The protein derived from Ta0984 is a thioredoxin reductase. Our structural and
biochemical studies reveal a protein with a FAD cofactor and an overall similar fold to
the ecTrxR. However, unlike all other characterized TrxRs, taTrxR is not reduced by
NADPH. This lack of reactivity is not due to redox potential differences between TrxRs
(See accompanying paper). The redox potential of taTrxR is similar to that of ecTrxR (-
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305 vs. -270 mV) (34), and when reduced with a xanthine / xanthine oxidase system,
taTrxR is able to react stoichiometrically with taTrx.
Examination of the taTrxR structure suggests that the lack of activity with
NADPH is due to amino acid substitutions as compared to the E. coli enzyme. The
"NADPH-binding site" of taTrxR does not appear to be designed to bind NADPH, with
neutral and negatively charged amino acids replacing the canonical Arg-rich motif. The
"NADPH-binding site" is also structurally constrained by P188. Sequence analysis
shows that only one other organism, the closely related Thermoplasma volcanicum,
shares taTrxR's unusual sequence.
The lack of a NADPH-dependent TrxR / Trx reduction system in T. acidophilum
led us to investigate whether this organism might rely heavily on GrR / Grx systems
instead of on thioredoxins. Analysis of the T. acidophilum genome, however, revealed
no GrR / Grx system, nor enzymes for the biosynthesis of glutaredoxin (35). Our
extensive data mining and sequence alignments have not produced any near or distantly
related GrR / Grx proteins from this organism.
We also considered whether T. acidophilum uses NADH or NADPH in other
cellular processes. Our genomic analysis reveals a putative NAD kinase, the enzyme
responsible for the conversion of NAD to NADP, and several putative NADH and
NADPH utilizing enzymes, which suggests that T. acidophilium does use these cofactors.
To date, there are only a few characterized enzymes in T. acidophilum that use NADH
(aldohexose dehydrogenase) (37) or NADPH (glyderaldehyde dehydrogenase) (36) or
both NADH and NADPH as substrates (38). However, the use of NADPH or NADH by
any T acidophilum enzyme, in addition to the presence of the NAD kinase gene,
indicates that availability of these cofactors is not the reason for the observed variation in
the TrxR protein.
The above data challenges the paradigm shown in Figure lA. Our data blocks the
arrow to the left, and the lack of GrR / Grx blocks the arrow to the right. Given this, we
revisited the T. acidophilum genome to search again for other putative TrxR sequences
and found none. Unless there is a TrxR with a very different sequence, we have cloned
the only one in T. acidophilum.
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If NADPH does not reduce this taTrxR, and this TrxR is the only TrxR in T.
acidophilum, and there are no obvious GrR / Grx candidates, there must be some small
molecule that can provide reducing equivalents or the cytoplasmic environment would
quickly oxidize and the organism would expire. One such molecule, coenzyme F420, has
been shown to be a physiological reductant in methane reducing thermophilic organisms
(Reviewed in (39-41)). However, genomic analysis of T. acidophilum does not reveal any
of the enzymes involved in the biosynthesis of F420. The lack of molecular pathways for
the biosynthesis of coenzyme F420, along with the lack of other F420-dependent
enzymes in T. acidophilum, seems to indicate that coenzyme F420 is not a reductant of
taTrxR. Of course, we cannot rule out the possibility that F420 is generated by a
different set of enzymes in this organism.
Conclusions. To date, there is no well characterized example of an organism that
uses a reductant other than NADPH to maintain its intracellular redox environment. Here
we present evidence that one organism, T. acidophilum, which does not contain a Grx
system, uses an alternative method to reduce the bound FAD of the TrxR system. This
work lays the foundation for a biochemical search for the molecular redox partners of T.
acidophilum TrxR.
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Table 3.1. Crystallographic and refinement data statistics for taTrxR structure.
Dataset Native
Wavelength (A) 1.2710
Beamline ALS 5.0.2
Space Group 123
a=b=c (A) 165.95
Resolution (A) 50. - 2.35
R.sym (%). 6.9 (52.1).a
No. of Observations 434,549
Unique Observation 31,586
I/Ill 32.9 (7.6)
Completeness (%) 99.9 (100.0)
Refinement Statistics
Resolution Limits (A) 50. - 2.35
# Unique Reflections 31,123
# Reflections - Test Set 1,824
Rwk. (%)b. 23.4
Rf= (%)e. 26.7
Wilson B factor (A) 68.3
B factor Chain A (A) 55.4
B factor Chain B (A) 62.1
B factor FAD 1 (A) 49.2
B factor FAD 2 (A) 59.4
B factor Waters (A) 68.0
Solvent Content (%) 56.4
# protein atoms 2272 (2282)d
# water atoms 115
# non-protein atoms (FAD) 106
Bond length deviation (A) 0.007
Bond angle deviation (0) 1.10
Ramachandran Plot
Residues in most favored regions (%) 93.4
Res in allowed region (%) 6.1
Res in disallowed region (%) 0.5
aPhighest resolution shell is 2.35 A to 2.43A
PbPRBworkB = YIIFobsl - IFcalcI / ~IFobs
PCPRBfrCeB calculated using 5% of the total reflections, which were not used in refinement
PdPNumber of atoms in chain A and chain B
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Figure 3.1. NADPH participation in cellular redox regulation. (A) The NADPH-
dependent redox regulatory pathways. (B) Mechanism of NADPH dependant cellular
reduction by the thioredoxin reductase system.
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Figure 3.2. Alignment of selected TrxR sequences from PSI-BLAST (1). Sequences
were aligned using the program ClustalW (2) and the output was rendered using the web
interface ESPript 2.2 (3). Sequences are E. coli
(gi:28898025), V cholerae 0395 (gi:147674 57 2 ),
(gi:16128 8 55 ), V parahaemolyticus
S. boydii BS512 (gi:825433 74 ), S.
enterica subsp. enterica serovar Typhi str. CT18 (gi:6217948 2),
(gi:16121654), and S. pneumoniae R6 (gi:15903355).
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Figure 3.3. Alignment of selected Trx sequences from PSI-Blast (1). Sequences were
aligned using the program ClustalW (2) and the output was rendered using the web
interface ESPript 2.2 (3). Sequences are E. coli
(gi:28899775), V cholerae 0395 (gi:147675356),
(gi:67005950), V. parahaemolyticus
S. boydii BS512 (gi:82546135), S.
enterica subsp. enterica serovar Typhi str. CT18 (gi:62182391),
(gi:16124003), S. pneumoniae R6 (gi:15903644). White letters in red blocks are strictly
conserved residues. Red letters in black boxes are more than 50% conserved residues.
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Figure 3.4. DNA and corresponding amino acid sequence of ORF Ta0984 from T.
acidophilum encoding for a putative TrxR. DNA sequence was confirmed by the MIT
Biopolymers Laboratory.
atggaatttaacctgcatgcagtatcatcagaggaaaaagaaagagattttgatgttgtc 60
M E F N L H A V S S E E K E R D F D V V
atcgtcggcgccggtgctgccggtttttcagcggcagtctatgctgcaaggtcaggattc 120
I V G A G A A G F S A A V Y A A R S G F
agcgttgcaattctcgacaaggccgtagctggaggccttactgcagaggcaccactggta 180
S V A I L D K A V A G G L T A E A P L V
gagaattatcttggtttcaagagcattgtcggatcagagcttgcgaaacttttcgccgac 240
E N Y L G F K S I V G S E L A K L F A D
catgcagcgaactatgccaagataagggagggcgtagaggtaagatccataaagaaaacg 300
H A A N Y A K I R E G V E V R S I K K T
caaggcggctttgacattgagacaaatgacgatacgtaccatgccaaatatgtgataata 360
Q G G F D I E T N D D T Y H A K Y V I I
acgactggaacaacgcataagcatttaggtgtcaaaggcgaatccgaatactttgggaag 420
T T G T T H K H L G V K G E S E Y F G K
ggtacctcttactgctctacctgcgatggatacctcttcaagggaaaacgtgtggtcacg 480
G T S Y C S T C D G Y L F K G K R V V T
ataggtggcggaaactcaggggccatagctgccatatcaatgagtgaatacgtcaaaaac 540
I G G G N S G A I A A I S M S E Y V K N
gtcaccataattgaatacatgcctaagtacatgtgcgaaaacgcctacgtacaggagatc 600
V T I I E Y M P K Y M C E N A Y V Q E I
aagaaaagaaacataccctacataatgaacgctcaggtaaccgagatcgttggggatgga 660
K K R N I P Y I M N A Q V T E I V G D G
aagaaggtcaccggagttaaatacaaagacaggacaacgggtgaagaaaaactcatagaa 720
K K V T G V K Y K D R T T G E E K L I E
actgacggcgtcttcatatacgtcggcctcataccgcagacttcatttctcaaggatagt 780
T D G V F I Y V G L I P Q T S F L K D S
ggcgtaaaactggatgagagagggtacatagtggtggattcaaggcagagaactagcgtt 840
G V K L D E R G Y I V V D S R Q R T S V
ccaggggtatatgcagcaggagacgttacatccggcaacttcgcacagattgcctctgcc 900
P G V Y A A G D V T S G N F A Q I A S A
gttggagatggctgcaaggcagcgctttccttgtattctgattctatccaaaaaa 957
V G D G C K A A L S L Y S D S I S K K
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Figure 3.5. DNA and corresponding amino acid sequence of ORF Ta0866 from T.
acidophilum encoding for a putative Trx. DNA sequence was confirmed by the MIT
Biopolymers Laboratory.
atgaagaattatatgggctgcgttaaagatataacattcaatgatttcaatcgtctcata 60
M K N Y M G C V K D I T F N D F N R L I
gatgagaaaaaaagcttcataattgagttatgggctgattggtgccatccctgcaagatc 120
D E K K S F I I E L W A D W C H P C K I
atggcgccatacctggaggaggcgtgtcagaagttgaacgcctgctacttttacaagata 180
M A P Y L E E A C Q K L N A C Y F Y K I
aatatcgatgagaatcctgagatcgttgacacgcttaatgtgaacagcataccaaggata 240
N I D E N P E I V D T L N V N S I P R I
ataatgtttgttgaaggccagcgccaggccgagcttaagggatttcagaagcttcaatca 300
I M F V E G Q R Q A E L K G F Q K L Q S
attattgaccagatttcaaaaattccctgcgattccgtc 339
I I D Q I S K I P C D S V
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Figure 3.6. SDS-PAGE [4-20% (w/v)] gel of the isolated (A) taTrxR and (B) taTrx from
the overexpression E. coli RosettaTM (DE3) pLysS strain.
A B
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Figure 3.7. Spectral recordings of temperature dependent degradation of NADPH and
NADH. (A) NADPH at 200 C (solid line), NADPH at 800 C (dashed line), and heat
treated NADPH cooled down to 200 C (dotted line). (B) Spectra of temperature
dependent degradation of NADH. NADH at 200 C (solid line), NADH at 800 C (dashed
line), and heat treated NADH cooled down to 200 C (dotted line). (C) Time dependent
degradation of NADPH at 200 C (square), 600 C (circle), and 800 C (triangle). (D) Time
dependent degradation of NADH at 200 C (square), 600 C (circle), and 800 C (triangle).
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Figure 3.8. Anaerobic titration of taTrxR and ecTrxR with NADPH and NADH. (A)
Visible spectra of taTrxR (43.3 jM) titrated with NADPH at 59 oC. Solid line is without
NADPH, dashed line is with 0.5 moles NADPH / mole FAD, dotted line is with 1.0 mole
NADPH, dash dot line is with 2.0 mole NADPH, dash dot dot line is with 5 mole
NADPH. (B) Visible spectra of taTrxR titrated with NADH at 59 oC. (C) Visible
spectra of ecTrxR (40.5 [M) titrated with NADPH at 25 oC. (D) Visible spectra of
ecTrxR (40.5 [M) titrated with NADH at 25 oC. Spectra (B), (C), and (D) were recorded
as in (A). (E) Time dependent reduction of taTrxR and NADPH at 59 oC (closed
triangles), taTrxR and NADH at 59 oC (closed circles), and ecTrxR at 25 'C (closed
squares).
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Figure 3.9. Reduction of insulin catalyzed by taTrx. The DTT dependent reduction of
bovine insulin was carried out as described in Methods. The increase in turbidity at 650
nm is plotted against the reaction time. Solid line is 70 tM taTr, dashed line is 66 ptM
taTr, and dotted line is 43 pM taTr.
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Figure 3.10. Tr activity in thioredoxin system using taTrx and ecTrxR. The assays were
performed using 3.8 tM ecTrxR and varying concentrations of taTr. Assays were
performed as described in Methods.
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Figure 3.11. Demonstration of taTrxR/Trx reactivity. Reduction of oxidized taTrxR (4
gM) was achieved by use of a modified xanthine/xanthine oxidase system, as described
in the Materials and Methods section. Oxidized taTrxR (solid line) was reduced with
xanthine as the source of electrons, over the course of 90 min, in order to build up a
stable reduced form of the enzyme (dashed line). Upon introduction of 2 equivalents of
the taTrx, the sample was completely reoxidized within 1 min (dotted line).
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Figure 3.12. Ribbon diagram structure of taTrxR dimer. (A) Monomers of taTrxR are
colored by chain. The flavin molecule (1 per monomer) is represented as space filled
spheres and colored in CPK color scheme. Circle highlights C145/ C148 disulfide. (B)
Superposition of the taTrxR NADPH binding domain with ecTrxR NADPH binding
domain. (C) Superposition of the taTrxR FAD binding domain with ecTrxR FAD
binding domain. (taTrxR is colored in yellow, ecTrxR is colored in cyan)
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Figure 3.13. View of the FAD binding pocket of taTrxR. The FAD molecule is shown
in composite omit map density contoured at 1 a. FAD atoms are colored in CPK format
(C in light grey, N in blue, O in red, P in orange).
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Figure 3.14. Schematic drawing of the FAD molecule in taTrxR. Polar atoms of
residues of molecule A that are within 4 A of atoms of FAD are listed. Distances are in
A.
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Figure 3.15. Ribbon representation of the ecTrxR NADPH binding domain (cyan) (PDB
code ITDF) and taTrxR "NADPH" binding domain (yellow). (A) ecTrxR with NADPH
binding amino acids, H175, R176, R177, and R181, represented in stick form. (b) taTrxR
structure with corresponding structurally aligned amino acids, E185, Y186, M187 and
M191 represented in stick form with modeled NADPH. (C) Superposition of ecTrxR and
taTrxR NADPH binding domains with NADPH from ecTrxR structure (D) Sequence
alignment of the NADPH binding domain regions.
U
E. coli 171 VHLI G EKI 185
M. Tuberculosis 181 VTL I DE SKI 195
A. thaliana 185 VYII A SKI 199
T. acidophilum 181 VTII GX ENA 195
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Figure 3.16. Space filling surface model of (A) ecTrxR and (B) taTrxR NADPH binding
domain. The positively charged residues are represented in blue and the negatively
charged residues are represented in red. Neutral residues are represented as white.
Surface calculations were made using the APBS module in Pymol (4).
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Figure 3.17. Structural superposition of TrxR NADPH binding domains. (A) The
ecTrxR NADPH binding domains crystallized with NADPH analogue AADP (1TDF) is
in teal and without NADPH (1TDE) is in cyan. (B) The ecTrxR (1TDF) co-crystallized
with AADP, an NADPH analogue, is in teal, A. thaliana TrxR (1VDC) structure is in
orange, M. tuberculosis TrxR (2A87) co-crystallized with NADP is in magenta, and
taTrxR is in yellow.
A
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Figure 3.18. Surface representation of NADPH binding pocket with blue representing
basic residues, red acidic residues, and white neutral residues. (A) ecTrxR structure with
NADPH bound. (B) taTrxR structure with modeled NADPH. (C) ecTrxR structure with
NADH modeled in the NADPH binding site. (D) taTrxR structure with NADH modeled
in the NADPH binding site. (E) ecTrxR structure with coenzyme F420 modeled in the
NADPH binding site [1].
150
- Chapter3 - Thioredoxin Reductase from T. acidophilum -
REFERENCES
1. Jaeger, T., Flohe, L. (2006) The thiol-based redox networks of pathogens:
unexploited targets in the search for new drugs. Biofactors 27, (1-4), 109-120.
2. Arner, E. S., Holmgren, A. (2000) Physiological functions of thioredoxin and
thioredoxin reductase. Eur JBiochem 267, (20), 6102-6109.
3. Masutani, H., Ueda, S., Yodoi, J. (2005) The thioredoxin system in retroviral
infection and apoptosis. Cell Death Differ 12 Suppl 1, 991-998.
4. Mustacich, D., Powis, G. (2000) Thioredoxin reductase. Biochem J 346 Pt 1, 1-8.
5. Stroher, E., Dietz, K. J. (2006) Concepts and approaches towards understanding
the cellular redox proteome. Plant Biol (Stuttg) 8, (4), 407-418.
6. Toledano, M. B., Kumar, C., Le Moan, N., Spector, D., Tacnet, F. (2007) The
system biology of thiol redox system in Escherichia coli and yeast: differential functions
in oxidative stress, iron metabolism and DNA synthesis. FEBS Lett 581, (19), 3598-3607.
7. Herrick, J., Sclavi, B. (2007) Ribonucleotide reductase and the regulation of DNA
replication: an old story and an ancient heritage. Mol Microbiol 63, (1), 22-34.
8. Nordlund, P., Reichard, P. (2006) Ribonucleotide reductases. Annu Rev Biochem
75, 681-706.
9. Shao, J., Zhou, B., Chu, B., Yen, Y. (2006) Ribonucleotide reductase inhibitors
and future drug design. Curr Cancer Drug Targets 6, (5), 409-431.
10. Hashemy, S. I., Ungerstedt, J. S., Zahedi Avval, F., Holmgren, A. (2006)
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and
ribonucleotide reductase. JBiol Chem 281, (16), 10691-10697.
11. Darland, G., Brock, T. D., Samsonoff, W., Conti, S. F. (1970) A thermophilic,
acidophilic mycoplasma isolated from a coal refuse pile. Science 170, (965), 1416-1418.
12. Searcy, D. G. (1976) Thermoplasma acidophilum: intracellular pH and potassium
concentration. Biochim Biophys Acta 451, (1), 278-286.
13. Hsung, J. C., Haug, A. (1975) Intracellular pH of Thermoplasma acidophila.
Biochim Biophys Acta 389, (3), 477-482.
14. Ruepp, A., Graml, W., Santos-Martinez, M. L., Koretke, K. K., Volker, C.,
Mewes, H. W., Frishman, D., Stocker, S., Lupas, A. N., Baumeister, W. (2000) The
151
- Chapter3 - Thioredoxin Reductasefrom T. acidophilum -
genome sequence of the thermoacidophilic scavenger Thermoplasma acidophilum.
Nature 407, (6803), 508-513.
15. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W.,
Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein
database search programs. Nucleic Acids Res 25, (17), 3389-3402.
16. Thompson J.D., Higgins D.G., Gibson T.J. (1994) CLUSTAL W: improving the
sensitivity of progressive multiple sequence alignment through sequence weighting,
position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673-
4680.
17. Gouet, P., Courcelle, E., Stuart, D. I., Metoz, F. (1999) ESPript: analysis of
multiple sequence alignments in PostScript. Bioinformatics 15, (4), 305-308.
18. Holmgren, A. (1979) Thioredoxin catalyzes the reduction of insulin disulfides by
dithiothreitol and dihydrolipoamide. JBiol Chem 254, (19), 9627-9632.
19. Amer, E. S., Zhong, L., Holmgren, A. (1999) Preparation and assay of
mammalian thioredoxin and thioredoxin reductase. Methods Enzymol 300, 226-239.
20. Massey, V., Brumby, P. E., Komai, H. (1969) Studies on milk xanthine oxidase.
Some spectral and kinetic properties. JBiol Chem 244, (7), 1682-1691.
21. Otwinowski, Z., and Minor, W. (1997) Processing of X-ray diffraction data
collected in oscillation mode. Methods Enzymol 276, 307-326.
22. Waksman, G., Krishna, T. S., Williams, C. H., Jr., Kuriyan, J. (1994) Crystal
structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications
for a large conformational change during catalysis. J Mol Biol 236, (3), 800-816.
23. McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C., Read, R. J. (2005)
Likelihood-enhanced fast translation functions. Acta Crystallogr D 61, (Pt 4), 458-464.
24. BrUinger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-
Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice,
L. M., Simonson, T., Warren, G. L. (1998) Crystallography & NMR system: A new
software suite for macromolecular structure determination. Acta Crystallogr D 54, (Pt 5),
905-921.
25. McRee, D. E. (1999) XtalView/Xfit--A versatile program for manipulating atomic
coordinates and electron density. J Struct Biol 125, (2-3), 156-165.
152
- Chapter3 - Thioredoxin Reductase from T. acidophilum -
26. Kleywegt, G. J., Jones, T. A. (1998) Databases in protein crystallography. Acta
Crystallogr D 54, (Pt 6 Pt 1), 1119-1131.
27. Williams, C. H., Jr., Zanetti, G., Arscott, L. D., McAllister, J. K. (1967)
Lipoamide dehydrogenase, glutathione reductase, thioredoxin reductase, and thioredoxin.
JBiol Chem 242, (22), 5226-5231.
28. Thelander, L. (1967) Thioredoxin reductase. Characterization of a homogenous
preparation from Escherichia coli B. JBiol Chem 242, (5), 852-859.
29. Williams, C. H., Arscott, L. D., Muller, S., Lennon, B. W., Ludwig, M. L., Wang,
P. F., Veine, D. M., Becker, K., Schirmer, R. H. (2000) Thioredoxin reductase two modes
of catalysis have evolved. Eur JBiochem 267, (20), 6110-6117.
30. Biaglow, J. E., Miller, R. A. (2005) The thioredoxin reductase/thioredoxin
system: novel redox targets for cancer therapy. Cancer Biol Ther 4, (1), 6-13.
31. Williams, C. H., Jr. (1976); Flavin-Containing Dehydrogenases. In The Enzymes,
(Boyer, P. D., Ed. Academic Press) Third Edition ed.; New York, Vol. 1, pp 89-173.
32. Lennon, B. W., Williams, C. H., Jr., Ludwig, M. L. (2000) Twists in catalysis:
alternating conformation of Escherichia coli thioredoxin reducatase.Science 289, 1190-
1194.
33. Wang, P. F., Veine, D. M., Ahn, S. H., Williams, C. H., Jr. (1996) A stable mixed
disulfide between thioredoxin reductase and its substrate, thioredoxin: preparation and
characterization. Biochemistry 35, (15), 4812-4819.
34. O'Donnell, M. E., Williams, C. H., Jr. (1983) Proton stoichiometry in the
reduction of the FAD and disulfide of Escherichia coli thioredoxin reductase. Evidence
for a base at the active site. JBiol Chem 258, (22), 13795-13805.
35. Copley, S. D., Dhillon, J. K. (2002) Lateral gene transfer and parallel evolution in
the history of glutathione biosynthesis genes. Genome Biol 3, (5), 1-16.
36. Reher, M., Sch6nheit, P. (2006) Glyceraldehyde dehydrogenases from the
thermoacidophilic euryarchaeota Picrophilus torridus and Thermoplasma acidophilum,
key enzymes of the non-phosphorylative Entner-Doudoroff pathway, constitute a novel
enzyme family within the aldehyde dehydrogenase superfamily. FEBS Lett 580, (5),
1198-1204.
153
- Chapter3 - Thioredoxin Reductasefrom T. acidophilum -
37. Nishiya, Y., Tamura, N., Tamura, T. (2004) Analysis of bacterial glucose
dehydrogenase homologs from thermoacidophilic archaeon Thermoplasma acidophilum:
finding and characterization of aldohexose dehydrogenase. Biosci Biotechnol Biochem
68, (12), 2451-2456.
38. Smith, L. D., Budgen, N., Bungard, S. J., Danson, M. J., Hough, D. W. (1989)
Purification and characterization of glucose dehydrogenase from the thermoacidophilic
archaebacterium Thermoplasma acidophilum. Biochem J261, (3), 973-977.
39. Fischer, M., Bacher, A. (2005) Biosynthesis of flavocoenzymes. Nat Prod Rep 22,
(3), 324-350.
40. Graupner, M., Xu, H., White, R. H. (2002) The pyrimidine nucleotide reductase
step in riboflavin and F(420) biosynthesis in archaea proceeds by the eukaryotic route to
riboflavin. JBacteriol 184, (7), 1952-1957.
41. Mack, M., Grill, S. (2006) Riboflavin analogs and inhibitors of riboflavin
biosynthesis. Appl Microbiol Biotechnol 71, (3), 265-275.
42. Baker, N. A., Sept, D., Joseph, S., Holst, M. J., McCammon, J. A. (2001)
Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl
AcadSci USA 98, (18), 10037-10041.
154
- Chapter 4 - Characterization of thioredoxin 1-4from Archaeoglobusfulgidus
Chapter 4:
Direct electrochemical characterization of
four thioredoxins from Archaeoglobus
Fulgidus
Genomic analysis, cloning, amplification, purification, and insulin assays
were performed by Hector H Hernandez. Protein film voltammetry was
performed by Sarah E. Chobot.
Reproduced in part from: Chobot, S. E., Hernandez, H. H., Drennan, C. L.,
Elliott, S. J.,(2007) Dirrect Electrochemical Characterization of Archaeal
Thioredoxins. Angew Chem Int Ed Engl 46, 22 4145-4147
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INTRODUCTION
The thioredoxin (Trx) superfamily of proteins contains small soluble proteins that
function as 2 e-/2 H+ electron-transfer agents by virtue of a redox-active disulfide bond.
Although the members of this superfamily are known to contain disulfide bonds that span
a range of midpoint potential of at least 150 mV, (1) a detailed picture of the molecular
determinants of the disulfide-bond potential has yet to be attained. Herein, we
demonstrate that this goal is feasible through the application of protein-film voltammetry
(PFV), (2) an electrochemical technique that we use to directly observe the reversible 2 e
redox couple of thioredoxins.
Successful PFV yields a fast electrochemical connection between a submonolayer
of protein analyte and an electrode. Previous electrochemical investigations of plant-type
and Escherichia coli Trx disulfides did not yield reversible 2 e- voltammetry: instead
quasireversible 1 e- cyclic voltammetry for the disulfide/disulfide radical potential and an
second irreversible feature (corresponding to the reduction of the radical intermediate)
was observed (3, 4). Martin and co-workers have developed a modified gold electrode to
investigate His-tag-labeled E. coli Trx; they too were unable to directly observe a
reversible 2 e- potential (5) and could only establish reversible voltammetry for the 1 e-
disulfide/disulfide radical couple (5, 6). As the biologically significant reaction for
thioredoxins involves cooperative 2e- chemistry (7, 8), we have examined a series of
members of the Trx superfamily to observe a reversible 2 e-/2 H+ reaction by using PFV.
Herein, we report the successful extension of PFV to the direct measurement of a
reversible 2 e- disulfide/dithiol couple.
Members of the Trx superfamily contain a single disulfide bond within a -CXXC-
motif, and the differences in redox properties of Trx proteins are attributed to variation of
the -CXXC- motif (Figure 4.1) (1, 9). The difference in potential of the disulfide is
correlated to function: E. coli Trx is reducing in the cellular milieu (8) with a reported
potential from solution-based experiments of -270 mV (versus hydrogen) (10). More
oxidizing members of the thioredoxin superfamily, such as E. coli DsbA, bear a disulfide
bond with a reported reduction potential of -90(11) to - 122 mV (12). In comparison, the
disulfide bond proximal to the Rieske [2Fe-2S] center of the Thermus thermophilus
Rieske protein is electrochemically stable at sustained potentials as low as -0.85 V (13).
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Trx acts as a reducing agent for a wide array of critical biological pathways (e.g.,
ribonucleotide biosynthesis, oxidative-stress defense, and transcription-factor activation)
(14), whereas DsbA oxidizes target proteins, installing disulfides for proper protein
folding and maturation (15). Structures of the oxidized, disulfide-containing loops of E.
coli Trx and DsbA are shown in Figure 4.1 (16, 17).
Probing the influence of sequence and structure on the reduction potential of Trx
proteins has been limited by the methods used for determining 2 e- disulfide bond
potentials. Such potentials are typically measured by coupled, solution-based processes,
such as glutathione equilibria, which indirectly give a value for the disulfide potentials of
interest, though such studies have yielded variable values of potential previously (11, 12,
18, 19).
MATERIALS AND METHODS
Materials. Archaeoglobus fulgidus organism was obtained from the American Tissue
Culture Center. TOPO and TOPO Zero Blunt PCR Cloning kits were obtained from
Invitrogen (Carlsbad, CA). NovaBlue Cells Competent Cells, RosettaTM (DE3)pLysS
Competent Cells, and Plasmid pET28-A were purchased from Novagen (Madison, WI,
USA). pfuTurbo Polymerase and PCR Optimization Kit were obtained from Strategene
(Cedar Creek, TX, USA). Primers were obtained from Integrated DNA Technologies
(Coralville, IA, USA). Nickel nitrilotriacetic (Ni-NTA) acid-agarose gel was purchased
from Qiagen (Valencia, CA, USA). Restriction enzymes were purchased from New
England BioLabs (Beverly, MA, USA). Kanamycin, chloroamphenicol, TRIS-HC1,
EDTA, and phenyl methyl sulfonyl fluoride (PMSF) were obtained from Sigma-Aldrich
(St. Louis, MA, USA).
Genomic analysis of Archaeoglobus fulgidus genome. The genome of Archaeoglobus
fulgidus (RefSeq NC_000917.1, GenBank AE000782.1) was analyzed using the web
interface at the National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov) for putative thioredoxin (Trx) open reading frames
(ORFs). Four ORFs encoding a 119 amino acid protein, AF0711, a 93 amino acid
protein, AF0769, a 134 amino acid protein, AF1284, and a 91 amino acid protein,
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AF2144, were identified by sequence homology to known Trxs using PSI-BLAST (20).
Protein sequences were aligned using the program ClustalW (21) and the output was
rendered using the web interface ESPript 2.2 (Figure 4.2 - 4.8)(22).
Amplification of afuTrxs. The open reading frames (ORFs) coding for the putative A.
fulgidus thioredoxins, (afuTrx) (AF0711, AF0769, AF1284, and AF2144) were retrieved
from the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov).
The Trx genes were amplified by the polymerase chain reaction (PCR) using genomic
DNA of A. fulgidus. The oligonucleotides primers were designed based on the open
reading frames coding for the proteins: Trx 1 (AF0711) - 5' - ATC GCA TAT GCC AAT
GGT GAG GAA AG CTG CAT TTT ATG C-3' (N-terminus) and 5' - TAG GAT CCT
CAT TTC ATC CCC TCT ATT GCT GTC CTA ACC-3' (C-terminus); Trx 2 (AF0769) -
5' - ATC GCA TAT GGT TTT CAC CAG CAA ATA CTGCCC CTA C - 3' (N-
terminus) and 5' - TAG GAT CCT CAG TTT TTG TAA TCA GGC TTA AGA AAT GC
- 3' (C-terminus); Trx 3 (AF1284) - 5' - ATC GCA TAT GGA CGA GTT AGA GCT
AAT CAG ACA G - 3' (N-terminus) and 5' - TAG GAT CCT CAG AGA TTC CTC
TGA ACC CAT CTC TTC AGC - 3' (C-terminus); and Trx 4 (AF2144) - 5' - GGC AGC
CAT ATG GAG CGT CTT AAC AGT GAG AGG TTT AGG GAG G - 3' (N-terminus)
and 5' - GGT CGG ATC CTC ATC ATC AGG CTC CAA GTG CTT TCT CTA TTT
CCG- 3' (C-terminus).
PCR amplification of the four Trx genes was performed via 30 cycles using the
following conditions: initial denaturing at 94 oC for 10 min, 94 oC for 30 s, 55 'C for 30 s,
68 oC for 30 s) using pfuTurbo DNA polymerase with genomic DNA as a template along
with each respective primer. PCR fragments were gel purified and ligated into
TOPOBlunt vector. NovaBlue competent cells were transformed with ligated construct
and plated on kanamycin agar plates. Colonies were picked and the plasmids were
purified and followed by enzymatic digestion using NdeI and BamHI, then gel purified.
cDNA fragments were ligated into pET28a vector cut with the same restriction enzymes.
NovaBlue competent cells were transformed with pET28a/Trx construct and plated on
kanamycin agar plates. Colonies were grown and miniprepped as described above and
cDNA was sent to the Massachusetts General Hospital Sequencing facility or to the MIT
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Biopolymers Sequencing Facility. After confirmation of the correct sequences, the
resulting constructs were transformed into RosettaTM (DE3)pLysS cells for facile protein
expression.
Purification of recombinant proteins. One liter TB media was inoculated with overnight-
growth, grown at 37 oC to OD 600=0.8, induced with 0.8 mM isopropylthio-3-D-
galactoside (IPTG), and incubated for an additional 3 hrs. Cell paste was obtained by
centrifugation at 6,000 rpm for 10 min, resuspended in lysis buffer (10 mM TRIS-HC1,
pH 8.0, 150 mM NaC1, 10 mM imidazole, 1 mM PMSF) and cell lysis was accomplished
by ultrasonication. Cells were spun down at 18,000 rpm for 30 min. Supernatant was
heated at 700 C for 45 min, and again centrifuged for 30 min. The resulting supernatant
was loaded on a Ni-NTA column and eluted with elution buffer (10 mM TRIS-HCl, pH
8.0, 150 mM NaC1, 200 mM imidazole) and fraction samples run on SDS-PAGE 4-20%
gel. Fractions containing proteins with comparable size to Trxs were concentrated using
an Amicon stirred ultrafiltration cell. The molecular masses of the proteins with the (6)
His-tag were estimated to be about 15.6 kDa for AF0711, 12.4 kDa for AF0769, 17.7
kDa for AF1284, and 14.3 kDa for AF2144. A SDS-PAGE is in agreement with the
expected molecular weights (Figure 4.9).
Imidazole removed by dialysis into thrombin digest buffer (20 mM HEPES, pH
7.5, 20 mM NaC1, 0.5 mM (ethylenediamine)tetra acetic acid (EDTA), 1 mM 1,4-dithio-
DL-threitol (DTT)) followed by His-Tag removal in thrombin digest buffer. Protein was
loaded onto a SEC-30 high-prep size exclusion column from Amersham Biosciences
(Piscataway, NJ, USA) column and eluted into storage buffer (10 mM HEPES, pH 7.0,
20 mM NaC1). Final protein fraction was concentrated using Centriprep YM-3filter from
Amicon (Millipore, Bedford, MA, USA). Purity of protein was analyzed by 4-20%
gradient SDS/PAGE. Protein concentration was determined from theoretical extinction
coefficient (ProtParam, ExPaSy web server).
Thioredoxin Insulin Assay Activity Assays. Thioredoxin activity was determined by the
insulin precipitation assay (23). The assay mixture was composed of 100 mM potassium
phosphate, pH 7.0, 1 mM EDTA, and 0.13 mM bovine insulin in the presence and
159
- Chapter 4 - Characterization of thioredoxin 1-4 from Archaeoglobusfulgidus
absence of Trxs. The reaction was allowed to equilibrate for one min and then it was
initiated by the addition of 1 mM 1,4-dithio-DL-threitol (DTT). Reaction was carried out
on a Cary 300 spectrophotometer by monitoring increase in absorbance at 650 nm at 30
oC.
Protein Film Voltammetry. Protein-film voltammetry was carried out in a three-electrode
configuration by using a standard calomel reference electrode and constructed PGE
working electrodes. The electrochemical cell was water jacketed for temperature control
and the reference electrode maintained in a separate compartment at a fixed (room)
temperature. Electrodes were constructed of pyrolytic graphite (Advanced Ceramics),
which was machined into cylinders, mounted onto a steel rod with silver epoxy, and then
embedded in epoxy, yielding a graphite edge plane as the working surface. PGE
electrodes were polished with an aqueous slurry of 1.0 Pm alumina (Beuhler) and then
sonicated prior to use.
Electroactive protein films were generated by rotating the working electrode at
200 rpm in a diluted protein solution (10 PM Trx in 20 mM 3-(N-morpholine)
propanesulfonic acid (MOPS), 150 mM NaCl; pH 7.5) for 15 minutes while cycling the
applied potential from 0.2 to -0.5 V. The protein-containing solution was then remove,
the cell rinsed, and the working electrode then replaced in protein-free buffer solution
containing 150 mM electrolyte. PFV was initially conducted at 10 OC to observe an
electrochemical response at uniform conditions prior to adjusting the pH value or the
temperature. Baseline subtraction was achieved by first measuring the baseline response
of the electrode for a given set of buffer solution conditions prior to deposition of the
protein film.
RESULTS
Sequence Alignments. The afuTrxs vary in length from 91 amino acids (afuTrx 4)
to 134 amino acids (afuTrx 3). The shorter afuTrxs have sequence and length homology
to glutaredoxins while the longer ones resemble thioredoxins (see Table 4.1, Figures 4.4).
Analysis of the CxxC motifs for the cloned proteins reveals that each Trx has a unique
CxxC sequence (Table 4.1). Homology between E. coli Trxs and afuTrxs ranges from
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12% for afuTrx 2 to 40% for afuTrx 3. The afuTrx 3 resembles E. coli Trxl and Trx 2 in
that it contains the flanking tryptophan (WCxPC) (see Figure 4.2). afuTrx 1 and E. coli
protein disulfide isomerase A, (dsbA) share a conserved CPHC motif (Figure 4.3), but
little other similarity. The afuTrx 2 and afuTrx 4 CxxC motifs are identical to the E. coli
glutaredoxin CPYC motif (see Figure 4.4). However, there is little other conservation of
sequence between the afuTrxs and the E. coli glutaredoxins. All sequence alignments
were performed using ClustalW alignment program from European Bioinformatics
Institute. Alignment figures were generated using ESPript (22).
The purified afuTrxs yields proteins of an apparent MW of 15 kDa for AF0711,
13 kDa for AF0769, 18 kDa for AF1284, and 14 kDa for AF2144. A SDS-PAGE is in
agreement with the expected molecular weights (Figure 4.9). Subsequent gel-filtration
using a Sephacryl SEC-30 HR 16/60 column suggests that the afuTrxs are monomers in
their native state.
All four afuTrxs reduced the insulin disulfide bonds. afuTrx 3 had the fastest rate,
followed by afuTrx 2, than afuTrx 4, and than afuTrx 1 (Figures 4.10 - 4.13). Doubling
the concentration of the protein decreased the time for reduction of insulin showing that
the reduction of insulin was enzyme dependent. The controls with out protein or without
insulin did not display a change in absorbance over time caused by turbidity of the assay.
Figure 4.14 shows the cyclic voltammetric response of four purported
thioredoxins from the thermophilic archaeon Archaeoglobus fulgidus, at a pyrolytic
graphite edge (PGE) electrode. Baseline subtraction of the non-faradaic component of the
current reveals a single set of nernstian peaks in all cases. The peak height (Ip)
corresponds linearly to the scan rate (v) indicating that the Trx-based signal is due to
protein immobilized upon the PGE surface (data not shown).
The peaks resulting from oxidative and reductive scans appear highly symmetric,
and all of the Trx proteins demonstrate a value of peak width at half height (6) that
indicates a cooperative redox process; that is, the number of electrons (n) is greater than
1(24). Figure 4.15A shows that at lower temperatures, measured values of 6 are between
those found for n=1 e- and n=2 e- process, though at 25 'C, 3 approaches the anticipated
value for an immobilized system undergoing a n=2 e- reaction (equivalent to two highly
rapid n=l e- steps) (24). Values of 6 decrease as a function of temperature, suggesting a
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dispersion of Trx conformations exists at the electrode surface, yielding artificial peak
broadening at low temperatures and a nonzero peak separation. Upon heating,
conformations that result in faster electrokinetics dominate and peak narrowing is
observed. All experiments gave identical data regardless of the redox poise of the Trx.
The determined values of the midpoint potential (Em) and 6 are given in Table 4.2 for a
single set of conditions, demonstrating that Em for the 2 e- couple varies significantly
between Trxs.
The pH dependence of the Trx 3 electrochemical response is shown in
Figure 4.15B. In all cases, Trx films are stable upon the electrode surface from pH 4.5 to
9.5, though at pH values greater than 9.0, the intensity of the electrochemical signal
becomes discernibly smaller (the depletion of peak height is fully reversible, indicating
that protonation promotes conformations that yield reversible voltammetry). The slope of
the pH dependence is -57 mV per pH unit, implying a 1 e/1 H+ or 2 e/2 H+
stoichiometry. As the observed peak widths indicate that n=2 e-, the pH dependence
indicates a 2 e-/2 H + process is at work. Within the pH values studied, pKa events are not
observed, that is, Em always appears to have a linear dependence upon the pH value. The
absence of a pKa value for the buried thiol of the reduced form may be due to the
instability of the Trx-electrode interaction at pH values greater than 9.5. Protein films
readily desorbed at highly basic pH values and recent studies of the E. coli and
Chlamydomonas reinhardtii Trx, indicate that pKa values for the Trx thiol greater than
10.0 are common for Trx proteins (25).
Trx 1 has a strongly oxidizing potential, in analogy with DsbA from E. coli. This
variation can be generally understood by the hypothesis of Raines and co-workers that
the presence of a protonatable residue in the -CXXC- motif, which contains the Trx
disulfide bond, leads to a high potential (1). Indeed, the Trx 1 disulfide loop possesses the
-CPHC- sequence found in DsbA, suggesting that functionally Trxl is not a thioredoxin
at all, but an oxidizing protein. The identity of the residues in the -CXXC- motif cannot
be the sole determinant of the Trx reduction potential: Trx 3 and Trx 4 contain the same
motif (-CMPC-) and yet vary in potential by 20 mV.
DISCUSSION
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Although the four Trxs from A. fulgidus vary in sequence, they all contain the
CxxC motif in the active site. Direct electrochemistry experiments reveal that the
midpoint potential of the four afuTrxs range from -309 to -32 mV with afuTrx 1 being the
most oxidizing member of the enzymes (Table 4.1). Analysis of the amino acid variation
of the afuTrx 1 -CxxC- motif reveal an intervening The most oxidizing member of the
Trx family is DsbA (Table 4.2) (11). Expanding the CxxC motif to include the
neighboring amino acids shows a serine in N-terminal to the motif (SCPHCR) (Table
4.2). There are many hypotheses for the wide range of midpoint potentials of Trxs, and
many mutagenic studies have tried to address this topic, (Reviewed in (26)), but model
has emerged that explains the span of midpoint potentials. While one can speculate on
the physiological role of afuTrx 2-4 in the cell, the role of afuTrx 1 is a mystery.
In summary, we have characterized four Trxs from A. fulgidus. The reduction
potential of the Trx proteins in this archaeon represent the greatest range in a specific
organism. Also, we have determined that PFV is a useful tool in the study of the archaeal
thioredoxins as it does not depend upon other solution equilibria and it can relate
quantitative information regarding redox cooperativity. Thus, employment of PFV will
enable detailed studies of the relationship between sequence, structure, and redox
chemistry of thioredoxins.
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Table 4.1. Measured midpoint potentials and peak widths of Trx proteins; pH 7.0, 10 'C.
Sample Em [mVl 61 [mV] -CXXC-
Trx 1 -32 62 CPHC
Trx 2 -301 65 CPYC
Trx 3 -287 56 CMPC
Trx 4 -309 64 CMPC
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Table 4.2. Properties of Escherichia coli disulfide reductases and Archaeoglobusfulgidus
Trxs. The table lists the length of the different proteins in the alignments and the amino
acid composition of the CxxC motif plus and minus one amino acid.
Protein Length and xCxxCx motif composition
Protein Number of AA xCxxCx Em (V)
Trx 1 109 WCGPCK -0.270
Trx 2 130 WCGPCR N/A
afuTrx 1
afuTrx 2
afuTrx 3
afuTrx 4
ecdsbA
ecdsbC
ecGlutaredoxin I
ecGlutaredoxin III
119
93
134
91
108
136
SCPHCR
YCPYCR
WCMPCK
TCPYCP
FCPHCY
TCGYCH
GCPYCV
TCPYCH
-0.032
-0.301
-0.287
-0.309
-0.122
-0.130
-0.233
-0.198
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Figure 4.1. The -CXXC- motif of the thioredoxin superfamily is illustrated by (A) E.
coli Trx (-CGPC-) and (B) DsbA (-CPHC-).
A
GI
B
Pro3
H
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Figure 4.2 Alignment of ecTrx 1 and ecTrx 2 with afuTrx 1-4. The redox active CxxC
motif is conserved in all sequences. Red boxes with white letters and blue boxes with red
letters show identical and homologous residues, respectively. Last row displays
consensus of sequences. Capital letters show identical residues and lower case letters
show residues with greater than 50% occurrence.
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Figure 4.3 Alignment of ecdsbA and ecdsbC with afuTrx 1-4. The redox active CxxC
motif is conserved in all sequences. Red boxes with white letters and blue boxes with red
letters show identical and homologous residues, respectively. Last row displays
consensus of sequences. Capital letters show identical residues and lower case letters
show residues with greater than 50% occurrence.
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Figure 4.4 Alignment of ecGlutaredoxin 1 and ecGlutaredoxin 3 with afuTrx 1-4. The
redox active CxxC motif is conserved in all sequences. Red boxes with white letters and
blue boxes with red letters show identical and homologous residues, respectively. Last
row displays consensus of sequences. Capital letters show identical residues and lower
case letters show residues with greater than 50% occurrence.
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Figure 4.5 DNA and corresponding amino acid sequence of ORF AF0711 from A.
fulgidus encoding for a putative Trx 1. DNA sequence was confirmed by the MIT
Biopolymers Laboratory.
1 atgccaatgg tgaggaaagc tgcattttat gcaattgcag tcatttcagg agttctcgct
m p m v r k a a f y a i a v i s g v 1 a
61 gccgtagtgg ggaatgcctt gtaccacaat ttcaactcgg atttaggtgc tcaagctaaa
a v v g n a 1 y h n f n s d 1 g a q a k
121 atttacttct tctactccga ctcatgcccc cactgccgcg aagtgaaacc gtacgtggag
i y f f y s d s c p h c r e v k p y v e
181 gagtttgcaa aaacgcacaa cttaacctgg tgcaatgtcg cggaaatgga cgcaaactgc
e f a k t h n 1 t w c n v a e m d a n c
60
120
180
240
241 tccaaaatag ctcaggagtt tggaattaag tacgtgccta ctctcgttat aatggacgag 300
s k i a q e f g i k y v p t 1 v i m d e
301 gaggctcacg tttttgtggg ttctgatgag gttaggacag
e a h v f v g s d e v r t
caatagaggg
a i e
gatgaaatga 360
g m k -
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Figure 4.6 DNA and corresponding amino acid sequence of ORF AF0769 from A.
fulgidus encoding for a putative Trx 2. DNA sequence was confirmed by the MIT
Biopolymers Laboratory.
1 atggttttca ccagcaaata ctgcccctac tgcagggcct ttgagaaagt tgtcgagaga 60
m v f t s k y c p y c r a f e k v v e r
61 ttgatggggg agcttaacgg cactgtggaa tttgaagtcg tggacgttga cgagaaaagg 120
1 m g e 1 n g t v e f e v v d v d e k r
121 gagcttgctg agaagtacga ggttttgatg ctccccacct tggttcttgc agatggagat 180
e 1 a e k y e v 1 m 1 p t 1 v 1 a d g d
181 gaggttttgg gaggcttcat gggctttgcc gactacaaaa cagcccgaga agccatattg 240
e v 1 g g f m g f a d y k t a r e a i 1
241 gagcagattt cagcatttct taagcctgat tacaaaaact ga 282
e q i s a f 1 k p d y k n -
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Figure 4.7 DNA and corresponding amino acid sequence of ORF AF1284 from A.
fulgidus encoding for a putative Trx 3. DNA sequence was confirmed by the MIT
Biopolymers Laboratory.
1 atggacgagt tagagctaat cagacagaaa aaactcaagg agatgatgca gaaaatgagt 60
m d e 1 e 1 i r q k k 1 k e m m q k m s
61 ggtgaggaga aggctagaaa ggttttggat tctccggtaa agctgaactc atcgaatttc 120
g e e k a r k v 1 d s p v k 1 n s s n f
121 gacgagacgc tgaaaaacaa cgagaacgtg gtagtggact tctgggcgga gtggtgcatg 180
d e t 1 k n n e n v v v d f w a e w c m
181 ccgtgcaaaa tgattgctcc ggttattgag gagctggcaa aggagtacgc gggaaaggtg 240
p c k m i a p v i e e 1 a k e y a g k v
241 gtgttcggaa agctgaacac agacgagaat ccaaccatcg cggcaaggta cggaatttca 300
v f g k 1 n t d e n p t i a a r y g i s
301 gccattccaa cgctgatatt tttcaaaaaa ggaaagccgg tggaccagct tgtgggagca 360
a i p t 1 i f f k k g k p v d q 1 v g a
361 atgccgaaaa gcgagctgaa gagatgggtt cagaggaatc tctaa 405
m p k s e 1 k r w v q r n 1 -
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Figure 4.8 DNA and corresponding amino acid sequence of ORF AF2144 from A.
fulgidus encoding for a putative Trx 4. DNA sequence was confirmed by the MIT
Biopolymers Laboratory.
1 atggagcgtc
m e r
61 gtggacttct
v d f
121 ctctcgaagg
1 s k
181 gatgtggcct
d v a
241 aaggttgttg
k v v
301 aaagcacttg
k a 1
ttaacagtga
i n s
acgccgactg
y a d
agtacaacgg
e y n
ttgaatacgg
f e y
gtggattcat
g g f
gagcctga
g a -
gaggtttagg
e r f r
gtgcatgccc
w c m p
cgaagtggag
g e v e
cattgcgagc
g i a s
tggagcgatg
i g a m
gaggtaatcc
e v i
tgcaggtaca
c r y
ttctacaagc
f y k
atcccaacag
i p t
cctgaaagtg
p e s
agagcgacaa
q s d
tctcgccgat
i s p
tcaacgtcga
1 n v
tgctgttctt
v 1 f
cggtgagggc
a v r
gctggtggtg 60
k 1 v v
acttgagaag 120
i 1 e k
tgaaaaccag 180
d e n q
caggaacggc 240
f r n g
ggaaatagag 300
a e i e
318
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Figure 4.9 SDS-PAGE gel of afuTrxs. SDS-PAGE gel electrophoresis of afuTrxs.
Locations of molecular weight standards are given by the positions of the molecular
weight labels. Lanes of purified Trx proteins are labeled as per the thioredoxin.
Trxl Trx2 Trx3 Trx 4 Std
40 kDa
25
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Figure 4.10 Reduction of insulin by afuTrx 1. Blue line is 6.7 jtM afuTrx 1, red line is
3.3 jtM afuTrx 1, green line is afuTrx 1 and DTT without insulin and black line is insulin
and DTT with no enzyme.
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Figure 4.11 Reduction of insulin by afuTrx 2. Blue line represents 6.8 jtM afuTrx2, red
line represents 3.4 jiM afuTrx2, and black line is insulin and DTT with no enzyme.
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0 20 40 60 80
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Figure 4.12 Reduction of insulin by afuTrx 3: Blue line is 7.8 gM afuTrx 3, red line is
3.9 gM afuTrx 3, and black line is insulin and DTT with no enzyme.
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Figure 4.13 Reduction of insulin by afuTrx 4: Red line is 6.8 pM afuTrx 4, blue line is
3.4 gM afuTrx 4, and black line is insulin and DTT with no enzyme.
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Figure 4.14 Voltammetric response of A. fulgidus Trx proteins as both raw and baseline-
subtracted data at 10 'C. All data were acquired at a pyrolytic graphite edge electrode
with pH 7.75 for Trx 1, Trx 2, and Trx 3, and with pH 4.5 for Trx 4. SHE=standard
hydrogen electrode.
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Figure 4.15 Temperature and pH dependence of the afuTrxs electrochemical response.
a) Experimentally determined values of peak width for Trx 1 (n), Trx 2 (.), and Trx3 (-)
(Trx 4 protein films were not sufficiently robust to heating) compared with calculated
values for n=l and n=2 electron reactions. b) The pH-dependent behavior of Trx 3
midpoint potentials for three distinct sets of experiments. The data are fit to a linear
progression with a slope indicating a 1 e1l H+ process. The buffer solution was
composed of 10 mM P-morpholinoethanesulfonic acid (MES), MOPS, 3-
[tris(hydroxymethyl)methylamino] -1-propanesulfonic acid (TAPS), and 2-
cyclohexylaminoethanesulfonic acid (CHES) with 150 mM NaCl, and the pH value was
determined independently for each data point.
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Appendix 1:
Direct Electrochemical Analyses of a
Thermophilic Thioredoxin Reductase:
interplay between conformational change
and redox chemistry
Reproduced in part from: Michael J. Hamill, Sarah E. Chobot, Hector H. Hernandez,
Catherine L. Drennan, and Sean J. Elliott
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INTRODUCTION
The ubiquitous protein Thioredoxin (Trx)1 functions as a reductant for many key
cellular processes, including DNA synthesis, oxidative stress response and transcriptional
activation (1). The reduced form of Trx is generated by thioredoxin reductase (TrR), and
the pair maintains the reducing conditions of the cytoplasmic environment, as well as
being responsible for the reduction of ribonucleotide reductase and peroxiredoxins, and
the reductive activation of several transcription factors (2). The maintenance of redox
environment is achieved through the coupling of reduction equivalents available from
NAD(P)H to the TrR active site, which includes a flavin moiety, and a redox-active
disulfide bond (3, 4, 5). TrRs are homodimeric enzymes that are differentiated by
complexity and molecular weight: the prokaryotic enzymes (exemplified by the enzyme
from Escherichia coli) are of relatively low Mr (-35,000 Da per monomer) when
compared to their higher Mr mammalian homologs (-55,000 Da per monomer) which
contain an additional redox active unit, such as a selenocysteine-cysteine pair (6). To date
the E. coli TrR (ecTrR) has proven to be a robust model system for studies of low Mr TrR
structural dynamics and catalytic chemistry. Preliminary structural analyses by Kuriyan
revealed that NADPH binding occurs far from the flavin domain of the protein, while the
redox active disulfide pair (Cys135 and Cys138) are on the re face of the flavin, in a
buried state, forbidding direct interaction with Trx (7). Further analysis of this conformer,
the flavin oxidizing (FO) state, by Waksman suggested that flavin reduction could be
achieved by a 670 ball-in-socket rotation of the NADPH-binding and flavin domains (8).
Additional kinetic and spectroscopic studies of wild-type and mutant forms of ecTrx have
indicated that not only is a large conformation change required in the course of ecTrR
catalysis for the generation of the flavin reducing (FR) form of the enzyme, but that the
two forms, FO and FR are in equilibrium in solution (9, 10, 11,12). By
crystallographically characterizing a site-directed mutant of TrR crosslinked to a Trx
"doorstop", Ludwig and co-workers successfully provided the first structural snapshot of
the FR conformation of ecTrx, as shown in Figure Al.1 (13, 14).
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The picture of the ecTrR mechanism that emerges requires a ternary complex (15)
that redox cycles between the two- and four-electron reduced states (16), where redox
transformations must be coupled to potential conformational changes. However, it has
proven challenging to develop a detailed picture of the impact of conformational
dynamics upon the redox properties of the FAD cofactor and the Cysl35-Cysl38
disulfide. Previous potentiometric titrations suggest that the thermodynamic potentials of
the ecTrR redox cofactors (FADH2/FAD and the Cysl35-Cysl38 disulfide) are very
close, with Em varying by only 7 mV at pH 7.6 (16, 17). Specifically, the enzyme
FAD/FADH2 potential has been calculated as -263 mV and -280 mV, for the active site
disulfide and dithiol forms, respectively; while the enzyme active site disulfide/dithiol
potential has been calculated as -270 mV and -287 mV for the flavin oxidized and flavin
reduced forms, respectively (16, 17). However, such calculations have been previously
based upon data that cannot discriminate between the FR and FO conformers, which
rapidly interconvert at room temperature (18). Thus, we hypothesize that the former
measurements represent potentials that are best considered as an average between the
populations of each conformation.
Here we have looked to direct electrochemical methods in order to parse the
relationship between conformational dynamics and redox chemistry. We have used
protein film voltammetry (PFV) as a method to investigate the redox characteristics of
the low Mr TrR enzymes from E. coli, as well as the enzyme for the archaeon
Thermoplasma acidophilum, an enzyme that has been biochemically and structurally
characterized in the accompanying report (19). PFV has the ability to interrogate redox
equilibria that are coupled to additional chemical processes - particularly when chemical
steps result in modulations in the midpoint potential of the system. For example, studies
of proton-coupled steps in redox reactions of bacterial ferredoxin (20, 21) has resolved
proton transfer reactions of a single sidechain transfer. No electrochemical studies of TrR
(of any type) have been reported to date, and the reports of potentials have been limited
to techniques that will average away any contribution due to distinct conformational
changes, which are rapid on the timescale of potentiometry. However, typical
electrochemical investigations of flavoenzymes are at times hindered by the stability of
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the flavin-bound form of the protein: protein binding of the flavin cofactor can be
compromised upon exposure to a typical graphite working electrodes frequently used in
PFV experiments, as has been reported for flavodoxin and P450 BM3 (22, 23). Given
this, we have opted to study both the low Mr ecTrR and a novel TrR from the
thermophilic organism Thermoplasma acidophilum, whose crystal structure and
preliminary biochemical characterization are reported in the accompanying paper (19).
Using this strategy, it is our hope that the greater protein stability of the thermophilic
enzyme will yield not only better electrochemical results, but will enable a dissection of
the contribution of FO and FR conformations to the control of flavin and disulfide
reduction potentials. As described in the preceding paper, the taTrR has recently been
cloned, purified, and subjected to structural and biochemical analyses, demonstrating that
this new TrR is an excellent homolog of the ecTrR, with the caveat that it cannot use
NADPH as an electron donor (19).
MATERIALS AND METHODS
Protein purification. The taTrR was purified as a His-tagged construct following
cloning from genomic DNA from T. acidophilum. The details of protein purification and
characterization are described in Chapter 3 of this thesis. The ecTrR was produced from
the system described by Mulrooney (24), with the following modifications: cells were
streaked on 2xYT agar plates with 100 ptg/ml ampicillin, and 25 jtg/ml kanamycin and
incubated at 310 K overnight. One colony was used for a 600 ml culture that grew with
gentle shaking overnight at 310 K in 2xYT media with 50 mM phosphate (pH 7), 20mM
glucose, 100 [tg/ml ampicillin, and 25 tg/ml kanamycin. The cell mixture was cooled on
ice and centrifuged then the pellets were collected and frozen at 253 K overnight. Frozen
cells were thawed and resuspended by adding 20 ml of 10mM phosphate (pH 7.6), 0.3
mM EDTA, and 0.5 mM phenylmethylsulfonyl fluoride. Cells were then sonicated 5
times for 10 seconds, allowing 20 seconds between sonications to cool on ice. After
sonication, 100 mg streptomycin sulfate was added and the mixture was centrifuged,
supernatant was saved, and ammonium sulfate was added to the final concentration of
0.56 g/ml. The precipitate was collected by centrifuging the mixture and the pellet was
resuspended in 10 ml of 10mM phosphate (pH 7.6), 0.3 mM EDTA and dialyzed
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overnight in 1 L 10 mM phosphate (pH 7.6), 0.3 mM EDTA, the solution was refreshed 3
times. The protein solution was then passed through a 45 gtm syringe filter and then
loaded onto a 3 cm x 5 cm 2',5'-ADP Sepharose 4B column. Protein was eluted using an
120 ml 10 mM phosphate (pH 7.6), 0.3 mM EDTA buffer with a 0.15 mM - 1 M NaCl
linear gradient. Fractions were combined based on 280 nm/ 456 nm ratio and then
precipitated by adding ammonium sulfate to the final concentration of 0.56 g/ml. The
protein precipitate was collected by centrifugation and the pellet was resuspended in 10
mM phosphate (pH 7.6), 0.3 mM EDTA, and 100 jtM FAD, incubated for several hours
at 4'C and then dialyzed overnight in 1 L 10mM phosphate (pH 7.6), 0.3 mM EDTA, the
solution was refreshed 3 times. Protein was refrigerated for immediate use. The plasmid
pTrR301 was the generous donation of Dr. Scott B. Mulrooney.
Protein electrochemistry.
Protein film voltammetry was conducted using a PGSTAT 12 electrochemical
analyzer (EcoChemie), in a three electrode cell configuration, using a pyrolytic graphite
edge (PGE) working electrode, a calomel reference electrode and a platinum wire counter
electrode. All experiments were performed in a water-jacketed all-glass electrochemical
cell that was thermostatted using a circulating water bath. The reference electrode was
maintained at room temperature in the course of the experiments, and all potentials
described here are reported versus the hydrogen potential, correcting for the discrepancy
between SHE and the calomel electrode as a function of temperature. Electroactive films
of taTrR were generated by first polishing the PGE surface with and aqueous slurry of
1.0 gM alumina (Buhler), followed by sonication. The polished electrode was washed
thoroughly with distilled water, and 1.0 jtL of TrR (typically a 100 pM solution in pH 8.0
HEPES buffer with 150 mM NaCI) was deposited on the graphite surface. Excess protein
was removed with washing, and the resulting protein film was placed immediately in the
electrochemical cell compartment, in which 2.0 mL of a working cell buffer was purged
under a continuous nitrogen blanket. Electroactive films of ecTrR were similarly obtained
by first poising a freshly polished PGE at -510 mV in a protein free cell solution for five
minutes. Then, 1.0 jiL of ecTrR (260 pM) was directly to the electrode tip, and excess
protein was removed by washing with a small amount of ice-cold buffer.
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Electrochemistry was conducted as staircase cyclic voltammetry. The resulting
voltammograms were subjected to baseline subtraction of a polynomial background,
representing the non-faradaic (charging) component of the current. The entropic
component of the redox reaction of TrR was determined using the slope of a plot of Em
vs T (ASo rc = nF(dEm/dT)) for data collected using a cell in which the reference calomel
electrode was maintained at a constant temperature (293 ± 0.5 K), while the working
electrode-containing cell temperature was varied. The enthalpic component was similarly
determined by a Gibbs-Helmholtz plot (Em/T vs 1/T).
Redox potentiometry.
Additional determinations of the thermodynamic potentials of ta and ecTrR were
conducted using the xanthine/xanthine oxidase system described by Massey (25).
Specifically, potentials were determined under anaerobic conditions in a glovebox using a
S. I. Photonics 400 series spectrophotometer. The solution contained 100mM HEPES (pH
7.0), 1 ItM benzyl viologen, 1 IM methyl viologen, 250 gM xanthine, xanthine oxidase, 18
tM enzyme, and 5tpM Safranine O as a reference dye (-289 mV).
RESULTS
Protein electrochemistry.
The taTrR was investigated at pyrolytic graphite edge electrodes using cyclic
voltammetry, at 283 K, as shown in Figure 2 (solid line). The electrochemical response
reveals a single pair of highly broadened voltammetric peaks, centered at a midpoint
potential of -315 mV. On initial analysis, the data do not seem to be in accord with
theoretical predictions of redox active molecules adsorbed at an electrode: ideal peak
shapes would display zero separation of cathodic and anodic peaks, while the data shown
in Figure 2A display a peak separation of nearly 110 mV. However, the relationship of
cathodic and anodic peak heights (ic and ia) with respect to the scan rate (v) show a linear
relationship, indicating an adsorbed species. Further, the ratio of ic/ia is invariant with
respect to scan rate, indicative of a simple redox process with no further preceding, or
following, chemical reactions (Figure Al.2A, inset). Like the unusual increase of peak
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separation at 283 K, the peak-widths (6) of both the cathodic and anodic peaks (Figure
2B) also deviate from a simple, ideal system. By theory, 8 z3.53(RT/nF), so at 283 K, a 6
value of 86/n mV is predicted. Thus, even if the voltammogram represents the sum of
two distinct, over-lapping electrochemical responses, each corresponding to an n = 2
redox reaction (for the FAD/FADH2 and active site disulfide/dithiol couples) the
observed data appears to be unusually broad. Plotting the peak-width at half-height
versus temperature (Figure A1.2B) shows that the peak-width decreases substantially as
the temperature increases, becoming closer to the predicted value for a n=2 process at
temperatures greater 313 K. Notably, theory states that for a routine redox process, the
decrease should not occur (6 should increase as a function of temperature) indicating that
other processes must be at work.
The observed voltammetric response is strongly affected by changes in
temperature. The dependence of the voltammetric peak shape upon temperature is shown
in Figure A1.3A. By warming the cell solution using externally controlled circulator, the
peak separation, peak-width and midpoint potential of the taTrR PFV response was
altered. As mentioned above, the peak width decreases as a function of temperature
(Figure A1.2B) and as Figure Al.3A indicates, no additional features are observed in the
voltammetry. At low temperature, a broad envelop-like signal appears, while at elevated
temperatures the voltammetric response sharpens considerably. In a similar way the peak
separation also decreases as a function of temperature - which is also unexpected on the
basis of electrochemical theory for a simple reversible redox equilibrium. Figure 3B
shows that as the temperature increases to the upward limit of the stability of the
electroactive protein film, 333 K, the peak separation decreases, though the ideal value of
0 mV is never attained. While perfect reversibility is not observed at higher temperatures,
the peak separation (typically -30-50 mV) is close to values observed for other systems
analyzed with PFV. As discussed below, the non-zero peak separation may due to
heterogeneity upon the electrode, including distinct global conformations of taTrR at the
electrode surface, but also the FR and FO conformations unique to low MR TrR enzymes.
The intensity, or area, of the electrochemical response is also strongly affected by
temperature - as Figure Al.3A indicates, the area of both the oxidative and the reductive
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signals is reduced as the temperature is elevated. In the higher temperature regime (e.g.,
313 K), the taTrR electrochemistry still corresponds to an immobilized species, as
determined by a linear relation of ia or ic with v (data not shown). In the minutes required
to attain and stabilize the protein at a specific temperature, desorption of the protein film
did occur, though as all experiments were conducted in fresh, protein-free solutions, the
desorption was not significant in the time-scale of a single cyclic voltammogram,
collected at 150 mV/s. Figure A1.3A clearly indicates that cooled protein films initially
yield pronounced surface coverage (heavy, solid line). Heating not only leads to peak
narrowing and a decrease in peak separation, but when a protein film at elevated
temperature is returned to the cool temperature (283 K), broadening and peak separation
occurs again, and although the signal intensity is depleted (Figure A1.3A, dotted line) the
peak width (Figure 2A, open square) and peak separation (Figure A1.3B, closed square)
are nearly identical upon the return to 283 K, as compared to the initial experiments. We
interpret the dramatic changes in the PFV response as a demonstration of the
conformational dynamics of the FR and FO states as the temperature approaches the
optimal growth temperature of T. acidophilum.
The redox thermodynamics for the overall taTrR electrochemical response is
illustrated in Figure A1.4, which depicts the measured midpoint potential of the overall
voltammetric response (taking as Em the average of the cathodic and anodic peak) as
function of temperature. The dependence of the observed midpoint potential displays a
clear downward trend, as in the case of the redox thermodynamics of flavins measured in
non-aqueous solvents (26), as well as in flavoproteins (23, 27). If the mid-point potentials
are taken as a super-position of the two redox cofactors (i.e. the FAD/FADH2 and the
disulfide/dithiol couples), and the behavior of the two couples is assumed to be similar,
the slope of the linear fit shown in Figure A 1.4A can be related to the entropy change for
the redox reaction, ASo rc/nF, yielding a value of -78.1 J/K*mol. As the individual redox
couples cannot be observed directly, this value can serve only as an estimate of ASo rc. A
similar interpretation of a Gibbs-Helmholtz plot (Figure A1.4B) conveys AHo rc for the
process at the electrode, giving a value of -19.2 kJ/mol.
Possible Role of Adsorbed Flavin.
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The propensity for several flavoproteins and enzymes to lose flavin cofactors at graphite
electrodes forced us to consider the possibility that the apparent electrochemical reponse
of taTrR could be due to FAD adsorbed upon the electrode. To investigate this
possibility, we have conducted several experiments: First, we have compared adsorbed
FAD at a graphite electrode with the taTrR response. A microliter of a buffered FAD
solution (50 pM) was deposited on a graphite electrode, in a similar fashion to the taTrR
PFV. The resulting electrochemically active species displayed a midpoint potential -50
mV more positive than the taTrR response.
Second, in order to ensure the that our taTrR data did not correspond to denatured
protein in the presence of extra FAD in a non-native conformation, we have
supplemented taTrR solutions used to generate protein films with additional, 'free'
flavin. Free FAD can be added to the electrochemical cell, with taTrR already adsorbed
onto the working electrode. In this experiment, the typical taTrR PFV signal (Figure
A1.5A, light solid line) in the absence of exogenous flavin, transforms into a
voltammogram that is a convolution of overlapping 'free FAD' and 'taTrR-based' signals
as a function of the added FAD (Figure Al.5A). Identical results are achieved with FMN
or riboflavin addition, and it is clear that the FAD-based signal is discernible from the
TrR-based signal, at all pH values in this study (Figure A1.5B). In the case of both FAD
and taTrR, a pH dependence of -60 mV/pH is observed (Figure A1.5B), indicating a 1:1
ratio of protons and electrons involved in the redox couples.
Third, the E. coli TrR (ecTrR) can be interrogated using PFV (Figure A1.6), and
reveals a significant loss of 'free flavin' at the EPG electrode, indicating that a simple
difference between the Ec and Ta enzymes is the enhanced stability of the TrR from the
thermophile T. acidophilum in retaining flavin, when bound to the electrode. Similar to
the taTrR findings, the ecTrR shows a 'free flavin' based electrochemical signature that
grows upon the addition of exogenous flavin into the cell solution (data not shown). In
general, the ecTrR behaves very much like the taTrR although the overall electroactive
surface coverage (F) is significantly lower for the ecTrR as compared to the taTrR. Yet,
the average peak width of the ecTrR does decrease with increasing temperature (Figure
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A1.6B), as observed for the T. acidophilum protein (Figure A1.2B); thus, we believe that
the essential characteristic of redox function the TrR cofactors are nearly identical.
Finally, we have noted that electrodes modified with taTrR behave very much
like other protein film electrodes, in contrast with FAD-modified electrodes.
Electroactive films generated from taTrR solutions are easily removed by repolishing the
electrode surface with an alumina slurry, and electrodes are themselves sensitive to
changes in buffer conditions. Neither of these parameters is true for a graphite electrode
modified with FAD, which is quite difficult to remove from the graphite surface, even
with multiple cycles of mechanical abrasion and alumina polishing. Thus, due to these
four lines of inquiry, we are convinced that the Ta TrR-based electrodes genuinely
represent the redox chemistry of the taTrR, and are not grossly compromised due to the
loss of the flavin cofactor.
Verification of Potentials via Redox Potentiometry.
In order to verify that observed reduction potentials were analogous to measurements
obtained by redox potentiometry for the TrR from E. coli, we measured the observable
flavin potential for taTrR using the xanthine/xanthine oxidase-coupled potentiometric
assay described by Massey (25). Figure A1.7 depicts the result of this experiment, using
the redox indicator safranine O (SafO). The solution-based method cleanly reduces the
taTrR flavin from the oxidized to reduced forms, without the generation of the flavin
semiquinone, yielding a value of the flavin potential of -305 +5 mV, at 303 K, agreeing
with the measurement made with PFV (-322 mV for the entire taTrR envelop, Figure
A1.4). Control experiments were conducted using the ecTrR, which we analyzed using an
identical protocol, resulting in a potential of -291 mV ± 5 mV, in a reasonable agreement
with previous measurements of the ecTrR flavin potential, -252 mV, as determined by
O'Donnell and Williams, using a potentiometric method involving NADPH- and Trx-
based equilibria.
Variable Scan Rate Measurements.
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In order to better describe the temperature-induced alteration of the taTrR
electrochemical response, we examined the impact of scan rates (and therefore, time
scale) used in PFV. By collecting voltammetry data at faster and faster time-scales
(increasing scan rate), we presumed that in the higher temperature regime, fast scan rates
would allow us to detect the distinct FO and FR conformations on the electrochemical
timescale. Thus, if conformational dynamics were a substantial contributor to the narrow
voltammetric envelop observed at higher temperatures, we could reverse the narrowing
effect by using fast scan rates. Figure, A1.8 shows the impact upon the PFV experiment
achieved by increasing the scan rate over two orders of magnitude, while the temperature
is held at a constant value of 308 K. By normalizing the baseline-subtracted data for the
scan rate (and small deviations overall area due to film-loss associated with the thermal
desorption of the TrR from the electrode), it clear that as v is increased from 200 mV/s
(Figure A1.8, dotted line) to 2 V/s (dashed line) to 20 V/s (solid), the data mimic the
impact of lowering the temperatures. As shown in Figure A1.8, as v is increased by two
orders of magnitude, the oxidative and reductive peaks shift from the mid-point position
by over 110 mV, and the shape of the peak broadens by -50%. At temperatures greater
than 308 K identical behavior was observed when the scan rate is increased, though the
electrochemical response is complicated by thermal desorption of the taTrR which yields
signals of smaller magnitudes (and for this reason, we show illustrative data at 308 K in
Figure A1.8). The overall scan-rate dependent behavior is likely compounded with the
natural increase of peak separation and peak-width at half-height that can otherwise be
utilized to find interfacial electron transfer kinetics. Yet, qualitatively, we have found a
striking similarity between experiments conducted using faster scan-rate yet higher
temperatures, and those at slower scan-rates and lower temperatures. As discussed below,
we take these findings as supportive of the model of TrR conformational dynamics upon
the electrode.
DISCUSSION
We have shown that the direct electrochemistry can be used to interrogate the redox
active cofactors of low Mr TrRs, through the study of the newly characterized enzyme
from T. acidophilum as well as the TrR from E. coli. In the most general terms, the data
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are in reasonable agreement with control experiments carried out with a
xanthine/xanthine oxidase method for the determination of flavoprotein redox potentials.
Other methods of spectrophotometrically titrating the reduction potential of the flavin
would typically utilize the soluble redox agent responsible for supporting turnover in
vivo, such as NADPH. As described in the preceding paper, however, the taTrR cannot
be reduced by NADPH, due to clear structural determinants that preclude binding of the
co-substrate. At this time, the nature of the in vivo reduction system is unknown.
Regardless, the use of the xanthine/xanthine oxidase method revealed a flavin potential
for taTrR of -305 mV at 303 K, consistent with the broad electrochemical response
centered at -322 mV observed at the same temperature. We have ruled out the possibility
that the PFV results are due to free flavin cofactor that has dissociated from the taTrR
during the course of our experiments, and we have found that there is a similarity
between the ecTrR electrochemistry, and that observed for the ta enzyme. In both cases,
the voltammetric response shows broad, yet symmetrical voltammetry, that likely
contains information about both the flavin cofactor as well as the redox-active disulfide
group associated with thioredoxin reductases. However, two distinct voltammetric
features are not clearly resolved, regardless of the temperature, pH, or ionic strength (not
shown), each of which could be a factor that would preferentially modulate one of the
two cofactors' redox properties. Further, the redox thermodynamics of the voltammetric
feature observed shows a single, linear dependence of Em as a function of temperature,
indicating that PFV is reporting upon redox processes which are behaving similarly at the
electrode. However, taTrR reveals a very stable electrochemical response that displays a
peak shape that is very sensitive to the temperature of the electrochemical cell. While
requiring significantly lower temperatures, McEvoy and Armstrong have also noted that
cryotemperature-induced broadening can occur for thermophilic proteins, such as the ta
ferredoxin (28). Here we hypothesize that low temperature induced "broadening" is
further enhanced by the dynamics of the TrR enzyme. In following points, we will
attempt to resolve an electrochemical model of the data, which rationalizes how the
distinct conformations associated with TrR activity (FR and FO) result in a modest
modulation in the potentials for redox active cofactors associated with TrR, thus yielding
the apparently broadened voltammograms.
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General considerations of an electrochemical model.
As the FO and FR conformations can interconvert regardless of redox-state, a model
describing the relationships between the conformational states and redox potentials must
allow for each redox reaction and each interconversion between FO and FR, as shown in
Scheme Al.A1. As depicted, either the flavin or the disulfide cofactor may undergo
redox chemistry (indicated by either top or bottom face of the cube illustrated in Scheme
Al.1) regardless of the conformer. The interconversion between the conformers is
indicated as a transition between the top and bottom faces of the cube. Thus, if both FO
and FR are populated with equal probability at the electrode, there are eight distinct
microscopic potentials that should be associated with electrochemical steps. This scheme
can be simplified to Scheme A1.1B, which considers that PFV will report upon
thermodynamic potentials, resulting from just four features (Em for the FAD/FADH2 and
the disulfide/dithiol couples, in both the FR and FO conformations). In the case of the
taTrR, the relative populations of the FR and FO conformers are not known; for our
electrochemical analyses, this should make itself manifest as a specific electroactive
coverage for both the FR (FFR) and the FO (FFO) conformers. In the following analysis,
we will assume that the broad electrochemical envelope observed at low temperature is
due to kinetic trapping of FR and FO states upon the electrode; thus, heating the taTrR
allows for interconversion between the states, and the resulting voltammetric features
represent an averaging between specific redox couples (e.g., the FAD/FADH2 couple) as
experienced in the FO and FR conformers.
PFV results of the taTrR at 333 K.
As observed in the raw data (Figure A1.3A) conducting PFV at temperatures near the
growth optimum of T. acidophilum results in highly symmetric, nearly reversible
voltammograms. In our model this feature should contain information regarding the
FAD/FADH2 and disulfide/dithiol redox couples of the taTrR, averaged between the
interconverting FO and FR conformations. Thus, we have initially attempted to describe
this data by a set of two redox couples of equal electroactive area, as the stoichiometry of
the flavin cofactor to the disulfide is 1:1. Figure A1.9 shows the result of fitting the
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baseline-subtracted, oxidative scan, computing an electroactive coverage for the TrR, and
determining a two-electron mid-point potential for both the flavin and the disulfide, each
of which is described by the formalism derived by Laviron, given in Equation Al.1 (29;
30).
F2A (A( k PF(npFRT)(E - Ek)
Eq. A.1. ,,,, = ", (1 + e p[(n,F/RT)(E - Ek)]
Where,
S--expl2f(E Egi)l and
f - F/11'
(Here, F is the Faraday, R the ideal gas constant, T the temperature, v the scan rate, A the
geometric area, and F the electroactive coverage.) In all cases, qualitatively identical
results were observed for the reductive scan of each experiment. As Figure A1.9
illustrates, at 333 K the PFV response of taTrR is modeled by just two n=2 e- features
that are indicated by the dotted lines. In this way, the two voltammetric features at -295
mV and -330 mV are directly observed, and most likely represent the cooperative
FAD/FADH2 and disulfide/dithiol couples. The two features are separated in potential by
approximately 35 mV, somewhat larger than the difference of 7 mV suggested by
Williams and co-workers for the E. coli enzyme (9; 16; 17).
Additionally, the higher potential feature is in good agreement with the value for
the FAD cofactor determined by redox titration at 303 K, -305 mV. Figure A1.9A shows
the fitting for a case where the cooperativity of each cofactor is perfect (by requiring a
large separation in the crossed, formal one electron potentials described by Eq. Al.1).
The result is only slightly improved by allowing for the possibility that the redox
behavior is somewhat nonideal. Figure A1.9B shows that a discernible, but modest
improvement in the fit (and less than 5 mV total separation in the two detectable
potentials) is achieved by allowing for breakdown of perfect n=2 e- behavior,
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represented here by slight broadening of the component features (Figure A1.9B, dotted
lines). In the Laviron description of two-electron redox chemistry, a decrease in
cooperativity corresponds to the two one-electron potentials becoming closer in value.
The apparent loss of cooperativity could also be reflective of dispersion of the taTrR
molecules upon the electrode, that is still present at the elevated temperature. From this
analysis, it is clear that the averaged potentials are close in absolute value, and cannot be
more than -35 mV separated from one another, or the electrochemical data would reveal
a clear indication of two peaks in the raw data.
PFV results at 283 K.
A similar approach to the analysis of data collected at lower temperatures (here, 283 K) is
shown in Figure Al.10. Attempting to describe the data in terms of two n = 2e-
components is not at all possible, given the overall broadening observed in the data.
However, allowing for the loss of cooperativity is illustrated in Figure Al.1OA, which
shows the fitting of the oxidative half-scan of data collected at 283 K, where the dotted
lines correspond to two n = 2e- components that both display artificially broadened peak
shapes. The breadth in the case of the fitting shown in Figure Al.10A arises from the loss
of cooperativity for the redox-chemistry of both co-factors (i.e., for both features the two
one-electron potentials are apparently no longer crossed.) However, there are no
additional indicators from solution experiments that at 283 K, either the taTrR flavin or
the disulfide engage in one-electron chemistry. Indeed, the redox titrations of the flavin
all show clean n = 2e- behavior at low temperatures (Figure A1.7). As such, we take the
apparent loss of cooperativity to be synonymous with the effect dispersion generated by
the "freezing out" of the FO and FR conformations. If we do attempt to account for the
possibility of distinct conformations, by modeling the low-temperature response with
four species, we can indeed obtain an excellent agreement with the data, shown in Figure
Al.1OB. In this model, four features are apparent, corresponding to both n = 2e- redox
cofactors being present in the FO and FR conformations. The key result from this
analysis is that we can estimate that the impact of FR and FO conformers is a modulation
of 40-60 mV for both the FAD/FADH2 and disulfide/dithiol reduction potentials.
However, we cannot assign specific redox couples to the voltammetric components of the
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envelope. Instead, PFV elucidates the similarity in the formal potentials for the cofactors,
and the dynamics of TrRs at an electrode interface.
While the development of a more precise mechanistic model will require greater
insight into the assignment of the nernstian peaks observed in our fitting (potentially
through the generation of a disulfide-free mutant of the taTrR), an attractive hypothesis
would allow for the flavin to possess a higher potential in the FR conformation, such that
reduction of the flavin is efficient; and then in the FO conformation if the potential has
been lowered by -40-60 mV with respect to the disulfide, reduction of the disulfide will
again be favored. Finally, when the FR conformer is adopted again, the resulting dithiol
will be able to readily react with Trx in a thermodynamically favorable manner. Thus, the
TrR scaffold may be able to achieve precise and unidirectional redox chemistry by tuning
the potential of flavin and disulfide by discreet steps.
Concluding Remarks
Here we have interrogated low Mr thioredoxin reductases using direct
electrochemistry for the first time. We investigated the redox properties of a classic TrR
from E. coli, as well as newly described TrR from the archaeon Thermoplasma
acidophila (19). Structural and biochemical studies have demonstrated that the taTrR is
very much like the better characterized bacterial homolog from E. coli except in its
selection for its reductant. By using PFV we have been able to exploit the superlative
thermostability of the taTrR to our advantage, and demonstrate that protein dynamics
between the FO and FR conformations contribute to the formal potentials of the flavin
and disulfide cofactors.
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Figure A1.1. The FO and FR conformations of ecTrR, superimposed in grey and wheat
respectively. Orange spheres are used to represent the disulfide-forming cysteines in the
FO conformation, and the cysteine/serine pair used in the crystallographic trapping of the
ecTrR FR conformation. The image was constructed from the FO and FR pdb files
1TDF.pdb and IF6M.pdb, respectively.
/
201
- APPENDIX 1 - Direct Electrochemical Analyses of afuTrs -
Figure A1.2. PFV response of taTrR upon EPG electrodes. (A) Raw PFV data of taTrR,
at low temperature (solid line) superimposed upon the baseline response of the EPG
electrode used for taTrR immobilization (dashed line). Experimental conditions were as
follows: scan rate, 100 mV/s; pH 7.0; 100 mM NaCl electrolyte; 283 K. (inset). Inset:
dependence of peak height (ip) as a function of scan rate. (B) The average peak width at
half height for oxidative and reductive scans, as a function of temperature (open squares),
compared to computed values of peak-width for a n = le- (solid) or n = 2e- (dashed)
features. The solid square represents the observed average peak width, after returning a
heated taTrR protein film to 293 K.
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Figure A1.3. Variable temperature, PFV response of the taTrR. (A) The taTrR PFV
response as a function of temperature. Protein films generated at 283 K (solid line, heavy)
were then subsequently warmed to 293 (blue dashed), 303 (green dash), 313 (yellow) and
then 323 K (red dash). Finally, the experimental temperature was lowered to 283 again
(dotted line), indicating the loss of the protein surface coverage during the course of the
experiment. All data were collected at pH 7.0, 100 mM NaCl electrolyte, and with a scan
rate of 150 mV/s. (B) Peak separation as a function of temperature, for a single
experiment, heating the protein film in increasing steps of five degrees; the open square
represents the peak separation observed when returning the taTrR film to 283 K.
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Figure A1.4. Redox thermodynamics of taTrR protein films, modeling the data to two
overlapping 2e- features. (A) ASo rc is determined from the slope of the Em vs T plot.
Data are fit to a linear regression analysis, and the slope of which is interpreted as slope =
ASo rc/nF, where n is assumed to be 2e-. (B) Gibbs-Helmholtz plot of the same data.
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Figure A1.5. Demonstration that the PFV response of taTrR is not due to flavin desorbed
from the protein. (A) Addition of exogenous FAD to a taTrR protein film. Build up of
the voltammetric response of the FAD/FADH2 couple is observed by starting with a
taTrR-bound electrode (light solid line) and adding FAD to the electrochemical cell at
final concentrations of 2, 4 and 10 pM (dotted, dashed, and heavy solid line). The build
up of the free FAD species is observable at -- 220 mV. Other experimental features: pH
7.0, 10 oC, v = 150 mV/s. (B) Free FAD (e) and taTrR (open square) midpoint potentials,
as a function of pH.
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Figure A1.6. PFV response of ecTrR. (A) Raw PFV and baseline-subtracted
voltammetric features for ecTrR; parameters for the experiment: pH 7.0, 10 oC, v = 150
mV/s. (B) Average peak width at half height as a function of temperature, for the ecTrR
component of the PFV response shown in (A).
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Figure A1.7. Redox titration of the taTrR flavin using the xanthine/xanthine oxidase
reduction methodology of Massey (25), showing the decrease in the visible absorption
spectrum, as collected every -5 minutes during the course of the reduction of the flavin
cofactor. SafO was used as the reporter dye (maximum at 520 nm), as described in the
materials and methods. Inset: Plot of log [Ox]/[Red] for SafO vs. log [Ox]/[Red] for TrR,
used to find the midpoint potential with respect to the reference value of SafO (-289 mV).
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Figure A1.8. Impact of increasing scan-rate upon the taTrR voltammetry at 308 K.
Baseline substracted data are given to illustrate how at elevated temperatures, the scan
rate of the experiment can be raised from 200 mV/s (dotted line) to 2 V/s (dashed) to 20
V/s (solid), which results in broadening due to the observation of FO and FR states.
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Figure A1.9. Fitting of the baseline-subtracted, oxidative half-scan of taTrR to two
distinct nernstian features, with an identical value of the electroactive coverage, at 333 K.
For each feature the stoichiometric number of electrons was held to 2, while the
separation between the EI/R and EO/R potentials was allowed to vary, as indicated by
Equation 1. (A) The case where the two one-electron potentials are crossed, with the
difference in potential being greater than 200 mV; (B) the difference in crossing of
potentials is -50 mV.
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Figure A1.10. Fitting of the baseline-subtracted, oxidative half-scan of taTrR to either
two noncooperative (A) or four cooperative (B) n = 2e- nemstian features, assuming
identical electroactive coverages, and a temperature of 283 K.
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Scheme A1.1. (A) A model of microscopic potentials and the distinct FO and FR
conformations for a low Mr TrR. (B) A simplified model in which individual microscopic
potentials will not be addressable in the PFV experiment.
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INTRODUCTION
The mechanisms differentiating very high affinity protein interactions (sub-
picomolar dissociation constants) from high affinity (nanomolar dissociation constants)
have seldom been possible to study (1, 2), because few protein interaction families that
span this range of affinity have been identified from either nature or engineering efforts.
Antibodies provide a natural affinity series of related proteins but, in vivo, rarely surpass
a 0.1 nanomolar dissociation constant (Kd) due to physiological limits on the selection
(3). Further affinity improvements are often desired for pharmaceutical and
biotechnology uses, and can be attained through directed evolution protein engineering
techniques (4, 5, 6, 7). Computational methods have also provided some limited
predictions of specific changes needed to improve high affinity interactions (8), although
they have yet to realize substantial improvements experimentally. To date, the transitions
from micromolar to nanomolar (9, 10, 11, 12, 13, 14) and from femtomolar back to
picomolar (2, 15) affinity have been studied, providing little guidance into the
mechanistic means to engineer an enhancement from nanomolar to femtomolar affinity.
Previous studies of antibody maturation from weak binding (micromolar) to high
affinity binding (nanomolar) have shown that a number of factors are involved in
improving affinity across this range. Several studies have noted that decreased loss of
entropy on binding, with creation of a lock and key fit mechanism, contribute to affinity
improvements (11, 14, 16, 17). In a structural, thermodynamic, and computational
energetic analysis of an esterolytic antibody bound to a p-nitrophenyl phosphonate
hapten, affinity maturation occurred through a reorganization of the binding site
geometry so as to optimize gaining favorable electrostatic interactions with the hapten
and losing those with solvent during the binding process (9, 18). In a study of an anti-
testosterone antibody affinity maturation, improvement was derived from small structural
changes providing more comprehensive packing around the antigen (12). A study of an
anti-(4-hydroxy-3-nitrophenyl) acetate affinity matured antibody suggests that "relief of
cramped contacts" in the wild-type provided the increased affinity in the mutant (19). In
the first structural mechanistic study of affinity matured antibodies to a protein antigen,
216
-APPENDIX 2 - Substantial Improvement with Minimal Structural Perturbations in a
High Affinity Mutant Antibody
the higher affinity was attributed to an increased burial of hydrophobic surface area on
binding and improved shape complementarity between antigen and antibody (13).
Across these affinity maturation studies, mutations were found in antigen contact and
non-contact regions; however, it was not always clear whether all the cited mutations
were contributing to the improvements. It is perhaps to be expected that insights derived
from studies of micromolar to nanomolar affinity improvements may not translate
directly to mechanisms involved in fine-tuning an interaction from nanomolar to
femtomolar affinity levels.
The monoclonal antibody 4-4-20 directed against the hapten fluorescein was
originally isolated to facilitate studies of immunological recognition (20). The 4-4-20
binding has been extensively studied as the whole IgG, the Fab, the Fv, and the scFv by
thermodynamic, kinetic, structural, computational, spectroscopic, and mutational
methods (21, 22, 23, 24, 25, 26, 27, 28). A recent comparative structural study compared
the 4-4-20 Fab structure with an idiotypically related lower affinity Fab, 9-40 (29). This
study revealed a reorganization of the binding site and a more closed structure with fewer
water molecules at the binding pocket for 4-4-20, compared with 9-40, to account for the
change in binding affinity.
Ten femtomolar affinity mutants of 4-4-20 were previously identified through
directed evolution with random mutagenesis over the whole Fv followed by screening
with yeast surface display (7). Clone 4M5.3 from that study was chosen for further study
here. This clone contains 14 mutations, including all ten of the consensus mutations
observed in the final directed evolution round clones.
Here, we compare 4M5.3 to 4-4-20 by kinetic, thermodynamic, structural, and
theoretical analyses. No individual structural change was unambiguously associated with
the -4.5 kcal/mol improvement in binding free energy. However, these results implicate a
sum of many small structural changes in combination with specific mutations that
improve electrostatics, which together result in a large binding free energy change.
MATERIALS AND METHODS
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Over-expression and purification of scFv proteins
The 4-4-20 and 4M5.3 scFvs (7) were subcloned into the pRS316 backbone with
the Gall-10 promoter (40). A Flag tag (amino acid sequence Asp-Tyr-Lys-Asp-Asp-
Asp-Asp-Lys) was inserted between the EagI and NheI sites N-terminal to the scFv
sequence and the first expressed amino acid was changed to alanine by site-directed
mutagenesis (Stratagene, La Jolla, CA). The sequence expressed was Ala-Ala-Arg-Pro-
(Flag-tag)-(scFv). The scFvs were expressed solubly in Saccharomyces cerevisiae strain
YVH10, which has an integrated PDI gene, using the growth conditions of SD (2% (w/v)
dextrose, 0.67% (w/v) yeast nitrogen base, 50 mM sodium phosphate buffered to pH 6.6)
containing 2x SCAA amino acid supplement (lacking Trp, Leu, and Ura, as described
(40)) with one liter of culture in a 2.5 1 fully baffled Tunair flask (Shelton Scientific,
Shelton, CT) at 30 oC, 250 rpm shaker for 32-48 hours. For induction, the cells were
centrifuged to remove the supernatant, and resuspended in YPG medium (1% (w/v)
Bactoyeast extract, 2% (w/v) Bactopeptone, 2% (w/v) galactose); one liter of culture in a
2 1 glass Erlenmeyer flask. The flasks were placed in a 20 'C, 250 rpm shaker for 48-60
hours. The supernatant was then separated by centrifugation and filter sterilized. The
supernatant was concentrated to -_100 ml with a PREP/SCALE TFF 10k MWCO
concentration unit (Millipore, Bedford, MA), and the buffer was exchanged to Tris-
buffered saline (TBS: 50 mM phosphate buffer (pH 8), 150 mM NaC1), with 500-750 ml
of TBS in four batches. The final volume was . 100 ml. The protein was purified with
M2 anti-FLAG resin (Sigma, St. Louis, MO) by batch method. Final protein was
identified as a single band by Coommassie blue staining of an SDS-PAGE gel and
purified yields were .. 5 mg and , 10 mg per one liter initial culture, for 4-4-20 and
4M5.3, respectively. Mass spectrometry was performed to confirm the desired sequence.
Equilibrium Kd Of scFv
The concentrations of the scFv were determined by fluorescence quench
titrations, as described using the quenching constant (Q) of 0.94 and 0.95 for 4-4-20 and
4M5.3, respectively (7). The soluble 4-4-20 equilibrium binding constant, Kd, was also
determined by fluorescence quench titration, as described (7). The equilibrium Kd of
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4M5.3 displayed on the surface of yeast was determined by a competition assay with
soluble 4-4-20. The 4M5.3 was displayed on the surface of yeast as reported (7).
Labeling reactions contained 2x106 4M5.3 displaying yeast (,0.2 nM 4M5.3 scFv),
1.7 nM fluorescein-biotin (Molecular Probes, Eugene, OR) and varying concentrations of
soluble 4-4-20 (0.01-40 gM). The experiments were either mixed with the 4M5.3
displaying cells and fluorescein-biotin first, allowed to incubate for one hour at 25 'C,
and then the 4-4-20 competitor was added, or the competitor and fluorescein-biotin were
allowed to incubate together for one hour at 25 'C, and then the 4M5.3 displaying cells
were added. All experiments contained a final concentration of 1xPen-Strep. The tubes
were then incubated at 25 'C for 15 days, with daily mixing of the samples. Controls
were also performed as above with either no competitor protein or with 10 pM soluble
4M5.3 as the competitor. Fluorescein-biotin binding to the cells was checked by
secondary labeling with streptavidin-Phycoerythrin (Pharmingen, BD Biosciences, San
Diego, CA), with analysis by flow cytometry (XL cytometer, Beckman Coulter,
Fullerton, CA).
Isothermal titration calorimetry
The enthalpy of binding was determined with both 4-4-20 and 4M5.3 scFv using a
MicroCal isothermal titration calorimetry (ITC) instrument (VP-ITC, MicroCal Inc.,
Northampton, MA). The scFvs were at 1-20 jiM concentrations in TBS in the cell, while
the fluorescein-biotin was at 10-200 pM concentrations in TBS in the syringe being
titrated. The final fully bound titration injections were used as the heats of dilution
standards (41). The enthalpy of binding was determined from a fit to the resulting curves.
The same enthalpy of binding results could also be obtained by subtracting the heats of
dilution of the fully saturated titrations from the heats of binding of the unsaturated scFv.
Kd values were not obtainable due to the steepness of the curves.
Differential scanning calorimetry
The melting temperatures of the scFvs in their bound and unbound forms in TBS
were determined with a differential scanning calorimeter (VP-DSC, MicroCal Inc.,
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Northampton, MA). Each 0.5 ml sample (,17 tM (,,0.5 mg/ml) scFv or . 17 jtM
scFv+,.30 [iM fluorescein) was placed in the cell and the instrument was heated at
1 deg. C/minute from 20 'C to 90 oC. A reference trace of buffer without protein,
collected as above, was subtracted from the protein sample traces.
Association rates
Association rates were determined by stopped-flow fluorescence measurements.
Using a fluorimeter (Varian Eclipse Instrument, Varian Inc., Mulgrave, Victoria,
Australia) connected to a manual stopped-flow instrument (RX-200 Rapid Kinetics
Accessory from Applied Photophysics, Leatherhead, Surrey, United Kingdom), 10 nM
fluorescein-biotin in TBS (pH 8), was mixed in a 1 : 1 (v/v) ratio at 25 'C with 10-60 nM
scFv (final concentrations: 5 nM fluorescein biotin, 5-30 nM scFv), and data were
collected on the millisecond time-scale for up to 240 seconds depending on the rate of the
binding reaction. The quenching data were fit with a single association rate, using the
dissociation rates determined previously, with the program Gepasi (42).
Crystallization and data collection
4M5.3 was concentrated to 5 mg/ml in a solution of 200 pM fluorescein (Aldrich,
St. Louis, MO), 10 mM Tris-HCl (pH 8.0). Standard hanging-drop, vapor-diffusion
methods were used to crystallize 4M5.3, at 4 oC in the dark, over a reservoir solution of
0.15 M sodium acetate (pH 4.6), 0.1 M ammonium acetate, 20% (w/v) PEG 4000, and
10% (v/v) glycerol (Hampton Scientific, Chalfont, PA). Crystals grown from these
conditions appeared in four to seven days and all had an intense yellow color, presumably
due to bound fluorescein. Prior to data collection, crystals were transferred to reservoir
solution and flash-cooled in liquid nitrogen. The crystals belong to the space group
P212121 with unit cell dimensions a=55.78 A, b=57.45 A, and c=79.22 A, a=P3=y=90,
and contain two molecules of 4M5.3 per asymmetric unit. Data were collected to 1.5 A
resolution at the Stanford Synchrotron Radiation Laboratory (SSRL) beam line 9.11 and
reduced using DENZO and SCALEPACK (43). See Table A2.1 for data collection
statistics.
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Structure determination and refinement
The structure of 4M5.3 was determined by molecular replacement with EPMR
(44) using a polyalanine-substituted model derived from 4-4-20 (IgG2a) with the
fluorescein ligand bound (entry IFLR in the Protein Data Bank) (24). Initial refinement
using a simulated annealing method was carried out using CNS (45). Final refinement
using positional and individual B-factor refinement was carried out using REFMAC (43).
Anisotropic B-factor refinement was used in the final stages of refinement. Manual
protein model rebuilding was done between rounds of refinement in XtalView (44, 45).
Of 268 residues per monomer, residues 14-268 were observed in electron density maps,
with one chain break per molecule (from 124-149, which corresponds to the linker
region). Residues 15-124 correspond to VL 1-111 and residues 151-269 correspond to
VH 1-117. For the structures, most (99%) chain angles fall into allowed regions of the
Ramachandran plot with only one residue (L57) disallowed. This agrees with previous
structures in which the corresponding residue (L56) is disallowed. The average B-factor
for the structure is 14.26 A2. See Table A2.1 for refinement statistics. Numbering used
here will correlate with the 4-4-20 Fab (1FLR) structure numbering. Shape
complementarity and solvent-accessible surface area calculations were performed with
the Sc and Areaimol programs in CCP4, respectively (31, 46). The solvent probe radius
for Areaimol was 1.4 A.
Computational structure preparations
The 1.85 A 4-4-20 Fab structure (1FLR) (24) and the solved 1.5 A structure of
4M5.3 (this work) were used as the basis for molecular modeling and continuum
electrostatic calculations and theoretical analysis. The two structures were prepared in
parallel to minimize differences that might bias comparative analysis. Only residues with
corresponding crystallographic data in both structures were used, prompting the removal
of the 4-4-20 CL and CH1 domains (residues after L1 12 and after H117) and a few N and
C-terminal residues corresponding to the flexible linker (4-4-20 VL112 and 4M5.3 VLO,
VH-2, VH-1, VHO), all of which are solvent-exposed and at least 15 A from the
fluorescein-binding pocket. Six water molecules were retained in each structure (4-4-20:
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606, 608, 615, 618, 676, 689; 4M5.3: 6, 3, 1, 11, 26, 47); these six solvent molecules
make corresponding interactions in the two structures. All other water molecules were
removed from the structure files and were modeled implicitly. Side-chain titration states,
single conformations for all multiple-occupancy residues, and the crystallographic
carbon/nitrogen/oxygen uncertainties in asparagine, glutamine, and histidine side-chains
were resolved based on examination of side-chain local environments. The fluorescein
was modeled in its net charge -2 state reflecting the pH of 8 in the binding experiments,
and this choice is supported by the local environments of the fluorescein protonatable
sites in each structure.
Molecular mechanics was used to prepare the protein structures. The HBUILD
facility (47) in the program CHARMM (48) was used to build all hydrogen atoms onto
each structure. The CHARMm22 all-atom parameter set (49) with the CHARMM-
adapted TIP3P water model was used for molecular mechanics calculations, assigning
appropriate general atom types for the fluorescein. Fluorescein partial atomic charges
were obtained as described (50) by first using the program GAUSSIAN98t with
restricted Hartree-Fock and the 6-31 G* basis set to optimize the geometry of fluorescein
starting from that in the 4-4-20 structure, and subsequently fitting the electrostatic
potential using the restrained-fitting methods (RESP) described (51).
A second set of 4-4-20 and 4M5.3 structures for comparison were prepared by
subjecting each to a harmonically restrained minimization to convergence with
10 kcal/mol per A2 force constants on every atom in the system, no non-bonded cut-offs,
and a 4r distance-dependent dielectric constant. The root-mean-square deviation for
structures before and after minimization were 0.093 A (0.094 A) and 0.053 A (0.053 A)
for 4-4-20 and 4M5.3, respectively, taken over all atoms (taken over side-chain atoms
only).
Electrostatic calculations
Electrostatic contributions of individual functional groups to the binding free
energy were computed using a rigid binding model with continuum solvent following
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previous work (52). A locally modified version of the DELPHI program (53, 54, 55) was
used to solve the linearized Poisson-Boltzmann equation with finite-difference methods.
PARSE parameters (56) were used for atomic radii and partial atomic charges of protein.
Fluorescein partial atomic charges were obtained from the RESP fitting procedure
described above, and radii were assigned based on the PARSE convention. PARSE
parameters do not include aliphatic hydrogen atoms and thus the appropriate hydrogen
atoms were removed from the system. Fluorescein does not contain any aliphatic
hydrogen atoms. The dielectric constant was assigned to 4 for protein, ligand, and explicit
water, and 80 for the implicit solvent regions. A salt concentration of 0.145 M was used
with a 2.0 A Stem layer and a molecular surface generated with a 1.4 A probe sphere.
Each molecule was oriented to minimize the volume of the bounding cube. A focusing
procedure was used that includes a low grid spacing using 23% fill and Debye-Hiickel
boundary conditions followed sequentially by higher resolution calculations first at 92%
and then at 184% fill centered on the specific functional group of interest. Ten
translations relative to the grid were performed and averages were used. The standard
error of the mean was of the order of 0.001 kcal/mol, much less than the 0.1-1.0 kcal/mol
range of differences identified between 4-4-20 and 4M5.3 components. A 129x 129x 129
grid was used, resulting in final grid spacings of 4.49 and 4.40 grid units per A for 4-4-20
and 4M5.3, respectively. Convergence of free energies with respect to grid resolution
(data not shown) indicates that a difference of 0.09 grid unit per A results in about
0.01 kcal/mol change in net binding free energy. Therefore, the comparison between 4-4-
20 and 4M5.3 electrostatic calculations on slightly different grids remains valid. For
binding calculations, all explicit water molecules remained associated with the antibody
in the unbound state. Overall electrostatic contributions to binding were dissected into
component contributions from individual chemical groups and physical sources based on
the work of Hendsch & Tidor (53).
RESULTS
Kinetics and thermodynamics
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The fluorescein-biotin equilibrium binding constant for 4-4-20 in both the soluble
form and displayed on the surface of yeast has been determined previously, with a Kd of
0.7 nM at 25 'C for both (7). The 4M5.3 binding constant with fluorescein-biotin was
previously determined to be 270 fM through the ratio of dissociation and association
kinetic rates (7). To test for the presence of kinetic intermediates that would cause the
ratio of the measured association and dissociation rates to differ from the equilibrium
binding constant, the 4M5.3 equilibrium binding constant was determined through
equilibrium competition titration. A competition assay was developed with 4M5.3
displayed on the surface of yeast, with varying concentrations of soluble 4-4-20 scFv
used to compete for binding to fluorescein-biotin. By this method, the equilibrium
binding constant was found to be 0.27(±0.05) pM at 25 oC (Figure A2.1), in agreement
with the previous kinetic ratio-determined Kd of 0.27 pM (7). Thus, the equivalence
Kd=koff/kon is consistent with a two-state transition from the unbound to the bound states,
and is not consistent with the presence of any substantially populated kinetic
intermediates. The AG of binding for 4-4-20 and 4M5.3 calculated from these Kd values
is -12.4(+0.1) kcal/mol and -16.9(+0.1)kcal/mol, respectively, for a
AAG=-4.5(0. I1)kcal/mol. Multi-step binding mechanisms such as an encounter complex
intermediate are not consistent with the observed equivalence between Kd and koff/kon.
In order to investigate the fast association rates found previously by manual
mixing fluorescence experiments for the presence of encounter complexes,
conformational selection, or induced fit, (7) stopped-flow fluorescence binding kinetics
were used to study the association rates of the 4-4-20 and 4M5.3 scFvs with antigen in
the 0.5 to 240 second range. Non-linear regression of the fluorescein-biotin quenching
curves was consistent with single, concentration-independent association rate constants
for fluorescein-biotin binding by 4-4-20 or 4M5.3 (Figure A2.2). The association rates
for 4-4-20 and 4M5.3 were 3.3(+0.3)x107 M - ' s- and 3.8(±0.3)x106 M-l s- 1 for 4-4-20
and 4M5.3, respectively. These rates were quantitatively consistent with those previously
reported for soluble 4-4-20 and 4M5.3 binding (7), and are also in agreement with the
association kinetics for 4-4-20 determined on the surface of yeast (data not shown). The
kinetic traces shown in Figure A2.2 are well fit by a single rate constant, and therefore
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provide no evidence for substantial population of an encounter complex, or the existence
of induced fit or conformational selection. This is consistent with the equivalence
between the equilibrium affinity constant and the ratio of kinetic rate constants.
In order to parse the binding free energy into enthalpic and entropic components,
isothermal titration calorimetry (ITC) was used to measure binding enthalpy. The change
of enthalpy on binding fluorescein-biotin (AHbinding) for 4-4-20 and 4M5.3 were found to
be -10.2(±0.3) kcal/mol and -14.2(+0.1) kcal/mol at 25 oC, respectively (Figure A2.3).
The binding interactions for both 4-4-20 and 4M5.3 were enthalpically and entropically
favorable at 25 oC. The AAHbinding between 4-4-20 and 4M5.3 was -4.0(±0.3) kcal/mol of
the total -4.5(±0.1) kcal/mol of the AAGbinding. The binding free energy change is,
therefore, primarily enthalpic with only -10% attributable to the entropic component of
binding (A(-TAS)). This largely enthalpic change in 4M5.3 fluorescein-binding
energetics could suggest improved 4M5.3/fluorescein contacts via electrostatics,
hydrogen bonds, and/or van der Waals interactions.
Differential scanning calorimetry was performed on the 4-4-20 and 4M5.3 scFvs
with and without ligand. The higher affinity 4M5.3 scFv had a slightly lower melting
temperature of 49.2(+0.1) oC without ligand present, compared to a 53.0(+0.1) 'C
melting temperature for the 4-4-20 without ligand (data not shown). The fluorescein-
bound scFvs both possessed higher melting temperatures but retained the pattern of the
high affinity clone possessing the lower melting temperature; 64.8(±0.4) ' C for the
4M5.3 bound complex compared to 65.8(+0.3) 'C for the 4-4-20 bound complex melting
temperature. It would be formally possible to convert these changes in Tm to AG of
binding; however, this would require reversibility of the traces and the evaluation of ACp
for the binding reaction as well as for at least one of the unfolding reactions, since the
melting temperatures of the complexes also occur at different temperatures. Determining
ACp by performing ITC at various temperatures is a fairly arduous procedure complicated
somewhat by the narrow temperature range of folding stability for these scFvs.
ScFv structural comparison
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The 4M5.3 scFv was crystallized in complex with fluorescein and the structure
was solved by molecular replacement using the previously solved 1.85 A resolution Fv
portion of the 4-4-20 Fab fluorescein-bound structure (24). The final model had an R
value of 16.48 and an Rfree of 19.29 solved to 1.5 A resolution (Table A2.1). The 4M5.3
structure contained 231 amino acid residues, including all of the light and heavy chain
residues, but excluding most of the linker between the light and heavy chains, and the
Flag epitope tag peptide at the N-terminal end. When the structures of the 4-4-20 Fv
domains and the 4M5.3 scFv structure were aligned by their backbone atoms, the RMS
difference was 0.60 A, and with alignment by only the C" atoms, the RMSD was 0.57 A.
No large differences were seen in alignment of 4-4-20 Fab and 4M5.3 scFv structures
(Figure A2.4A); however, on the side opposite the binding site there is evidence of a
heavy chain loop (residues H40-H44) packing differently in 4M5.3 than in 4-4-20. This
is most likely due to the removal of the constant portion of the Fab in the 4M5.3
structure. The variable light (heavy) chain domains aligned with a backbone RMSD of
0.46(0.92) A, which indicates greater rearrangement of variable heavy chain structure
(the heavy chain contains a greater share of the mutations).
The 14 mutations in 4M5.3 are distributed throughout the scFv structure with
eight mutations located in the complementarity determining regions (CDRs) and six in
the framework regions (Figure A2.4B). Two of the mutations are in the light chain while
12 are in the heavy chain. Three of the mutations (AspH31His, SerH101Ala, and
TyrH102Ser) are within 5 A (first contact shell) of fluorescein, four mutations
(AspHIGly, SerH30Gly, IleH51Phe, and AspH106Glu) are in the second contact shell,
and an additional three mutations (PheL60Val, AlaH24Thr, and TrpH108Leu) are in the
third contact shell surrounding the fluorescein. The final four mutations are well outside
of these ligand contact shells (SerL81Asn, ArgHl6Gly, ProH17Ala, and MetH93Thr)
and are all surface-exposed residues.
The interaction of fluorescein in the binding pocket of 4-4-20 has been previously
observed in two crystal structures of the 4-4-20 Fab complex (4FAB and IFLR) (24, 30).
These show the binding pocket to be a relatively deep slot formed by a network of
tryptophan and tyrosine side-chains, with the fluorescein participating in a network of
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electrostatic interactions. The planar xanthonyl ring of the hapten is accommodated at the
bottom of the slot while the phenylcarboxyl group is exposed to the solvent.
The binding site remains very similar in the 4M5.3 structure compared to the 4-4-20 Fab
(Figure A2.5). The 4-4-20 fluorescein-binding slot is surrounded by four tyrosine
residues (L37, H56, H102 and H103) and two tryptophan residues (L101 and H33)
(Figure A2.5A). Of these aromatic residues, only H102 was mutated in 4M5.3 (to a
serine). There is also an extensive hydrogen-bonding network in the binding pocket. The
five hydrogen bonds formed with fluorescein in the 4-4-20 Fab remain in the 4M5.3
structure (Figure A2.5B). Four of these polar interactions become slightly closer, but one
is lengthened in the 4M5.3 structure (Figure A2.5C). The very small differences in
hydrogen-bonding distances (one or two tenths of an angstrOm unit) could very well be
insignificant, given the different sources and space groups of the two structures.
From the structural alignment there appears to be a slight movement of the 4M5.3
residues toward the ligand. In order to quantify this, we tabulated the differences between
the distance from the closest atom of each CDR residue to the closest atom of fluorescein
in 4M5.3 compared to 4-4-20 (Figure A2.6). By this measure the majority of CDR
residues are closer to the fluorescein ligand in the 4M5.3 structure. However, most df
these changes are small, and individual refinement parameter differences or
crystallization conditions between the two structures may account for some of the
differences observed. All 11 residues that are greater than 0.5 A closer to the fluorescein
(four in VL and seven in VH) are at positions that are not within 5 A contact. Three of the
four residues that moved greater than 1 A (VL61Ser, VH65Ser, and VH67Lys) are surface-
exposed side-chains. The fourth residue is a site of mutation, PheVL60Val, and the new
valine beta-branch adds a methyl group for the closer approach to the fluorescein,
although the distance only reaches about 12 A. Six of the CDR residues in 4M5.3
contained mutations from the 4-4-20 structure and of these locations only the VL6 0
position moved more than 0.5 A closer to the ligand. Furthermore, the mutated residues
did not always move toward the ligand. Notably, the mutated residue SerVH102Tyr
moved further from the ligand in 4M5.3 by almost 0.5 A. Nevertheless, the general trend
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of residues within 5 A contact of the fluorescein is a slight movement of 4M5.3 toward
the fluorescein.
Another measure of the close packing can be obtained from the relative change in
solvent-accessible surface area upon binding. The measure of the change in solvent-
accessible surface area (ASAS) between the structures with and without fluorescein (rigid
binding) yields 24 A2 less solvent-accessible surface area lost in the 4M5.3 structure
compared with the 4-4-20 structure (Table A2.2). The change is slightly more localized
to the VL domain interface with the fluorescein, with a contribution of 15 A2, compared
with a contribution of 9 A2 for the VH domain interface with fluorescein. This reduced
loss of solvent-accessible surface area for 4M5.3 is due, in net terms, to polar residues
(25 A2), with 1 A2 gained from non-polar residues. Essentially, the 4-4-20 complex buries
more polar residue surface area than the higher affinity 4M5.3 complex, which suggests
that some form of electrostatic undercompensation may be operating in the 4-4-20
complex.
Shape complementarity (Sc) is a measure of the geometric shape matching
between two molecular surfaces (31). Values range from 0 to 1.0, where a value of 1.0
describes an interface with perfect geometric fit. The shape complementarity was
calculated for the crystal structures of both 4-4-20 and 4M5.3 with fluorescein (Table
A2.2) and indicates negligible change in the overall complementarity between the scFvs
and fluorescein. The shape complementarity of VL with fluorescein remains the same
between 4-4-20 and 4M5.3 while the shape complementarity of VH with fluorescein is
slightly less in 4M5.3. However, when the shape complementarity measure is applied to
the interface between the VH and VL domains, there is a larger difference between 4-4-20
and 4M5.3. The 4M5.3 has higher shape complementarity between the two domains than
4-4-20.
Electrostatic contributions to binding
The role of improved electrostatic interactions was investigated through
continuum electrostatic binding calculations on the two prepared, unminimized crystal
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structures. The overall electrostatic contribution to binding computed by this model is
summarized in Table A2.3a. An overall improvement of -3.5 kcal/mol for binding 4M5.3
was computed due to improved interactions with fluorescein (-5.7 kcal/mol) despite
increased desolvation penalty for the fluorescein (1.8 kcal/mol). Interestingly, the
antibody desolvation cost was very similar for both complexes and in neither case was
the full cost of desolvating the binding partners recovered in intermolecular interactions.
These energetic calculations of desolvation are in contrast to the simple solvent-
accessible surface area measurements. To further understand these results, the
-3.5 kcal/mol total electrostatic affinity difference was dissected into individual
"components". A separate component for each backbone amino (C"-N-H), each
backbone carbonyl (C=O), and each side-chain group beyond Ca was computed, and
each component was divided into desolvation (changed interactions with solvent due to
binding) and interaction components (new interactions made intermolecularly with the
binding partner in the complex). The components provide additive contributions to the
computed difference in binding affinity. This type of dissection is possible in a strictly
additive manner because of the superposition properties of the linearized Poisson-
Boltzmann equation. Table A3.3B shows the difference of component analyses between
the two crystal structures; a negative (positive) value corresponds to a contribution
towards improvement (reduction) for 4M5.3 binding relative to 4-4-20. The scFv
components are ranked by the metric SumAbs, given by equation (1), which gives a
measure of the sum of the unsigned difference of the contributions for each component:
Gt&n*?0* - - 000--0R1
+ - l
DOE*represents the desolvation penalty for component i in complex X, and
i"1represents the interaction free energy between the atoms in component i and the
atoms in componentj in complex X. Three of the top four components and four of the top
20 components, ranked by this difference metric, are 4M5.3 side-chain mutations. The
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direct role of the 14 mutations together was calculated by summing together the
components involving the 14 mutated side-chains, which revealed a total of
-1.1 kcal/mol (Table A2.3C). Four side-chains dominate this value. The remaining
-2.4 kcal/mol in computed electrostatic improvement is the result of secondary effects
resulting from the mutated residues (e.g. altering the binding conformation of fluorescein
in the site). Three components dominate this -2.4 kcal/mol, His L31, Arg L39, and Ser
L96, and were previously identified in Figure A2.5C, which identified hydrogen bond
distance differences.
Because the results of this analysis produced significant free energy differences
that were the sum of quite small values from individual changed interactions, further
calculations were performed to investigate sensitivities to precise crystal structure atomic
locations. The electrostatic component analyses were repeated on 4-4-20 and 4M5.3
crystal structures each subjected to a constrained minimization (see Materials and
Methods). Table A2.4 summarizes the effects of minimization on electrostatic
calculations. The net improvement decreased from -3.5 kcal/mol down to -1.3 kcal/mol.
Analysis of the effects of the minimization on the component analyses reveals that
changes in three interaction differences account for most of the net change. His L31, Arg
L39, and Ser L96, the same three residues identified above as having shortened hydrogen
bond lengths and a large role in the 4M5.3 improvement, are no longer calculated to be as
different between 4-4-20 and 4M5.3 when using the minimized structures. The small
changes in the hydrogen bond distances due to the minimization result in relatively large
changes in the interaction differences. On the other hand, the contribution of the 14
mutated side-chain components after minimization is predominantly unchanged, still
totaling -1.1 kcal/mol. Thus, the calculations suggest that the subtle structural differences
between the crystal structures ("secondary effects") appear to coalesce during
minimization and may not be real, but the direct computed effects appear robust to small
structural changes.
Four residues of the 14 mutations account for almost all of the electrostatic
differences in Table 3C: H31 Asp/His, H101 Ser/Ala, H102 Tyr/Ser, and H106 Asp/Glu.
Examination of the 4-4-20 and 4M5.3 structures together with the electrostatic results
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reveals several mechanistic hypotheses for 4M5.3 improved binding affinity. These
mechanisms are outlined in Discussion. Here, we simply refer to Figure A2.7, which
illustrates the desolvation and interaction differences of these four residues in a spatial
diagram, and Figure A2.8, which shows structural details of these residue-interactions in
the 4-4-20 and 4M5.3 complexes.
Discussion
The entropic and enthalpic components of protein-ligand binding free energy
include: (1) covalent, van der Waals, hydrogen-bonding, and electrostatic interactions
within and between protein and ligand; (2) solvation effects, including desolvation costs
and the hydrophobic effect; and (3) overall translational and rotational, as well as internal
(often represented as vibrational) degrees of freedom within the protein and ligand. It
remains unclear how best to create substantial enhancements in binding affinity through
structural changes that have multiple effects on free energetic contributions to binding.
Here, we have analyzed the difference between a wild-type and mutant (evolved)
complex to understand how affinity enhancements are arrived at in evolved systems. The
results shown here exemplify the complex situation of a large number of small structural
changes resulting in a large energetic effect.
The 4M5.3 affinity matured scFv has an 1800-fold higher affinity than its wild-
type 4-4-20 parent with a difference in the change in free energy of binding (AAGbinding)
of -4.5 kcal/mol between the 4-4-20 and 4M5.3 scFvs. The primary contribution to the
AAGbinding is enthalpic, -4.0 kcal/mol of the -4.5 kcal/mol. The small entropic
contribution to the change in free energy of binding, combined with the lack of an
observation of two-step association kinetics, suggests that the single-step binding model
has not changed in the affinity maturation and remains a lock-and-key fit. This is in
contrast to several previously studied lower affinity antibody maturations, where
improvement was observed to be derived primarily from entropic factors and an induced
fit in the wild-type to a lock and key model in the affinity matured mechanism was
implicated from studies of bound and unbound structures (14, 16, 17).
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Enthalpic and entropic changes in binding free energy often compensate for each
other and lessen the possible overall gain in affinity in improved binding interactions (32,
33). In 4M5.3, both the enthalpic and entropic changes were favorable, with the
enthalpic contribution (AAH) providing the majority of the change. A major component
of entropic change is often contributed by solvent molecules fixed at, or liberated from,
non-polar surfaces. Five buried water molecules are present near the fluorescein-binding
pocket between the VL and VH domains and one additional water molecule is partly
buried in the surface-exposed portion of the binding pocket in 4-4-20 and 4M5.3. Each of
these six water molecules is in a corresponding location and each makes similar
interactions in 4-4-20 and 4M5.3. The minimal change in entropic contribution to
AAGbind in the mutant structure is supported by the lack of visible changes in the bound
water locations.
The enthalpic change in binding for 4M5.3 over 4-4-20 is consistent with
improved van der Waals interactions, hydrogen bonds, and electrostatic interactions
between 4M5.3 and fluorescein. However, the crystallographic snapshot shows no large
spatial changes between the 4-4-20 and 4M5.3 complexes. The majority of the CDR
residues are closer to fluorescein in 4M5.3; however, the changes are all very small, with
most below 0.5 A. Individual changes of this magnitude may not be statistically
significant; however, the overall trend shows that 50/63 of the differences shown in
Figure 6 are negative. This fraction is different from 50% with confidence p<3x10 -6,
considering each difference as an independent binomial trial. The sum of these small
changes may provide a significant addition to the enthalpic component through small
favorable changes.
Thermal B values are sometimes interpreted as providing information on relative
mobility between related crystal structures. In the 4M5.3 structure the apparent motions
are of more similar magnitude across VH and VL than in 4-4-20, where the B factors vary
substantially between the two domains. In the 4-4-20 structure the VH domain has 38%
higher average B-values compared to the VL domain, while in the 4M5.3 structure, the
VH domain has average B-values only 13% higher than the VL domain (data not shown).
It is interesting that most of the mutations, 12 of the 14, were in the VH domain, which is
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the domain that has the higher B-values in the 4-4-20 structure, and that after these
mutations, both domains have similar B-value averages. This result could be simply due
to the differences in crystal lattice packing between the 4-4-20 and 4M5.3 crystal space
groups (P1 versus P212121, respectively); however, a different, consistent theory is that
rigidification of VH due to the mutations in 4M5.3 allows greater time-averaged contacts
with fluorescein, thereby decreasing the mobility in the 4M5.3 VH compared to 4-4-20.
Shape complementarity is considered important in high affinity binding.
However, in this study, and in agreement with a recent study of protein-antibody
interactions, shape complementarity did not significantly improve between the wild-type
and higher affinity antibody-ligand binding interaction (13). The shape complementarity
did improve between the Fv domains (VH and VL domains) in our study. The mechanism
of antigen binding affinity modified by VL and VH domain interactions has been proposed
to occur by changing the relative positions of the CDR loops (34). Although in this study
the shape complementarity of the VL and VH improved in 4M5.3, no noticeable shift of
the domains was observed.
The higher shape complementarity of the Fv domains did not produce an
increased melting temperature in 4M5.3. The wild-type 4-4-20 was more thermally stable
than the high affinity 4M5.3 in both the bound and unbound states. The melting
temperature data are consistent with 4M5.3 destabilizing the unbound antibody at a cost
of only slightly destabilizing the complex. It remains interesting to determine the effect of
the four mutations that fall at the VL-VH interface in this study and their importance in
both the VL-VH shape complementarity, stability, and antigen affinity contributions.
The effect of non-covalent interactions on binding was examined by comparing
solvent-accessible surface (SAS) area in the presence and absence of fluorescein in the 4-
4-20 and 4M5.3 complexes. This shows that the ASAS area has decreased slightly in
4M5.3, relative to 4-4-20, suggestive of a better fit. However, this better fit was not
illustrated through the shape complementarity parameter. The change also did not
correspond to a change in the calculated desolvation penalty between 4-4-20 and 4M5.3,
suggesting that the small decrease in polar amino acid residue surface area buried is not
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playing a significant role in the improved affinity of 4M5.3. Aromatic-aromatic
interactions are known to contribute to specific, energetically favorable interactions (35).
Since several tyrosine residues and tryptophan residues surround the aromatic rings of
fluorescein, these interactions were considered as possible components of the 4M5.3
improved binding interactions. An ideal aromatic-aromatic interaction has been defined
as occurring in pairs of phenyl ring centroid separations greater than 4.5 A and less than
7 A with dihedral angles of 300 to 900. They are suggested to provide between
-0.6 kcal/mol and -1.3 kcal/mol. Again, however, only small changes are seen in the
aromatic ring positions surrounding the fluorescein in 4M5.3, and it is unclear whether
any would be more favorable than in 4-4-20. Additionally, amino-aromatic interactions
are possible with the aromatic rings of the fluorescein and the amino groups of nearby
residues (36). This interaction could be possible with amino groups of lysine, arginine,
glutamine, or histidine when within 6 A of the fluorescein ring centroid, making van der
Waals contact with the 8(-) a-electrons while avoiding the 8(+) ring edge. However, the
nearby histidine and arginine residues are in hydrogen-bonding interactions with the
fluorescein and do not appear to be involved in these possible amino-aromatic
interactions.
Electrostatic components of the binding free energy were calculated using crystal
structure snapshots and the framework of a rigid binding model with continuum solvent.
Calculations on the two crystal structures revealed -3.5 kcal/mol in favor of 4M5.3,
though subsequent analysis revealed that hydrogen bonds between fluorescein and the
conserved residues Arg L39, Ser L96, and His L31 account for much of the -3.5 kcal/mol
improvement and are highly sensitive to precise atomic locations. At the same time,
however, four of the mutated residues dominated -1.1 kcal/mol of the binding affinity
improvement, regardless of whether the structures used for analysis had been subjected to
the constrained minimization. It is possible, but still uncertain, that mutations in 4M5.3
are responsible for small structural changes in conserved residues that improve binding to
fluorescein. On the other hand, the four residues identified for a calculated -1.1 kcal/mol
improvement reveal several specific mechanisms for mutated residues in the affinity
maturation.
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A diagram of the calculated differences between 4-4-20 and 4M5.3 in electrostatic
components of binding is presented in Figure A2.7. Besides the three interaction
differences from the three sensitive residues discussed above, seven out of the nine
significant energetic changes (values in red) are associated with one or more of the four
mutated residues H31, H101, H102, or H106. H31 and H102 are not coupled to other
mutations while H101 and H106 are coupled by the significant change in indirect
interaction between them, an initial suggestion for cooperativity. Improvements are found
in all three terms of the electrostatic binding free energy: direct interactions (e.g. a
hydrogen bond between the scFv and fluorescein), indirect interactions (e.g. a hydrogen
bond within the scFv that is buried upon binding and hence strengthened due to loss of
solvent-screening), and desolvation (i.e. the penalty paid by a polar group for leaving its
unbound, aqueous environment and entering a buried environment upon binding).
Binding affinity improvements can be the result of either the introduction/strengthening
of a favorable interaction, the removal/weakening of an unfavorable interaction, or the
reduction of a desolvation penalty.
Figure A2.8A and A2.8B show the local environment of the mutated sites H101,
H106, and H108. H108 was not indicated by the electrostatic analysis for binding free
energy, although the position is part of an scFv intramolecular hydrogen-bonding
network that includes H101 and H106. Integrating the quantitative calculations in Table
3c with the structures shows the following mechanisms for enhanced affinity. The H101
serine to alanine mutation eliminates the unsatisfied hydroxyl oxygen, removing a small
desolvation penalty, yet loses the favorable indirect interaction from the H106 aspartate
hydrogen bond (mutated to glutamate), for a net favorable effect. This effect is captured
in the context of the other 13 mutations, but this analysis does not preclude the possibility
of it also being present in a single mutant (although some interaction with the mutation at
H106 is likely). The H106 aspartate to glutamate mutation reduces the residue
desolvation penalty by burying the negative charge further into the protein, but more
notably facilitates the serine to alanine mutation by maintaining a clear intramolecular
hydrogen-bonding network. Either the H101 serine or the H106 aspartate mutation alone
might disrupt antibody stability (work in progress, S.M.L. & B.T.). Likewise, the H108
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tryptophan to leucine mutation in the bordering region with two bound water molecules
may be coupled to the H101 and H106 mutations via hydrogen bonds.
Figure A2.8c and A2.8d shows the local environments of H31 and H102. The
mutation at H102 from tyrosine to serine creates a new intramolecular hydrogen bond to
the backbone carbonyl group at residue H31. This hydrogen bond is buried and
strengthened upon binding and appears as the -0.73 kcal/mol term in Figure A2.7.
Though the hydrogen bond is to residue H31, it is to the backbone and therefore the
independence from the side-chain of H31 makes it a distinct mechanism from the actual
mutation at H31. The aspartate to histidine mutation at H31 removes a negative charge,
which although solvent-exposed, was within 7 A of the -2 charged fluorescein.
Therefore, this mutation is calculated to improve the direct interaction by eliminating a
long-range electrostatic repulsion (-0.3 kcal/mol).
The electrostatic calculations indicate four of the 14 mutations for a role in the
affinity improvement. Mechanisms discovered include the removal of an unsatisfied
hydrogen-bonding group (H101 Ser/Ala), reduction of desolvation penalty (H106
Asp/Glu), creation of an intramolecular hydrogen bond for an indirect effect (H102
Tyr/Ser), and removal of long-range charge repulsion (H31 Asp/His). Other hypothesized
mechanisms include the maintenance of a well-ordered intramolecular scFv hydrogen-
bonding network.
The 4-4-20 and 4M5.3 structures used for computational analysis were prepared
to minimize bias from inherent crystal structure differences; however, a few differences
remain between the structures used for computational analysis and the scFvs used in the
binding experiments. The N-terminal residue of the heavy chain in 4-4-20 is a glutamate
in all experiments but the crystal structure contains an aspartate at this position (24). This
discrepancy is most likely minimal, since both side-chains are charged -1, solvent-
exposed, and about 20 A from the fluorescein. Second, the fluorescein used in all binding
experiments was biotinylated at the 5-carbon position of fluorescein, which points out of
the binding site, whereas both crystal structures were obtained with neat fluorescein. A
concern is whether the 4M5.3 mutations enhance binding affinity through interaction
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with atoms present only in the biotinylation. Two of the mutated residues, H31 Asp/His
and H102 Tyr/Ser are within at least 5 A of the beginning of the biotinylation, a thiourea
group with hydrogen-bonding capabilities. Experiments to indicate the extent of the
importance of the linker in the binding interaction have not yet been successful.
The results summarized here do not definitively elucidate the mechanism for the
full 1800-fold affinity improvement of 4M5.3. The largest change in the enthalpic
contribution to the binding in 4M5.3 is attributed to improved electrostatics. A lack of
visible changes in the structural comparison with a large change of affinity is not
unprecedented. In a structural study of the four binding-site tryptophan residues in the
streptavidin-biotin complex, where the affinity for biotin dropped up to 107-fold with a
Trp to Ala mutation at any of these sites, the crystal structures showed no major changes
in the binding mode for biotin compared to the wild-type streptavidin (1). In a study of
the Fv fragment of the D1.3 anti-hen egg-white lysozyme antibody, a single change in the
VL92 site from tryptophan to phenylalanine, aspartate, histidine, serine, or valine created
a drop in affinity of ten- to 100-fold with no significant shifts in the positions of the
protein atoms at the mutation site (37, 38). Although it remains difficult to attach
structural parameterization to the binding enthalpy, recent work by Luque & Freire (39)
suggested that at least the following three terms are needed to account for the structural
parameterization of binding enthalpy of small ligands: (1) the interactions between the
ligand, antibody, and solvent; (2) changes in conformations within the antibody or ligand
upon binding; and/or (3) protonation/deprotonation events in binding. Most of the effort
here has been placed on studying the intrinsic enthalpy from the binding between the
ligand and antibody. Preliminary calorimetry data suggests that the protonation effects on
binding are the same between 4-4-20 and 4M5.3 (data not shown). Changes in
conformations within the 4-4-20 and 4M53 on binding have thus far been difficult to
study but may hold more information about this affinity maturation mechanism.
It would also be of interest to observe the unbound structures of both scFvs.
However, perhaps notably, we were not able to crystallize either the 4-4-20 or 4M5.3
scFv in the absence of ligand. In a study of the 4-4-20 and 4M5.3 scFvs on a size-
exclusion gel-filtration column (Superdex 200), 4-4-20 scFv eluted as expected at the
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predicted molecular mass of .. 30 kDa (data not shown), while the 4M5.3 scFv eluted
much later with a standard of 17 kDa. However, in dynamic light-scattering studies, both
unbound scFv proteins had a radius of 2.55 nm, indicating the same globular size (data
not shown). The results from size-exclusion chromatography nevertheless indicate that
the 4M5.3 unbound structure is interacting differently with the column material than the
unbound 4-4-20, although not in direct correlation with the protein radius by
crystallography or light-scattering.
The studies presented here add insight into high affinity binding mechanisms. By
studying improvements to a protein that began with high affinity, we are addressing the
mechanisms that are most important in fine-tuning the subtle aspects of affinity. In
studying a protein that was developed by a random mutagenesis approach, we may be
exposing binding mechanisms important to affinity that may rarely be identified by site-
directed loss-of-function approaches or from studying only a bound and unbound form of
a single protein. Since the binding affinity improvement of 4M5.3 does not appear to be
attributable to any single large change in structure, hydrogen bonds, or salt bridges, this
1800-fold improved interaction would be difficult to predict computationally at this time.
This interaction is an example of a binding improvement formed through the interaction
of a variety of interactions and the sum of many small changes. Future experimental
studies to dissect the energetic contributions of the individual mutations and specific
combinations should prove interesting in the understanding of which mutations are
contributing to this very high affinity 4M5.3 mutant antibody.
Protein Data Bank accession code
The atomic coordinates for the complex of fluorescein with the 4M5.3 scFv have
been deposited with the Protein Data Bank under accession code 1X9Q.
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Table A2.1: Crystallographic data statistics
A. Data collection statistics
Space group P212121
Unit cell (A) a=55.78 b=57.45 c=79.22
Wavelength (A) 0.9840
Resolution (A) 50-1.50
Rsym and _ (%) 3.0 (38.2)
Total observations 257,289
Unique reflections 40,648
Avg. redundancy 7.0
(_i/) 56.8 (3.46)
Completeness - (%) 98.8 (97.4)
B. Refinement statistics
Resolution (A) 28.75-1.50
Reflections (working/test) 40,648/4049
Rcryst/Rfree (%) 16.48/19.29
Residues 231
Total protein atoms 2113
Total ligand atoms 81
Total solvent atoms 233
Disordered side-chains 11
Alternate conformations 21
RMS deviation
Bond lengths (A) 0.013
Bond angles (deg.) 1.448
Ramachandran analysis (%)
Most-favored 176 (92.1)
Allowed 14 (7.3)
Disallowed 1 (0.6)
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a ( ~J ~ - ((liaf ir I h' for n independent reflections and i
observations of a given reflection. 'J(hkl)/, average intensity of ith observation.
b Numbers for the highest resolution shell are shown in parentheses.
c r E ~ I kI - LF )  Fh], where Fo and F, are the observed and calculated
structure factors, respectively. Rfrec was calculated using the same equation, and included a test set of
reflections that were not used during refinement.
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Table A2.2: Characteristics of antibody-fluorescein complexes
Perturbations in a
Shape complementarity (Sc) is a measure of the geometric shape matching between two
molecular surfaces.31 Values range from 0 to 1.0, where a value of 1.0 describes an
interface with perfect geometric fit. The shape complementarity was calculated for the
crystal structures of both 4-4-20 and 4M5.3 with fluorescein (Table 2) and indicates
negligible change in the overall complementarity between the scFvs and fluorescein. The
shape complementarity of VL with fluorescein remains the same between 4-4-20 and
4M5.3 while the shape complementarity of VH with fluorescein is slightly less in 4M5.3.
However, when the shape complementarity measure is applied to the interface between
the VH and VL domains, there is a larger difference between 4-4-20 and 4M5.3. The
4M5.3 has higher shape complementarity between the two domains than 4-4-20.
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A. Solvent-accessible surface area (SAS) (A2)
4-4-20 4M5.3 A
ASAS (scFv&Flu-scFv) -284 -260 24
ASAS (VL&Flu-VL) -109 -94 15
ASAS (VH&Flu-VH) -175 -166 9
ASAS polar residues -217 -192 25
ASAS apolar residues -67 -68 -1
ASAS VL, polar residues -101 -90 11
ASAS VL, apolar residues -8 -4 4
ASAS VH, polar residues -116 -102 14
ASAS VH, apolar residues -59 -64 -5
B. Shape complementarity 4-4-20 4M5.3
(VL & VH) versus Flu 0.812 0.808
VL versus VH 0.640 0.710
VL versus Flu 0.820 0.815
VH versus Flu 0.792 0.756
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Table A2.3: Comparison of computed electrostatic contributions to binding in 4-4-20 and
4M5.3
A. Computed total electrostatic contributions to binding, (C' -N -" , in kcal/mol
4-4-20
4M5.3
4M5.3-4-4-20
scFv desolvation
14.36
14.68
0.32
Fluorescein desolvation
14.80
16.64
1.84
B. Electrostatic components of the difference, 4M5.3-4-4-20, in kcal/mol
Component Desolv.a IndirectO DirectI Contrib.d  Mut.s SumAbs
Fluorescein 1.84 N.A. -5.65 -0.98 -3.81
L 39 Arg 0.01 1.24 -1.45 -0.09 -0.20 6.57
H 106 Asp/Glu -0.33 0.11 -0.13 -0.34 -0.35 4.50
H 101 Ser/Alal -0.11 0.38 -0.79 -0.31 -0.52 4.01
H 102 Tyr/Ser_ 0.68 -0.51 -0.46 0.19 -0.29 3.59
H 105 carbonyl -0.32 0.28 -0.16 -0.26 -0.20 3.13
W615 water 0.04 0.42 -0.85 -0.18 -0.40 2.53
H31 carbonyl 0.21 -0.95 0.24 -0.15 -0.50 2.36
H 102 amino -0.21 0.13 0.15 -0.07 0.07 2.18
H 101 carbonyl -0.04 -0.17 0.14 -0.05 -0.07 2.15
L 31 His -0.15 -0.30 -0.47 -0.53 -0.91 I1.85
H 74 Arg 0.05 0.21 -0.18 0.07 0.08 1.68
H 102 carbonyl -0.07 0.15 0.10 0.06 0.19 1.64
L 96 Ser -0.02 0.15 -0.76 -0.32 -0.63 11.64
H 104 amino -0.04 0.01 10.28 0.11 0.26 11.55
H 53 Asn 10.27 -0.46 0.11 0.10 -0.07 1.52
H 52 Arg -0.01 0.15 T -0.12 10.00 10.01 1.46
H 103 carbonyl -0.01 -0.00 -0.23 -0.12 -0.24 1.31
H 31 Asp/His 1 -0.01 -0.04 -0.29 -0.18 -0.34 1.20
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Interaction
-19.97
-25.62
-5.65
Net binding
9.20
5.70
-3.50
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A. Computed total electrostatic contributions to binding, C' - , in kcal/mol
scFv desolvation Fluorescein desolvation Interaction Net binding
H 104 carbonyl -0.06 0.17 -0.27 -0.11
H 103 amino -0.04 0.09 1-0.04 -0.01
-0.16 1.19
0.02 1.17
All values are the differences between analyses on 4M5.3 and 4-4-20. Negative (positive)
values indicate an improvement (reduction) for 4M5.3.
a Desolvation penalty.
b Sum of indirect interactions with all other scFv components.
C Direct interaction between scFv component(s) and fluorescein.
d Contribution=desolvation+(1/2)indirect+(1/2)direct.
e Mutation=desolvation+indirect+direct.
f SumAbs, sum of the absolute value of desolvation and all interaction terms.
g Site of 4M5.3 mutation.
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Table A2.4: Effect of crystal structure minimizations on electrostatic analyses
A. Computed net electrostatics of binding,
W Q, using minimized structures (kcal/mol)
4-4-20
4M5.3
4M5.3-4-4-20
scFv desolvation
14.39
14.66
0.27
Fluorescein
desolvation
14.28
16.62
2.34
B. The largest component-component
interaction changes as a result of
minimization
Specific Change in strength
interaction (kcal/mol)
L 39 Arg- +0.575
fluorescein
L 96 Ser-
+0.548fluorescein
L 31 His-
+0.531fluorescein
C. Net electrostatic impact of the mutated side-chain components after minimization
Desolv. Ind. In Ind. out Direct
Total 0.29 
-0.29 0.27 -1.42
Total
-1.14
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Interaction
-21.57
-25.45
-3.87
Net
binding
7.11
5.84
-1.27
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Table A2.5:
For the mutations of L60 Phe/Val, L81 Ser/Asn, H16 Arg/Gly, H17 Pro/Ala, H24
Ala/Thr, H30 Ser/Gly, and H93 Met/Thr, each of the individual five electrostatic values
(in columns in part A) are <0.01 in magnitude, and these rows are left out of the Table.
All values are the differences between analyses on 4M5.3 and 4-4-20. Negative (positive)
values indicate an improvement (reduction) for 4M5.3.
a Desolvation penalty.
b Half sum of indirect interactions with the 13 other mutated side-chain components.
c Sum of indirect interactions with all but the 13 other mutated side-chain components.
d Direct interaction with fluorescein.
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C. Electrostatic impact of the mutated side-chain components
Component Desolv.1 Ind. ink Ind. outs Direct - Total
H 1 Glu/Gly 0.00 -0.01 0.03 -0.06 ]-0.03
H31 Asp/His -0.01 0.03 -0.09 -0.29 -0.37
H 51 Ile/Phe 0.00 0.00 0.02 -0.03 -0.02
H 101 Ser/Ala -0.11 -0.20 0.78 -0.79 -0.31
H 102 Tyr/Ser 0.68 0.03 -0.57 -0.46 -0.32
H106Asp/Glu -0.33 1-0.20 0.50 -0.13 -0.15
H 108 Trp/Leu 0.00 ]0.03 -0.13 0.18 0.08
TOTAL 0.23 -0.32 0.54 -1.58 -1.13
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Figure A2.1: Equilibrium binding constant for 4M5.3 by competition with 4-4-20. Four
replicates are shown: two starting from pre-incubation of 4M5.3 with fluorescein-biotin
(x and .), and two starting from pre-incubation with the 4-4-20 competitor with
fluorescein-biotin (a and .), as noted in Materials and Methods.
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Figure A2.2: Stopped-flow association rates. Fluorescein-biotin (5 nM) was mixed with
the specified concentrations of scFv. Curves were fit using koff determined previously and
solving for kon, using the Gepasi software; see Materials and Methods. (a) 4-4-20, (b)
4M5.3.
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Figure A2.3: Isothermal titration calorimetry of 4-4-20 and 4M5.3. Curves are fit to
determine AH; AG is determined from previously determined Kd; AS is calculated from
AG and AH. (a) 4-4-20, (b) 4M5.3.
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Figure A2.4: Comparison of 4-4-20 and 4M5.3 Fv domain structures. (a) Alignment of
4M5.3 and 4-4-20 crystal structures by protein backbone atoms. 4-4-20 is pink and
4M5.3 is blue. (b) The sequence of the 4-4-20 VL and VH domains. The 14 genetic
changes between 4-4-20 and 4M5.3 and their structural locations are noted.
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Figure A2.5: Comparison of 4-4-20 and 4M5.3 Fv domain crystal structures. Alignment
of 4M5.3 and 4-4-20 structures by protein backbone atoms. 4-4-20 is pink and 4M5.3 is
blue. (a) The hydrophobic fluorescein-binding pocket is lined with tyrosine and
tryptophan residues. (b) Hydrogen bonds with fluorescein. (c) Difference in distance (A)
of the five hydrogen bonds between scFv and fluorescein.
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Figure A2.6: Difference in distance of closest atom of each CDR residue to fluorescein
for the 4-4-20 and 4M5.3 structures. (a) Light chain CDR residues, (b) heavy chain CDR
residues. * Indicates a mutated position; c indicates residue within contact (<5 A) of the
fluorescein in the 4-4-20 and 4M5.3 structures; x indicates a residue within contact
(<5 A) of the fluorescein in only the 4M5.3 structure.
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Figure A2.7: Diagram of all major (>0.2 kcal/mol) electrostatic interaction and
desolvation penalty differences (4M5.3-4-4-20) among components in Table 3B. Arrows
connecting to fluorescein correspond to changes in direct interactions, whereas arrows
connecting scFv components correspond to changes in indirect interactions, and changes
in desolvation penalties are shown in parentheses. The three interaction differences
marked with * are those which dramatically decrease (become more positive) with
minimization. All other values <-0.25 kcal/mol are shown in red. Mutated side-chains
(four) are labeled in blue.
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Figure A2.8: Two regions of the binding site that include the four residues identified by
the electrostatic analysis. First, the region of H101 and H 106 together with neighboring
hydrogen-bonding residues L39, L41, and H108 are shown in (a) and (b) for 4-4-20 and
4M5.3, respectively. Second, the region of H31 and H102 is similarly shown in (c) and
(d).
(a) (mh)
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